Endocrine Abstracts

Contents

• Prize Lectures and Biographical Notes
• • The European Journal of Endocrinology Prize Lecture
  • • Tackling obesity: lessons from genetics

      ea0029eje1
    • The European Journal of Endocrinology Prize Winner

      ea0029eje1biog
  • The Geoffrey Harris Prize Lecture
  • • Glucocorticoid metabolism and the brain, from fetal programming to senescence

      ea0029gh1
    • The Geoffrey Harris Prize Winner

      ea0029gh1biog
  • The Fondation IPSEN Prize Lecture
  • • Common Threads: Epigenetics, Metabolism and the Clock

      ea0029ifpl1
    • The Fondation IPSEN Prize Winner

      ea0029ifpl1biog
• Plenary Lectures
• • Red wine Endocrinology
  • • New insights into the roles of sirtuins in metabolic decline and disease of aging

      ea0029pl1
  • Testosterone more than sex
  • • Testosterone: more than sex

      ea0029pl2
  • Mating, sex and the immune system in humans and fish
  • • Mating, sex and the immune system in humans and fish.

      ea0029pl3
  • Lecture by Endocrine Society President
  • • Abstract unavailable

      ea0029pl4
  • Why your bones break - from childhood to old age
  • • Why your bones break: from childhood to old age

      ea0029pl5
  • Maternal nutrition, metabolism and fetal programming
  • • Abstract unavailable

      ea0029pl6
  • Diabetes as a gut disease
  • • Diabetes as a gut disease

      ea0029pl7
  • Novel molecular link between the circadian clock and hypertension
  • • Novel molecular link between the circadian clock and hypertension

      ea0029pl8
• Symposia
• • Molecular mechanisms of differentiated thyroid cancer
  • • Molecular consequences of deregulated RNA genes in papillary thyroid carcinoma

      ea0029s1.1
    • Correlation between the BRAF V600E mutation, TGF[beta] pathway and tumour invasiveness in papillary thyroid carcinomas

      ea0029s1.2
    • Abstract unavailable

      ea0029s1.3
  • 40 years of male hormonal contraception research and no product
  • • Abstract unavailable

      ea0029s2.1
    • Clinical trials in male hormonal contraception to date

      ea0029s2.2
    • Acceptability of male hormonal contraception by the pharmaceutical industry and by the consumer

      ea0029s2.3
  • Absolute fracture risk assessment with FRAX
  • • Abstract unavailable

      ea0029s3.1
    • Use of FRAX in Asian populations

      ea0029s3.2
    • Beyond FRAX[Ograve]

      ea0029s3.3
  • The gut nutrient sensing in energy metabolism
  • • Bile acid metabolism for the control of metabolic disease

      ea0029s4.1
    • Taste receptors in gut regulate endocrine function

      ea0029s4.2
    • Gut microbiome and energy metabolism: the concept of MicrObesity

      ea0029s4.3
  • Transition from paediatric to adult care - do we have progress?
  • • GH use in Prader-Willi syndrome (PWS): an evidence-based approach to a clinical practice guideline (CPG), on behalf of the GH Research Society (GRS) and Workshop Participants

      ea0029s5.1
    • Fertility options for adults with panhypopituitarism

      ea0029s5.2
    • Sex steroid replacement in young males and females

      ea0029s5.3
  • Subclinical adrenal diseases
  • • Diagnosis and treatment of subclinical Cushing's syndrome (SCS)

      ea0029s6.1
    • Abstract unavailable

      ea0029s6.2
    • Subclinical Addison's disease

      ea0029s6.3
  • Hormones, metabolism and cancer: more than coincidences?
  • • An epigenetic switch linking inflammation to cancer and the use of metformin as an anti-cancer drug

      ea0029s7.1
    • The insulin-like growth factor system and cancer: what are the implications?

      ea0029s7.2
    • Obesity and cancer

      ea0029s7.3
  • Global phenotypes of endocrine disease
  • • Abstract unavailable

      ea0029s8.1
    • Ethnic specific PCOS

      ea0029s8.2
    • Obesity and diabetes in Asian Indians

      ea0029s8.3
  • The risk and benefits of tight glycaemic control
  • • What do type 2 diabetes outcome trials tell us about the CV risks and benefits of intensive glycaemic control

      ea0029s9.1
    • Abstract unavailable

      ea0029s9.2
    • Time course of the glucose legacy effect

      ea0029s9.3
  • Thyroid: From fetal life to adulthood
  • • Placental transport of thyroid hormone

      ea0029s10.1
    • Abstract unavailable

      ea0029s10.2
    • Thyroid hormones and fetal neurological development

      ea0029s10.3
  • Novel genetic and endocrine insights in the Klinefelter's syndrome
  • • Klinefelter mouse (41XXY): model for human Klinefelter syndrome

      ea0029s11.1
    • Endocrine changes in KS and the effects on growth, bone and body composition

      ea0029s11.2
    • The Muenster EXAKT project: epigenetic regulation of the supernumerary X chromosome and its escapee genes

      ea0029s11.3
  • Determinants of peak bone mass
  • • Epidemiology of peak bone mass, structure and strength in males as assessed by high resolution peripheral quantitative CT (HR-pQCT). A cross-sectional study

      ea0029s12.1
    • The contribution of genetic factors to bone mass

      ea0029s12.2
    • Estrogens as regulators of bone growth and bone mass

      ea0029s12.3
  • Novel therapies for protecting beta cell function at diagnosis of type 1 diabetes
  • • Abstract unavailable

      ea0029s13.1
    • Abstract unavailable

      ea0029s13.2
    • Abstract unavailable

      ea0029s13.3
  • Wnt/Beta-catenin in pituitary development and disease
  • • [beta]-catenin deficiency disrupts patterning of the ventral diencephalon, causing adenohypophysis over growth and dysmorphology

      ea0029s14.1
    • Wnt/beta-catenin signalling in craniopharyngioma

      ea0029s14.2
    • Wnt signalling in oestrogen-induced lactotroph proliferation

      ea0029s14.3
  • Adrenal cancer
  • • Molecular pathogenesis of adrenocortical cancer

      ea0029s15.1
    • Imaging of adrenocortical cancer

      ea0029s15.2
    • Genetics of micronodular hyperplasias (associated with Cushing syndrome)

      ea0029s15.3
  • Understanding growth
  • • From Galton to GWAS (and beyond): what we have learned about the genetics of human height?

      ea0029s16.1
    • Genes and the investigation of idiopathic short stature (ISS): are we ready for prime time?

      ea0029s16.2
    • Abstract unavailable

      ea0029s16.3
  • Hormonal control of pregnancy
  • • Hormone signalling between mother and fetus

      ea0029s17.1
    • What controls labour in humans?

      ea0029s17.2
    • Placental hormones as putative markers of gestational diseases

      ea0029s17.3
  • Molecular mechanisms in autoimmune thyroid disease
  • • Predictors of relapse of Graves' disease after antithyroid drug withdrawal

      ea0029s18.1
    • Genotype-phenotype correlations in GD

      ea0029s18.2
    • Regulatory cells, Th17 lymphocytes, and dendritic cells in autoimmune thyroid disease

      ea0029s18.3
  • Controversies in testosterone replacement
  • • Abstract unavailable

      ea0029s19.1
    • Late onset hypogonadism: who should receive testosterone?

      ea0029s19.2
    • Testosterone for women: why when and how?

      ea0029s19.3
  • Signalling to and from osteoclast
  • • Efferent signalling by osteoclasts

      ea0029s20.1
    • Immune signaling in osoteoclasts

      ea0029s20.2
    • Coupling of bone resorption and formation

      ea0029s20.3
  • Obesity and reproduction
  • • Integrating hypothalamic regulation of energy homeostasis and reproduction

      ea0029s21.1
    • Impact of obesity on male reproduction

      ea0029s21.2
    • Lifestyle modification and fertility

      ea0029s21.3
  • Pituitary tumorigenesis
  • • Molecular mechanisms: the genes involved in pituitary tumorigenesis

      ea0029s22.1
    • Tracing back a Gene's influence

      ea0029s22.2
    • Abstract unavailable

      ea0029s22.3
  • Advances in regulation of aldosterone synthesis
  • • Regulation of aldosterone synthase expression in normal adrenal and primary aldosteronism

      ea0029s23.1
    • Extra-adrenal aldosterone biosynthesis

      ea0029s23.2
    • Role of N-type calcium channel blockers in aldosterone biosynthesis

      ea0029s23.3
  • ManagemDiabetes in children
  • • Abstract unavailable

      ea0029s24.1
    • Hypotheses explaining the increase in type 1 diabetes

      ea0029s24.2
    • Abstract unavailable

      ea0029s24.3
  • Reproductive hormone action
  • • GnRH receptor signalling

      ea0029s25.1
    • Light on the structural communication in gonadotropin hormone receptors: implications in genetic diseases

      ea0029s25.2
    • Extragonadal FSH action- facts and dreams

      ea0029s25.3
  • TSH Receptor
  • • Low molecular weight antagonists of the TSH receptor

      ea0029s26.1
    • Learning from how antibodies interact with the TSH receptor

      ea0029s26.2
    • Structure and function of TSH receptor

      ea0029s26.3
  • Are endogenous testosterone levels predictors of cardiovascular events?
  • • Androgen action on the cardiovascular system

      ea0029s27.1
    • Abstract unavailable

      ea0029s27.2
    • Endogenous androgens, diabetes, and cardiovascular disease in women: the Rancho Bernardo study

      ea0029s27.3
  • Osteoporosis treatment in 2012 and beyond
  • • Controversial issues with bisphosphonate treatment

      ea0029s28.1
    • Sclerostin: a key bone regulatory molecule

      ea0029s28.2
    • Other emerging therapies

      ea0029s28.3
  • Are we ready for novel therapies in obesity?
  • • Abstract unavailable

      ea0029s29.1
    • Growth hormone replacement and metabolic syndrome in GH deficient adults

      ea0029s29.2
    • GLP-1 and analogues in obesity

      ea0029s29.3
  • New developments in pituitary adenomas
  • • Symposium 30: new developments in pituitary adenoma cytokines and other new genes in pituitary adenomas

      ea0029s30.1
    • 'Dopastatin': an evolving story

      ea0029s30.2
    • The use of temozolomide in pituitary tumours

      ea0029s30.3
  • Progress in treatment in primary aldosteronism
  • • Abstract unavailable

      ea0029s31.1
    • Abstract unavailable

      ea0029s31.2
    • Abstract unavailable

      ea0029s31.3
  • Disorders of sex development (DSD)
  • • Genetics of disorders of sex development

      ea0029s32.1
    • Psychosocial and psychosexual outcome in DSD

      ea0029s32.2
    • Abstract unavailable

      ea0029s32.3
  • Pollution Related Acromegaly
  • • Pollution mediated acromegaly

      ea0029s33.1
    • Exposure to endocrine disrupting chemicals may interfere with reproductive development in humans and affect timing of puberty

      ea0029s33.2
    • Effect of iodine intake on thyroid diseases in China

      ea0029s33.3
  • Effects of thyroid hormone derivatives
  • • Pathways of thyroid hormone (TH) metabolism

      ea0029s34.1
    • Thyroid hormone mimetic compounds

      ea0029s34.2
    • Abstract unavailable

      ea0029s34.3
  • Endocrinology and the Olympics: Will hormones help to win?
  • • Does the high performance athlete need hormone replacement?

      ea0029s35.1
    • Can an endocrine patient participate in high performance sports?

      ea0029s35.2
    • Hormone abuse in sports: the knowns and unknowns

      ea0029s35.3
  • Bone and metabolism
  • • Leptin and bone signaling

      ea0029s36.1
    • Insulin-bone axis

      ea0029s36.2
    • Functions and mode of action of osteocalcin

      ea0029s36.3
  • Diabetes and cancer
  • • Abstract unavailable

      ea0029s37.1
    • Abstract unavailable

      ea0029s37.2
    • Goiter throughout the pediatric ages

      ea0029s37.3
  • Craniopharyngioma: Hypothalamic complications
  • • Childhood Craniopharyngioma

      ea0029s38.1
    • Hypothalamic disorders in Clinical practice; relevance to clinical practice

      ea0029s38.2
    • Management of hypothalamic obesity in patients with craniopharyngioma

      ea0029s38.3
  • Adrenal insufficiency
  • • Abstract unavailable

      ea0029s39.1
    • Molecular pathomechanisms of steroidogenetic adrenal disorders

      ea0029s39.2
    • New developments in the immunology of Addison's disease

      ea0029s39.3
  • New familial endocrine cancer syndromes: pathophysiology and counselling
  • • DICER1 mutations characterize a novel syndrome with endocrine features

      ea0029s40.1
    • The paediatric patient with paraganglioma syndrome

      ea0029s40.2
    • Li-Fraumeni Syndrome: A paradigm of genetic testing to clinical surveillance for pediatric endocrine tumors

      ea0029s40.3
  • The endocrinology of adipose tissue
  • • Physiological and neuronal determinants of brown adipose tissue-mediated thermogenesis in small mammals and humans

      ea0029s41.1
    • 'Obesity and insulin resistance: the cross-talk macrophage-adipocyte view'

      ea0029s41.2
    • Abstract unavailable

      ea0029s41.3
  • Novel insights into regulation of puberty
  • • Central networks controlling the timing of puberty

      ea0029s42.1
    • Re-wiring the hypothalamus with new peptides to control puberty

      ea0029s42.2
    • Novel insights into regulation of puberty: lessons from human genetics

      ea0029s42.3
  • Graves' orbitopathy (GO)
  • • Immunopathogenesis of Graves' orbitopathy

      ea0029s43.1
    • How to restore euthyroidism in the presence of Graves' orbitopathy? Is there a best way?

      ea0029s43.2
    • Progress in immunosuppressive treatment of GO (selenium, steroid dosage, rituximab)

      ea0029s43.3
  • Genome wide studies in reproduction
  • • Genome-wide association study of endometriosis identifies a locus at 7p15.2 with pleiotropic effects

      ea0029s44.1
    • Cytogenetic analysis and genome-wide association study (GWAS) in chinese women with premature ovarian failure (POF)

      ea0029s44.2
    • Genetics of (In)fertility

      ea0029s44.3
  • Bone quality and bone strength
  • • Abstract unavailable

      ea0029s45.1
    • Finite element analysis in osteology

      ea0029s45.2
    • Abstract unavailable

      ea0029s45.3
  • Chronic inflammation and insulin resistance
  • • AIMing at metabolic syndrome: towards development of novel therapies for modern metabolic diseases via macrophage-derived AIM

      ea0029s46.1
    • Macrophage regulation of adipocyte biology

      ea0029s46.2
    • The inflammatory-adipokine hypothesis and stem cell abnormalities

      ea0029s46.3
  • Cushing's syndrome
  • • Abstract unavailable

      ea0029s47.1
    • Abstract unavailable

      ea0029s47.2
    • Learnings from ERCUSYN: the first 500 patients

      ea0029s47.3
  • Pathogenesis of primary aldosteronism
  • • Genomic profile in primary aldosteronism

      ea0029s48.1
    • Integrating genetics and genomics in primary aldosteronism

      ea0029s48.2
    • Potassium channels in primary aldosteronism

      ea0029s48.3
  • Genetic breakthroughs in reproductive pathology and physiology
  • • Abstract unavailable

      ea0029s49.1
    • Abstract unavailable

      ea0029s49.2
    • RANK ligand mediates hormone induced mammary epithelial proliferation and carcinogenesis

      ea0029s49.3
  • Circadian regulation of metabolism
  • • Basic mechanisms of circadian regulation in the brain

      ea0029s50.1
    • Abstract unavailable

      ea0029s50.2
    • Circadian rhythms in adipose tissue

      ea0029s50.3
  • Recent management of pheochromocytoma/paraganglioma syndrome
  • • Recent progress in biochemical testing for pheochromocytoma

      ea0029s51.1
    • Prevalence of SDH gene mutations in pheochromocytoma

      ea0029s51.2
    • Treatment of malignant pheochromocytoma

      ea0029s51.3
  • Thyroid & Pregnancy
  • • Outcome of the controlled antenatal thyroid screening study

      ea0029s52.1
    • The case for thyroid screen in pregnancy

      ea0029s52.2
    • Treatment of hyperthyroidism in pregnancy

      ea0029s52.3
  • Genetic polymorphism in reproduction
  • • Genetic variation of the androgen receptor: from gene regulation to prostate cancer

      ea0029s53.1
    • Abstract unavailable

      ea0029s53.2
    • Genetic complexity of FSH receptor function

      ea0029s53.3
  • Vitamin D
  • • Vitamin D is a multifunctional hormone Roger Bouillon Clinic and laboratory of experimental medicine and endocrinology

      ea0029s54.1
    • Vitamin D and primary hyperparathyroidism

      ea0029s54.2
    • Abstract unavailable

      ea0029s54.3
  • The fatty liver as an endocrine disease
  • • Pathogenesis of fatty liver disease

      ea0029s55.1
    • Abstract unavailable

      ea0029s55.2
    • Fatty liver disease in childhood

      ea0029s55.3
  • Pituitary development transcription factors: stem cells and beyond
  • • The GPS niche of stem cells in the pituitary

      ea0029s56.1
    • LHX3: an insightful model of pituitary hormone deficiency

      ea0029s56.2
    • Transcriptional and epigenetic mechanisms for cell fate choice in pituitary

      ea0029s56.3
  • What's new in congenital adrenal hyperplasia (CAH)?
  • • Congenital adrenal hyperplasia: counselling from birth to the next generation

      ea0029s57.1
    • CAH and adulthood

      ea0029s57.2
    • Abstract unavailable

      ea0029s57.3
  • Best Clinical Practice
  • • Towards a European Guideline for the treatment of hyponatremia

      ea0029s58.1
    • Abstract unavailable

      ea0029s58.2
    • Abstract unavailable

      ea0029s58.3
  • Obesity and thyroid function
  • • Obesity and thyroid function

      ea0029s59.1
    • Abstract unavailable

      ea0029s59.2
    • Type 2 deiodinase in muscle during health and disease

      ea0029s59.3
  • Performance enhancing hormones in sports
  • • The spectrum of hormones in sports doping

      ea0029s60.1
    • GH and testosterone: do they work?

      ea0029s60.2
    • Erythropoietin and its derivatives

      ea0029s60.3
  • New insights in thyroid cancer diagnosis
  • • BRAF(T1799A) can be detected in the blood of papillary thyroid carcinoma patients and correlates with disease status

      ea0029s61.1
    • Abstract unavailable

      ea0029s61.2
    • Abstract unavailable

      ea0029s61.3
  • Early Development and Treatment of PCOS
  • • Early hormonal abnormalities in children born to women with PCOS

      ea0029s62.1
    • Early development and pubertal prevention of polycystic ovary syndrome

      ea0029s62.2
    • Hyperandrogenism in obese girls: what is the significance?

      ea0029s62.3
  • Emerging ideas about phosphate metabolism
  • • Abstract unavailable

      ea0029s63.1
    • FGF23 and tumor-induced osteomalacia

      ea0029s63.2
    • FGF23 in chronic renal failure

      ea0029s63.3
  • Endoplasmic Reticulum Stress, Obesity and Metabolic Homeostasis
  • • Abstract unavailable

      ea0029s64.1
    • Abstract unavailable

      ea0029s64.2
    • Abstract unavailable

      ea0029s64.3
  • Somatostatin receptors in pituitary
  • • Imaging somatostatin activity in live pituitary

      ea0029s65.1
    • Is somatostatin receptor expression in adenomas related to pharmacological response?

      ea0029s65.2
    • Somatostatin receptors and filamin: a developing story

      ea0029s65.3
  • HPA axis, stress metabolism and adaptation
  • • Neuroendocrine and (epi)genetic impact on HPA function

      ea0029s66.1
    • Abstract unavailable

      ea0029s66.2
    • Modulation of cortisol action

      ea0029s66.3
  • Central regulation of energy homeostasis
  • • CNS control of energy and glucose metabolism

      ea0029s67.1
    • Gut hormones: history, physiology and therapeutic opportunities

      ea0029s67.2
    • Abstract unavailable

      ea0029s67.3
  • European network for the study of adrenal tumours (ENSAT)
  • • Genetics for pheochromocytoma and paraganglioma in 2012

      ea0029s68.1
    • Abstract unavailable

      ea0029s68.2
    • Abstract unavailable

      ea0029s68.3
  • Current progress in the management of thyroid cancer
  • • TSH suppression in differentiated thyroid cancer: how low should we go?

      ea0029s69.1
    • Abstract unavailable

      ea0029s69.2
    • Abstract unavailable

      ea0029s69.3
  • Young Active Researchers Symposium (YAR)
  • • New mechanisms underlying the role of the mTORC1 pathway in the hypothalamic control of energy balance

      ea0029s70.1
    • Abstract unavailable

      ea0029s70.2
    • DNA methylation of the body weight-regulating proopiomelanocortin gene: functional and ontogenetic aspects

      ea0029s70.3
    • Mineralocorticoid receptor antagonism counters metabolic dysfunctions induced by high fat diet in mice

      ea0029s70.4
    • A four-week fat overfeeding study in constitutional thin women: a human model of weight gain resistance

      ea0029s70.5
• Endocrine Nurse Symposium
• • (1)
  • • Puberty induction in males and females

      ea0029en1.1
    • The role of the endocrine nurse in puberty induction

      ea0029en1.2
    • Abstract unavailable

      ea0029en1.3
    • Choosing the right sex steroid replacement option for patients: the role of the endocrine nurse

      ea0029en1.4
    • Diagnosis and management of Cushing's syndrome

      ea0029en2.1
    • The role of the endocrine nurse in the diagnosis and management of the patient with Cushing's syndrome

      ea0029en2.2
    • Diagnosis and management of prolactinoma

      ea0029en2.3
    • Abstract unavailable

      ea0029en2.4
    • Abstract unavailable

      ea0029en3.1
    • The role of nurse prescribing in the care of endocrine patients

      ea0029en3.2
• JOE/JME Prize Presentation Sponsored by <emphasis role="italic">Journal of Endocrinology</emphasis>
• • (1)
  • • Melanocortin receptor accessory proteins (MRAPs) in adrenal gland physiology and beyond

      ea0029jp1
• Meet the Expert Sessions
• • (1)
  • • Adrenal incidentaloma and subclinical Cushing's syndrome

      ea0029mte1
    • Approach to the patient with Cushing's disease after pituitary surgery failure

      ea0029mte2
    • Abstract unavailable

      ea0029mte3
    • Challenges of transsphenoidal pituitary surgery

      ea0029mte4
    • Meet the expert: discussion of common but difficult thyroid cancer cases

      ea0029mte5
    • Clinical management of adrenocortical carcinoma

      ea0029mte6
    • Pregnancy and pituitary disorders

      ea0029mte7
    • Abstract unavailable

      ea0029mte8
    • Diagnosis and management of SIADH

      ea0029mte9
    • Elastosonography in the evaluation of thyroid and parathyroid lesions

      ea0029mte10
    • Diagnosis and treatment considerations in autoimmune polyendocrine syndrome type 1

      ea0029mte11
    • Abstract unavailable

      ea0029mte12
    • Graves' ophthalmopathy

      ea0029mte13
    • Hirsutism

      ea0029mte14
    • Pituitary tumours in adolescents and adults

      ea0029mte15
    • Management of non-functioning pituitary adenomas

      ea0029mte16
    • Multiple endocrine neoplasia type 2

      ea0029mte17
    • Normocalcemic primary hyperparathyroidism

      ea0029mte18
    • Abstract unavailable

      ea0029mte19
    • The diagnosis and treatment of secondary osteoporosis in children

      ea0029mte20
    • Autoimmune hyperthyroidism: initiation and duration of thionamide therapy

      ea0029mte21
    • Clinical management in transgender sex hormone treatment

      ea0029mte22
    • Subclinical hypothyroidism

      ea0029mte23
    • Approach to the management of the infertile couple

      ea0029mte24
    • Pituitary incidentalomas

      ea0029mte25
    • Abstract unavailable

      ea0029mte26
    • Differential diagnosis of Cushing's syndrome

      ea0029mte27
    • Abstract unavailable

      ea0029mte28
    • Management of bone loss induced by cancer treatment in early breast and prostate cancer

      ea0029mte29
    • Treatment of vitamin D deficiency

      ea0029mte30
    • Cryptorchidism

      ea0029mte31
    • Management of GEP-NET tumors

      ea0029mte32
• Oral Communications
• • Pituitary Clinical I
  • • Pasireotide LAR is significantly more effective than octreotide LAR at inducing biochemical control in patients with acromegaly: results of a 12-month randomized, double-blind, multicenter, Phase III study

      ea0029oc1.1
    • Patients with Cushing's disease achieve normal urinary cortisol with LCI699, a potent 11[beta]-hydroxylase inhibitor: preliminary results from a multicenter, proof-of-concept study

      ea0029oc1.2
    • Efficacy and safety of long-term treatment with pegvisomant in acromegaly: Italian pegvisomant observational study (ACROSTUDY)

      ea0029oc1.3
    • A multi-centre audit of the prevalence of cardiac valvulopathy in patients treated with dopamine agonists for hyperprolactinaemia

      ea0029oc1.4
    • Initial hypothalamic involvement is the major risk factor for impaired prognosis and quality of life in childhood craniopharyngioma regardless of chosen treatment strategies: results of KRANIOPHARYNGEOM 2000

      ea0029oc1.5
    • Normal weight adult patients with Prader-Willi syndrome are not protected from insulin resistance during treatment with GH: results from a 12 month prospective study

      ea0029oc1.6
  • Thyroid Clinical I
  • • Overt hyperthyroidism is associated with increased mortality: a nationwide register-based study of disease discordant Danish twins

      ea0029oc2.1
    • Identification and functional analysis of DUOX2 variants: biallelic mutations are associated with permanent congenital hypothyroidism

      ea0029oc2.2
    • Thyroid hormone levels in euthyroid young men are associated with body composition and metabolic parameters

      ea0029oc2.3
    • The thyroid hormone receptor-coactivator interface mediates negative feedback regulation of the human pituitary-thyroid axis

      ea0029oc2.4
    • Thyroid spongiform nodules are the best candidates for percutaneous laser ablation. A 5 year follow-up study in 72 patients

      ea0029oc2.5
    • Concurrent presence of nonendocrine autoimmune diseases with Hashimoto's thyroiditis: a systematic assessment on more than 5000 consecutive patients

      ea0029oc2.6
  • Diabetes Clinical
  • • Common variants of monogenic diabetes genes may affect [beta] cell functional mass in patients with newly diagnosed type 2 diabetes

      ea0029oc3.1
    • Weight-loss independent metabolic benefits of gastric bypass surgery? Experiences from the Swedish obese subjects (SOS) study

      ea0029oc3.2
    • Diabetic ketoacidosis at diagnosis influences complete remission after treatment of hematopoietic stem cell transplantation in adolescents with type 1 diabetes

      ea0029oc3.3
    • Glucose lowering therapies and cancer specific mortality in adult insulin-treated diabetes

      ea0029oc3.4
    • Study of toll like receptor 2 and 4 expression in monocytes in type 1 diabetes mellitus with and without micro-vascular complications

      ea0029oc3.5
    • Glucose disorders exert a detrimental effect on total brain volume in the elderly: a 2-year prospective MRI study

      ea0029oc3.6
  • Pituitary Basic
  • • Obestatin plays an opposite role in the regulation of pituitary somatotrope and corticotrope function in primates and mice

      ea0029oc4.1
    • Transcriptional regulation of prolactin by oestrogen in vivo

      ea0029oc4.2
    • miR-26a targets PRKCD in ACTH pituitary adenoma

      ea0029oc4.3
    • Identification of coupling specificity between somatostatin receptor 5 (SST5) and G proteins by a bioluminescence resonance energy transfer (BRET) technique: the role of GoA protein

      ea0029oc4.4
    • Targeting the IGF-IR system in pituitary tumors in vitro: antiproliferative action [amp] pitfalls

      ea0029oc4.5
    • Cell cycle G2/M transition is modulated by microRNAs in pituitary adenomas

      ea0029oc4.6
  • Obesity Basic
  • • GH ameliorates impaired glucose tolerance in obese mice by modifying the visceral fat condition through adiponectin

      ea0029oc5.1
    • Production of galectin-1, -3, -9 and -12 in adipose tissue of lean and obese mice

      ea0029oc5.2
    • Insulin action in brown adipose tissue is compromised during diet-induced obesity

      ea0029oc5.3
    • Bile acid binding resin shows anti-obese effect through the modifications of intestinal microbiota

      ea0029oc5.4
    • Development of leptin deficient Lepmkyo/Lepmkyo rat-evidence for its superiority over Lepob/Lepob mouse as a model for human obesity

      ea0029oc5.5
    • Semaphorin 3C-a novel adipokine modulating human adipose tissue plasticity in weight change

      ea0029oc5.6
  • Female Reproductioin Basic
  • • GnRH release failure in hyperprolactinemia is caused by a Kisspeptin deficiency

      ea0029oc6.1
    • Ghrelin modulates fertilization, early embryo development and implantation

      ea0029oc6.2
    • LH and hCG produce different responses in human granulosa lutein cells in vitro

      ea0029oc6.3
    • Female fertility and activin-stimulated Fshb expression do not require SMAD2/3 in murine gonadotropes

      ea0029oc6.4
    • Dihydrotestosterone treatment in mice induces a persistent polycystic ovary syndrome phenotype

      ea0029oc6.5
    • Kit ligand-c-kit interaction regulates estradiol production by rat granulosa cells via oocyte factors

      ea0029oc6.6
  • Adrenal Clinical
  • • Progression-free survival without treatment of malignant pheochromocytoma and paraganglioma at one year

      ea0029oc7.1
    • Activation of the PKA pathway triggers formation of an illicit serotonergic regulatory loop in primary pigmented nodular adrenal disease (PPNAD) tissues associated with Cushing's syndrome

      ea0029oc7.2
    • Ribonucleotide reductase large subunit (RRM1) gene expression predicts efficacy of adjuvant mitotane in adrenocortical cancer

      ea0029oc7.3
    • Differential diagnosis of primary aldosteronism by peripheral plasma levels of 18-oxo-cortisol: a noninvasive method with a high specificity

      ea0029oc7.4
    • Continuous subcutaneous hydrocortisone infusion (CSHI) as replacement therapy in Addison's disease (AD)

      ea0029oc7.5
    • Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study

      ea0029oc7.6
  • Bone
  • • Hypophosphatasia: enzyme replacement therapy (ENB-0040) decreases TNSALP substrate accumulation and improves functional outcome in affected adolescents and adults

      ea0029oc8.1
    • Comparison of high protein and normal protein weight loss diets on bone density in overweight post-menopausal women

      ea0029oc8.2
    • Profiling insulin like factor 3 (INSL3) signaling in human osteoblasts

      ea0029oc8.3
    • Radiological vertebral fractures in hospitalized elderly patients with heart failure

      ea0029oc8.4
    • Pathogenetic chromosomal rearrangements in a large series of patients with pseudohypoparathyroidism type I

      ea0029oc8.5
    • Simultaneous gain and loss of methylation at imprinted loci in a subset of patients with pseudohypoparathyroidism type 1b and GNAS epimutations

      ea0029oc8.6
  • Endocrine Tumours & Translation
  • • Temozolomide therapy for progressive metastatic paraganglioma/pheochromocytoma: SDHB mutation as a prognosis biomarker for efficacy

      ea0029oc9.1
    • GH protects breast cancer cells from chemotherapy by blocking cytotoxic-induced apoptosis in estrogen receptor negative breast cancer cells

      ea0029oc9.2
    • The central role of estrogen receptor [alpha] in IGF2 dependent adrenocortical carcinoma (ACC) cell proliferation suggests the use of selective estrogen receptor modulators (SERMs) for the treatment of ACC

      ea0029oc9.3
    • Functional characterization of mutations in the multiple endocrine neoplasia type 1 (MEN1) gene suggest therapeutic strategies

      ea0029oc9.4
    • Glucagon-like peptide 1 receptor (GLP-1R) imaging for the preoperative localization of benign insulinomas in 30 patients

      ea0029oc9.5
    • First in vitro study of human gastroenteropancreatic-neuroendocrine tumors: comparative effect of octreotide and pasireotide

      ea0029oc9.6
  • Pituitary Clinical 2
  • • Predictors of morbidity and mortality in acromegaly: an Italian survey on behalf of the Italian study group of acromegaly

      ea0029oc10.1
    • Food intake regulating hormones in adult craniopharyngioma patients

      ea0029oc10.2
    • Pathophysiology of renal calcium handling in acromegaly revisited

      ea0029oc10.3
    • Higher glucocorticoid supplementation doses are associated with increased overall mortality in patients with non-functioning pituitary adenoma

      ea0029oc10.4
    • Once-weekly, CTP-modified hGH (MOD-4023) is effective in growth hormone deficient adults: a phase II, dose and frequency finding study

      ea0029oc10.5
    • Second neoplasms in childhood cancer survivors with growth hormone deficiency treated or not treated with GH

      ea0029oc10.6
  • Thyroid Clinical 2
  • • Growth retardation and severe constipation due to the first human, dominant negative thyroid hormone receptor alpha mutation

      ea0029oc11.1
    • Subclinical thyroid disease and risk of new-onset atrial fibrillation

      ea0029oc11.2
    • Is overt hypothyroidism associated with increased mortality? A nationwide register-based study of disease discordant Danish twins

      ea0029oc11.3
    • Prevalence of TSH receptor mutation and clinical characteristics among 84 patients with hyperthyroidism with diffuse goiter and negative TBII

      ea0029oc11.4
    • Thyroid hormones and male sexual function

      ea0029oc11.5
    • Is age a risk factor for hypothyroidism in pregnancy? An analysis of 5223 pregnant women

      ea0029oc11.6
  • Obesity Clinical
  • • Circulating endocannabinoids are associated to cardiometabolic alterations independently from adiposity

      ea0029oc12.1
    • Lipid-induced insulin resistance is associated with a reduction of IGF1 bioactivity independent of changes in IGFBP-1 and -2 in humans

      ea0029oc12.2
    • Transient increase of beta-cell first phase secretion after smoking cessation: a possible contributor to carbohydrate craving and body weight gain?

      ea0029oc12.3
    • Genetic susceptibility, birth weight and obesity risk in young chinese

      ea0029oc12.4
    • Brown adipose tissue activation is inversely related with central obesity and metabolic parameters in adult human

      ea0029oc12.5
    • Eating speed and the risk of type 2 diabetes mellitus: a case-control study

      ea0029oc12.6
  • Adrenal Basic
  • • Targeting multiple signalling pathways showed high anti-tumour potential in two mouse phaeochromocytoma cell lines

      ea0029oc13.1
    • VSNL1 is upregulated in aldosterone producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis

      ea0029oc13.2
    • Cortisol secretion is dependent on intraadrenal production of ACTH in macronodular bilateral adrenal hyperplasia causing Cushing's syndrome

      ea0029oc13.3
    • A genome-wide methylation study of adrenocortical tumors shows specific alterations linked to gene expression, revealing new aspects of the molecular classification of adrenal carcinomas

      ea0029oc13.4
    • KCNJ5 mutations in Japanese patients with aldosterone-producing adenomas

      ea0029oc13.5
    • GATA-4 overexpression induces adrenocortical tumorigenesis and ectopic expression of luteinizing hormone receptor in C57Bl/6J mice

      ea0029oc13.6
  • Male Reproduction
  • • X chromosome-linked copy number variations in male infertility

      ea0029oc14.1
    • Deficient expression of genes involved in the endogenous defense system against transposons in cryptorchid boys with impaired mini-puberty

      ea0029oc14.2
    • Comparison of serum testosterone and estradiol levels in 3174 European men as measured by a platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men

      ea0029oc14.3
    • The prevalence of hypogonadism in men on methadone maintenance

      ea0029oc14.4
    • The muenster EXAKT project: X-inactivation in klinefelter patients

      ea0029oc14.5
    • Erectile dysfunction after liver transplantation

      ea0029oc14.6
  • Thyroid Basic
  • • PATZ1 is a new candidate tumour-suppressor gene in thyroid cancer

      ea0029oc15.1
    • Ligand bound-thyroid hormone receptor contributes to reprogramming of pancreatic exocrine cells to insulin-producing cells via induction of Ngn3 and MafA

      ea0029oc15.2
    • Radioiodine therapy of non-thyroidal cancer following systemic sodium iodide symporter (NIS) gene transfer using Transferrin-receptor (Tfr) targeted non-viral gene delivery vectors

      ea0029oc15.3
    • The DNA methylation as a predisposition factor in the pathogenesis of congenital hypothyroidism in premature infants

      ea0029oc15.4
    • Lymphatic endothelial markers podoplanin and Prox1 in differentiated thyroid tumors

      ea0029oc15.5
    • Thyroglobulin induces thyroid cell growth through suppression of miR-16 and miR-195

      ea0029oc15.6
  • Female Reproduction Clinical
  • • The association between birth weight and PCOS in adult life. A register-based study on 523, 757 Danish women born 1973-1991

      ea0029oc16.1
    • The first missense mutation of BMP15 mature domain identified in a Chinese family with primary ovarian insufficiency causes defective production of the bioactive protein

      ea0029oc16.2
    • Anti-mullerian hormone as a predictor of ovarian response to weight loss in overweight women with polycystic ovary syndrome

      ea0029oc16.3
    • Epidemiological survey on the prevalence of hyperandrogenic states in adolescent and young women

      ea0029oc16.4
    • Urinary glucocorticoid metabolite excretion is associated with insulin resistance independent of body mass index (BMI) in patients with polycystic ovary syndrome

      ea0029oc16.5
    • Kisspeptin-10 stimulation of gonadotropin secretion in women is modulated by sex steroid feedback

      ea0029oc16.6
  • Diabetes Basic
  • • Pdk1/Foxo1 pathway regulates macrophage migration, polarization, and insulin sensitivity

      ea0029oc17.1
    • Placental restriction co-ordinately alters hepatic expression of microRNAs and targets related to non alcoholic fatty liver disease, in adult male sheep

      ea0029oc17.2
    • Caerulin precursor fragment (CPF-AM1): a novel insulinotropic peptide from the skin secretion of the clawed frog, Xenopus amieti

      ea0029oc17.3
    • Syntaxin-3 regulates recruitment and exocytosis of newcomer insulin granules and granule-granule fusion during biphasic glucose-stimulated insulin secretion in pancreatic [beta]-cells

      ea0029oc17.4
    • Glucocorticoid receptor [alpha] expression is downregulated in gluteal subcutaneous adipose tissue of black South African women and associates with increased metabolic risk

      ea0029oc17.5
    • Meta-analysis of differentially expressed microRNAs in type 1, type 2 and gestational diabetes mellitus

      ea0029oc17.6
  • Paediatric Endocrinology
  • • Mutations in the NR5A1 gene in patients with 46,XY disorders of sex development (DSD): high frequency of familial multi-generational occurrence

      ea0029oc18.1
    • Clinical profile, gender choice and long term follow up of subjects with 5 alpha-steroid reductase 2 deficiency

      ea0029oc18.2
    • Effects of vitamin D insufficiency and its correction on insulin sensitivity and serum osteocalcin concentration in obese children

      ea0029oc18.3
    • Mortality in GH-treated (Tx) patients (pts) enrolled in the global genetics and neuroendocrinology of short stature international study (GeNeSIS)

      ea0029oc18.4
    • Earlier reactivation of the hypothalamo-pituitary-gonadal axis and advancement of puberty in boys under labour stress

      ea0029oc18.5
    • Functional characterization of a new mutation in the NKX2.1 in patients with thyroid-lung-brain syndrome

      ea0029oc18.6
  • Cardiovascular Endocrinology
  • • Both EPA/AA ratio and absolute AA levels constitute an independent risk factor for coronary atherosclerosis in type 2 diabetic patients

      ea0029oc19.1
    • Increased arterial stiffness is independently associated with cerebral infarctions and white matter lesions in patients with type 2 diabetes despite good blood pressure and lipid control

      ea0029oc19.2
    • Copeptin and adrenomedullin in a large cohort of patients with coronary heart disease and newly diagnosed glucose intolerance ('Silent diabetes study')

      ea0029oc19.3
    • Oxytocin is cardioprotective hormone

      ea0029oc19.4
    • Circulating adrenomedulin levels are associated with atrial natriuretic peptide and brain natriuretic peptide levels in heart failure patients

      ea0029oc19.5
    • Endothelial progenitor cells in acromegaly are reduced and responsive to treatment with somatostatin analogues

      ea0029oc19.6
• Nurses Abstracts
• • (1)
  • • Clinical practice guideline on linear growth measurement of children

      ea0029n1
    • The nurse's role in establishing modern testosterone replacement therapy in an endocrine clinic

      ea0029n2
    • Interdisciplinary risk assessment and patient discharge management: combining biomarker [amp] clinical scores, medical [amp] nursing aspects

      ea0029n3
    • Effect of metformin in teenagers with metabolic syndrome

      ea0029n4
    • Translation and cultural adaptation of the Brazilian version of patient assessment of chronic illness care: Pacic-Brazil

      ea0029n5
    • Perception of quality of care in patients with pituitary disorders

      ea0029n6
    • Neutralization of Flightless I (Flii) using Flii-specific monoclonal antibodies accelerates impaired healing in diabetic wounds through improved cell proliferation

      ea0029n7
    • Diabetes nurse leadership group: a forum for improving diabetes care in Brooklyn, NY

      ea0029n8
    • Childhood osteoporosis: screening, prevention, treatment and safe handling practices in a tertiary care pediatric hospital

      ea0029n9
    • Endocrine and exocrine function changes in acute pancreatitis

      ea0029n10
    • A prospective study of growth and development of children recently adopted from orphanage care

      ea0029n11
    • Improving the efficiency and safety of managing children with diabetic keto-acidosis

      ea0029n12
    • Socio-demographic factors associated with pediatric diabetic ketoacidosis admissions in Southern West Virginia

      ea0029n13
    • Failure to thrive due to inherited congenital isolated growth hormone deficiency

      ea0029n14
    • Diabetic foot in jordan: a qualitative content analysis of self-treated problems

      ea0029n15
    • Planning for the future: preparing the endocrine specialist nurse of tomorrow

      ea0029n16
    • The Swedish pituitary registry

      ea0029n17
    • Molecular genetics in turner syndrome

      ea0029n18
    • An Internet based protocol for examining transitional experiences of 16-26 year olds with Turner syndrome (TS)

      ea0029n19
    • Self care practice among diabetic patients attending metropolyclinic, Kathmandu

      ea0029n20
    • Abstract unavailable

      ea0029n21
    • Eat, Pray, Love...Yourself

      ea0029n22
    • Dance for health: implementation of a dance program to improve physical activity of children

      ea0029n23
    • Self-care competence in the case of Brazilian patients with diabetes mellitus in a multiprofessional educational programme

      ea0029n24
    • Primary hyperparathyroidism, vitamin D deficiency and quality of life

      ea0029n25
    • Evaluation of self management and diabetes education newly diagnosed with Type 2 diabetic patients in Mongolia

      ea0029n26
    • Individuals with Addison's disease and their experiences of onset and self-care: new knowledge?

      ea0029n27
    • A survey of knowledge related to cystic fibrosis related diabetes

      ea0029n28
• Poster Presentations
• • Adrenal cortex
  • • Targeting mutated [beta]-catenin in vitro and in vivo inhibits cell proliferation and stimulates apoptosis: a promising therapeutic target in adrenocortical carcinoma

      ea0029p1
    • Pathophysiological significance of CYP11B2 immunohistochemical staining in primary aldosteronism

      ea0029p2
    • The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in the diagnosis of subclinical hypercortisolism (SH) in patients with adrenal incidentaloma (AI).

      ea0029p3
    • Semen parameters in men with congenital adrenal hyperplasia (CAH) due to 21-hydroxilase deficiency (21-HD)

      ea0029p4
    • Non-radioactive strategies on the diagnosis of congenital adrenal hyperplasia due to 21 hydroxylase deficiency (CAH - 21OHD).

      ea0029p5
    • Diagnostic value of urinary steroid profiling in the evaluation of adrenal incidentaloma.

      ea0029p6
    • The combined use of nocturnal salivary cortisol and urinary cortisol to creatinine ratio in the evaluation of cycling in patients with Cushing's syndrome

      ea0029p7
    • Defining 17[alpha]-hydroxylase in zebrafish: expression pattern of two paralog genes (zCyp17a1; zCyp17a2) and comparative in vitro and in silico analysis

      ea0029p8
    • Progressive adrenal insufficiency in a patient with 46,XY DSD caused by two novel mutations in the cytochrome P450 side-chain cleavage (CYP11A1) gene

      ea0029p9
    • The mTOR-pathway in normal and tumoral human adrenocortical tissues

      ea0029p10
    • Measurement of cortisol in scalp hair can be a new tool in the diagnosis and follow-up of patients with Addison's Disease and (cyclic) Cushing's Syndrome

      ea0029p11
    • Pattern of adrenal hormonal secretion in patients with adrenal adenomas: the relevance of aldosterone in arterial hypertension

      ea0029p12
    • Influence of unilateral adrenalectomy on set point of Hypothalamic-pituitary-adrenal-axis in long-term survivors of childhood nephroblastoma and neuroblastoma

      ea0029p13
    • PET-tracers for differential diagnosis in primary hyperaldosteronism - in vitro studies

      ea0029p14
    • Role of Endogenous Somatostatin and Cortistatin in Regulating Adrenal Gland Function

      ea0029p15
    • Cyclical Cushing's syndrome masquerading as Polycystic Ovarian Syndrome - pitfalls in diagnosis

      ea0029p16
    • Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism following adrenalectomy

      ea0029p17
    • Use of the 250 mcg short synacthen test in the diagnosis of primary aldosteronism

      ea0029p18
    • Evaluation of sexual function and psychological attitudes in adult women with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase Deficiency (21-HD)

      ea0029p19
    • Role of adrenal vein sampling in primary aldosteronism. Impact of different diagnostic criteria on subtype diagnosis

      ea0029p20
    • Predicting factors of the post-surgical decline in renal function in patients with primary aldosteronism

      ea0029p21
    • Specialized surgery for adrenocortical carcinoma in The Netherlands: analysis of national cancer registry data

      ea0029p22
    • Long term follow-up of patients with adrenal incidentalomas - a prospective study

      ea0029p23
    • Effects of sugar cane extract (SCE) supplementation on steroidogenesis of the adrenal cortex in male rats

      ea0029p24
    • Evaluation of renal function of primary aldosteronism between pre- and post-treatment

      ea0029p25
    • Follow-up of nonsurgical nonfunctioning adrenal adenomas at five years

      ea0029p26
    • Importance of the genetic study in fertile women with nonclassical congenital adrenal hyperplasia

      ea0029p27
    • Aldosterone-producing cells regenerated from mesenchymal stem cells

      ea0029p28
    • The ACTH-independent macronodular adrenal hyperplasia gene hunt: from candidate genes to a pangenomic strategy

      ea0029p29
    • Superselective adrenal venous sampling for intra-adrenal localization of aldosterone hypersecretion.

      ea0029p30
    • Analysis of the glucocorticoid receptors polymorphism in patients with adrenal incidentaloma and patients with Cushing's syndrome.

      ea0029p31
    • KCNJ5 Mutations in European Families with Non-Glucocorticoid Remediable Familial Hyperaldosteronism

      ea0029p32
    • Applicability of the guideline for the diagnosis of primary hyperaldosteronism in patients with hypertension in Japan (PHAS-J2): Prospective multi-center study of national hospital organization

      ea0029p33
    • Copy number alterations and loss of heterozygosity in cortisol-secreting adrenocortical adenomas using SNP arrays: evidence of new candidate genes and pathways.

      ea0029p34
    • Differential DNA methylation of the CYP11B1 and CYP11B2 genes in association with human adrenal zonation

      ea0029p35
    • Super-selective ACTH-stimulated adrenal venous sampling can discriminate the main lesion from the normal tissue for doing partial adrenalectomy in unilateral aldosterone-producing adenoma

      ea0029p36
    • Deletion of TASK3 K+ channels leads to hyperaldosteronism in neonatal mice

      ea0029p37
    • Expression of kisspeptin and its receptor in aldosterone-producing adrenal adenomas

      ea0029p38
    • Reduction of the 10-year probability of fracture predicted by FRAX[reg] and bone mass recovery in patients with Cushing's Syndrome after 24 months from cure of hypercortisolism

      ea0029p39
    • The Wnt/Beta-catenin and Ras/Raf/MEK/ERK signaling pathways alterations in adrenocortical tumors

      ea0029p40
    • Cancer induces adrenal and pituitary alterations during the development of cachexia-anorexia syndrome

      ea0029p41
    • A revolution in the diagnosis of adrenal disorders: rapid multiplex quantitation of serum steroids by means of tandem mass spectrometry (MSMS)

      ea0029p42
    • Outcome of 232 patients with monolateral adrenal incidentaloma from a single centre

      ea0029p43
    • Female patients with primary aldosteronism are diagnosed earlier and have a better outcome

      ea0029p44
    • Influencing factors on quality of life in patients with Addison's disease

      ea0029p45
    • Differential methylation signature in benign and malignant cortisol producing adrenocortical tumors

      ea0029p46
    • 18-Hydroxycorticosterone, 18-hydroxycortisol and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes.

      ea0029p47
    • MicroRNA profiling of benign and malignant adrenocortical tumors reveals potential biomarkers of recurrence

      ea0029p48
    • Prevalence and Characteristics of Familial Hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino - GENetic forms).

      ea0029p49
    • Intercurrent Illness Dose Regimen in Adrenal Insufficiency with a Dual Release Hydrocortisone Formulation Derived from Population Pharmacokinetic Modelling

      ea0029p50
    • Cornell product left ventricular hypertrophy in electrocardiogram in patients with primary aldosteronism

      ea0029p51
    • Efficacy of long-term treatment with retinoic acid in patients with Cushing's disease

      ea0029p52
    • Relationship of current glucocorticoid dose with metabolic outcomes in CAH: analysis of the United Kingdom congenital adrenal hyperplasia adult study executive (CaHASE) cohort

      ea0029p53
    • Frequency and causes of adrenal crises over life-time in patients with 21-hydroxylase deficiency

      ea0029p54
    • Urinary cortisol metabolites in corticotroph and adrenal tumours

      ea0029p55
    • Soundwave's effect on hematic cortisol level: a pilot study

      ea0029p56
    • Reevaluation of the 4 mg intravenous dexamethasone suppression test for differentiation of Cushing's disease from pseudo-Cushing's syndrome

      ea0029p57
    • Treatment with mineralocorticoid receptor antagonists in 'subclinical' cases with adrenal adenomas and autonomous aldosterone secretion

      ea0029p58
    • The effects of the acute administration of alprazolam, a benzodiazepine, in patients with subclinical Cushing's syndrome

      ea0029p59
    • Is isolated secondary adrenal insufficiency more frequent than autoimmune Addison's disease?

      ea0029p60
    • Dyslipidemia in patients with adrenal incidentaloma with and without subclinical hypercortisolism and diabetes mellitus.

      ea0029p61
    • Prevalence of primary aldosteronism in Chinese patients with resistant hypertension

      ea0029p62
    • Genetic, anthropometric and metabolic features of adult norwegian patients with 21-hydroxylase deficiency

      ea0029p63
    • Relationship between plasma dexamethasone level and cortisol in the overnight dexamethasone suppression test

      ea0029p64
    • Mechanisms of gastroprotective action of corticotropin-releasing factor (CRF): involvement of CRF receptor subtypes 1 and 2

      ea0029p65
    • Comparison of salivary cortysol by chemiluminensce and mass spectometry in hypercortilosism

      ea0029p66
    • Renin-angiotensin-aldosterone system and inflammation - new aspects of an old system: results from the study of health in pomerania

      ea0029p67
    • MGMT expression in human adrenocortical carcinoma cell lines and tissues and effects of temozolomide on tumor cell growth.

      ea0029p68
    • New quick cortisol assay during adrenal vein sampling in patients with primary aldosteronism

      ea0029p69
    • Primary aldosteronism is very frequent in resistant hypertension and is associated to early renal vascular damage

      ea0029p70
    • Enhanced small dense LDL-subfractions, triglycerides and chemerin as early metabolic alterations in young patients with classic CAH due to 21-hydroxylase deficiency

      ea0029p71
    • ACTH and cortisol responses to the combined DEXA-CRH test in patients with adrenal incidentalomas

      ea0029p72
    • Idiopathic primary hyperaldosteronism frequently undergoes spontaneous remission: frequence and predictors

      ea0029p73
    • Anxiety and depressive symptoms in patients with primary aldosteronism in a longitudinal study

      ea0029p74
    • Drug prescription pattern in patients with autoimmune addison's disease in Sweden

      ea0029p75
    • Dosing regimens for glucocorticoid replacement therapy - a worldwide patient survey

      ea0029p76
    • Significance of ACTH stimulation test in the diagnosis of an aldosterone-producing adenoma

      ea0029p77
    • An open, multi-centre, phase IIIB, long term follow-up study to assess the safety, tolerability and efficacy of once-daily oral dual-release hydrocortisone in patients with adrenal insufficiency

      ea0029p78
    • Malignant adrenal incidentalomas: clinical analysis of 2300 patients with adrenal incidentalomas registered at a single endocrinological center

      ea0029p79
    • RRM1 Gene expression affects metabolization and activity of mitotane in adrenocortical cancer cell lines.

      ea0029p80
    • The routine application of the current clinical recommendations for adrenal incidentalomas the management is highly inefficient

      ea0029p81
    • The Effect of Glucocorticoid Receptor Polymorphisms on the Sensitivity to Cortisol in Addison's disease

      ea0029p82
    • Impact of reference values and published thresholds on clinically relevant cut-offs

      ea0029p83
    • Hormonal and metabolic features in patients with adrenal incidentalomas according to 1 mg overnight dexamethasone suppression test

      ea0029p84
    • Therapy with steroidogenesis inhibitors in Cushing's syndrome: a reappraisal

      ea0029p85
    • Ectopic Cushings and Nocardia series

      ea0029p86
    • Laparoscopic adrenalectomy for large adrenal tumors

      ea0029p87
    • Adiponectin gene polymorphisms in primary aldosteronism and their relation to the metabolic syndrome

      ea0029p88
    • Primary aldosteronism associated with subclinical Cushing syndrome

      ea0029p89
    • Primary aldosteronism during 2007-2011 in Iceland

      ea0029p90
    • Low SLC26A2 expression in adrenal cells is associated with high aldosterone output

      ea0029p91
    • Three-dimensional contrast-enhanced sonography in the diagnosis of incidentally discovered asymptomatic adrenal masses

      ea0029p92
    • Evaluation of uni- and bilateral adrenal incidentalomas with (131I) 6[beta]-iodomethyl-norcholesterol scintigraphy.

      ea0029p93
    • The confirmatory Tests of primary aldosteronism should be selected in each countries - the analysis of 83 patients in our hospital

      ea0029p94
    • ACTH stimulation improves the sensitivity of aldosterone to rennin ratio (ARR) for detecting inappropriate aldosterone secretion

      ea0029p95
    • Diagnostics of primary aldosteronism: is obligatory use of confirmatory tests justified?

      ea0029p96
    • Diagnosis of Cushing's syndrome by automatic face classification using frontal and side-view photographs

      ea0029p97
    • Cushing disease remission is independent of size tumor. twenty years experience in surgical treatment a Mexican Center

      ea0029p98
    • Cushing's disease - limitations and boundaries

      ea0029p99
    • Exogenous corticosteroids: guilty or innocent?

      ea0029p100
    • Pediatric Cushing disease: case report

      ea0029p101
    • Proteomic approach to human adrenocortical cancer biology

      ea0029p102
    • GH deficiency in patients with hypoadrenalism

      ea0029p103
    • The functional assessment and growth rates of adrenal incidentalomas: a single center experience

      ea0029p104
    • Adrenal venous sampling: local experience in Asian population

      ea0029p105
    • Comparison of four immunoassays for measurement of cortisol levels

      ea0029p106
    • Tertiary adrenal insufficiency: case report

      ea0029p107
    • A case of HIV presenting as primary adrenal lymphoma

      ea0029p108
    • Ketoconazole in surgery preparation and follow-up of Cushing's disease - our experience

      ea0029p109
    • Utility of CGM for the determination of optimal glucocorticoid replacement method in patients with adrenal insufficiency

      ea0029p110
    • A case of subclinical Cushing's syndrome who developed pseudo-aldosteronism caused by green juice

      ea0029p111
    • Adrenal masses as the first demonstration of non endocrine tumors metastatic disease

      ea0029p112
    • Usefulness of FDG-PET for detecting primary aldosteronism in patient who have bilateral adrenal incidentaloma

      ea0029p113
  • Adrenal medulla
  • • Next generation sequencing is a cost effective and time saving method in clinical genetic screening of patients with pheochromocytomas

      ea0029p114
    • Pheochromocytomas: a single centre experience

      ea0029p115
    • Removal of the dominantly secreting adrenal lateralized by bilateral adrenal venous sampling (BAVS) with glucagon stimulation significantly alleviated hypertension in patients with bilateral adrenal pheochromocytoma

      ea0029p116
    • Neuroendocrine markers in biochemical vs pathology diagnosis of pheochromocytoma

      ea0029p117
    • Geranylgeraniols are essential for adrenal catecholamine secretion

      ea0029p118
    • Neither classical symptoms of phaeochromocytoma nor elevated urinary catecholamines are always seen in patients with histologically verified phaeochromocytoma

      ea0029p119
    • The unique case of adrenal malignant non-functioning oncocytic pheochromocytoma

      ea0029p120
    • A rare case of adrenocorticotropic hormone-producing Pheochromocytoma

      ea0029p121
    • A Novel SDHC mutation associated with Head-Neck Paraganglioma

      ea0029p122
    • Features at presentation of adrenal pheochromocytomas in castilla la mancha (spain). Is the clinical spectrum changing ?

      ea0029p123
    • Incidentally discovered pheochromocytoma (PH)

      ea0029p124
    • Pheochromocytoma incidentally discovered after thyroid surgery manifesting dramatic hypertensive crisis induced by metoclopramide

      ea0029p125
    • A case of adrenoleukodystrophy presenting as progressive cerebellar dysfunction

      ea0029p126
    • Clinical peculiarities of pheochromocytoma in a MEN2A family

      ea0029p127
    • Pheochromocytoma in neurofibromatosis type 1

      ea0029p128
  • Bone & Osteoporosis
  • • Unilateral and bilateral adrenal incidentaloma: comparing clinical and biochemical features

      ea0029p129
    • Bone mineral density is associated with BsmI vitamin D receptor's polymorphism in adult patients with epilepsy

      ea0029p130
    • Vitamin D and estrogen receptors' polymorphisms in postmenopausal women

      ea0029p131
    • Osteoporosis and vitamin D deficiency in patients with lipid storage disease

      ea0029p132
    • De novo autoimmune hepatitis associated with PTH(1-34) and PTH(1-84) administration for severe osteoporosis in a liver transplant patient

      ea0029p133
    • Osteogenesis imperfecta: phenotypic characteristics and response to treatment in an Irish cohort

      ea0029p134
    • Bone mineral density in diabetic postmenopausal women with bone fracture

      ea0029p135
    • Evidence for vitamin D deficiency and increased fractures' prevalence in autoimmune bullous skin diseases

      ea0029p136
    • A correlation between bone mass density and body mass index and the lipid profile?

      ea0029p137
    • Vertebral fracture risk and bone metabolism in patients with addison's disease

      ea0029p138
    • Bone mineral density and muscle mass in women with multiple sclerosis

      ea0029p139
    • Teriparatide: effects on cortical bone microstructure

      ea0029p140
    • Serum soluble RANKL levels are related to breast arterial calcification and hypertension in Japanese osteoporotic postmenopausal women

      ea0029p141
    • BMP-3b inhibits osteoblast differentiation via Smad2/3 pathway by counteracting Smad1/5/8 signaling

      ea0029p142
    • Glucocorticoid - treatment in the adrogenital syndrome due to deficit of 21-hydroxylase: long-term bone side effects

      ea0029p143
    • Polymorphism of the vitamin D3 receptor gene and bone mineral density in girls with functional hypothalamic amenorrhea subjected to estroprogestagen treatment

      ea0029p144
    • Altered bone mineral density in unilaterally orchiectomized subjects

      ea0029p145
    • Effects of aminobisphosphonates and thiazides in patients with osteopenia/osteoporosis, hypercalciuria and recurring renal calcium lithiasis

      ea0029p146
    • Bone mineral density in patients with thalassaemia major in the UK

      ea0029p147
    • Abstract unavailable

      ea0029p148
    • Both high- and low levels of procollagen type 1 amino-terminal propeptide are associated with increased risk of hip fracture in elderly women. Norwegian Epidemiologic Osteoporosis Studies

      ea0029p149
    • Alendronate inhibits adipocyte differentiation in 3T3-L1 through a Vitamin D receptor mediated effect

      ea0029p150
    • Genetic predispositions do not explain short- and long-term effects of hormonal therapy on bone mineral density in girls with functional hypothalamic amenorrhea

      ea0029p151
    • Improved assessment of bone turnover by the PTH-(1-84)/ large C-PTH fragments ratio in dialysis patients

      ea0029p152
    • Comparaison of serum PTH concentrations obtained with a second and a third generation assay in a cohort of hemodialysis patients according to the KDIGO guidelines

      ea0029p153
    • Endoscopic comparison of esophageal and gastroduodenal mucosal effects of enterocoating alendronate with calcitriol combined drug and alendronate in Korean postmenopausal women

      ea0029p154
    • Functional hypoparathyroidism is a risk factor for bone fragility of postmenopausal women with vitamin D insufficiency

      ea0029p155
    • Platinum nanoparticle reduces ovariectomy-induced bone loss by decreasing osteoclastogenesis

      ea0029p156
    • The level of Osterix expression in osteoblasts is important to prevent IL6-induced inflammatory-prone state

      ea0029p157
    • Osteopenia/osteoporosis in patients with calcium nephrolithiasis

      ea0029p158
    • No effect of long-term valproate monotherapy on bone mineral density in adults with epilepsy

      ea0029p159
    • Bone cross-sectional geometry and strength parameters at the radius by pQCT in male obese adolescents

      ea0029p160
    • Osteonecrosis of the jaw (ONJ) with superimposed osteomyelitis related to actinomyces in a patient with multiple myeloma receiving thalidomide and intravenous zoledronic acid

      ea0029p161
    • Effect of alcohol consumption on bone mineral density in healthy elderly Spanish males

      ea0029p162
    • Effect of alendronate on bone mineral density in primary hyperparathyroidism

      ea0029p163
    • Association of monocyte chemoatractant protein-1 and adiponectin with bone mineral density and osteocalcin in postmenopausal women

      ea0029p164
    • Age-dependent and sexual features of bone mineral density changes in rats with hyperthyroidism

      ea0029p165
    • Sinomaxillary myopericytoma associated with oncogenic osteomalacia

      ea0029p166
    • Body composition in postmenopausal women with vertebral fractures

      ea0029p167
    • Bone mineral density in relation to metabolic syndrome in postmenopausal women with diabetes type 2

      ea0029p168
    • Assessment of bone turnover and vitamin D levels in women with postmenopausal osteoporosis and type 2 diabetes mellitus

      ea0029p169
    • Osteoblast and adipocyte differentiation from human adipose tissue-derived cells

      ea0029p170
    • Denosumab increases BMD in primary hyperparathyroidism

      ea0029p171
    • Relationship between bone metabolism markers, bone mineral density and insulinresistance in healthy and diabetic postmenopausal women

      ea0029p172
    • The relation between quantitative characteristics of smoking and level of female skeleton damage

      ea0029p173
    • The assessment of the behavior of the interleukins IL1[beta] and IL6 and bone mineral density (BMD) and bone metabolism (IBM) in women of postmenopausal age

      ea0029p174
    • Correction of bone mineral density losing in female rats with exogenous thyrotoxicosis with calcium and alendronate preparations

      ea0029p175
    • Reference intervals for serum N-MID osteocalcin concentration measured with the IDS-iSYS automated system

      ea0029p176
    • Prevalence of morphometric vertebral fractures and bone quality measured by spinal deformity index in type 1 diabetic patients

      ea0029p177
    • Clinical evaluation of a new specific 1-84 PTH automated platform

      ea0029p178
    • Successful treatment of thyrotoxicosis is accompanied by a decrease in serum sclerostin levels

      ea0029p179
    • Investigating recurrent hypophostaemia

      ea0029p180
    • Ovariectomy modulates the effect of phytoestrogens on creatine kinase specific activity in skeletal organs in female rats

      ea0029p181
    • Bone turnover markers in medicamentous and physiological hyperprolactinemia in female rats

      ea0029p182
    • Adiponectin and bone mineral density in obese postmenopausal women

      ea0029p183
    • The body mass index and heel quantitative ultrasound analyze in 300 women

      ea0029p184
    • Cimetidine (histamine H2-receptor antagonist and antiandrogenic drug) exerts a beneficial effect in the injured tissues by periodontal disease in male rat molars

      ea0029p185
    • Age-dependent and sexual features of bone mineral density changes in rats in remote terms after hyperthyroidism abolition

      ea0029p186
    • Features of bone mineral density losing in ukranian woman of different ages with thyrotoxicosis

      ea0029p187
    • Comparison of the effects of hormone replacement therapy on bone mineral density, lipid profiles, and biochemical markers of bone metabolism

      ea0029p188
    • Bone mass in diabetic patients measured by lumbar spine and hip densitometry

      ea0029p189
    • Efficacy, safety and adherence to treatment of teriparatide: an observational study

      ea0029p190
    • Thyroxin treatment of multinodular and normofunctional goiter and bone mass.

      ea0029p191
    • Vitamin D status in patients treated with intravenous ibandronate: a cohort study

      ea0029p192
    • Correlations between the bone matrix markers and bone mineral density in postmenopausal osteoporosis

      ea0029p193
    • Zoledronic acid treatment improve bone strenght parameters assessed by BMD

      ea0029p194
    • Therapeutical management in hypogonadal osteoporosis

      ea0029p195
  • Calcium & Vitamin D metabolism
  • • PTH levels are associated with insulin resistance in PCOS women

      ea0029p196
    • Dietary effect of calcium and vitamin D on the gene expressions of tight junction in the duodenum and kidney of calbindin-D9k, -D28k and -D9k/D28k knockout mice

      ea0029p197
    • Serum IGF1 concentration is positively associated with 25-hydroxyvitamin D level and increases upon treatment with vitamin D

      ea0029p198
    • Incidence of diabetes and vitamin D deficiency: a prospective cohort study

      ea0029p199
    • Tissue-specific expression of transcellular calcium transport and paracellular tight junction genes in the placentas of calbindin-D9k, -D28k, and -D9k/D28k knockout mice

      ea0029p200
    • Gitelman's syndrome presenting with hypercalcaemia due to severe primary hyperparathyroidism

      ea0029p201
    • Vitamin D pathway in non-functioning pituitary adenomas

      ea0029p202
    • A new cause of malignancy associated hypercalcemia (MAH): PTH releasing breast cancer

      ea0029p203
    • Two cases of alendronate induced atypical fracture of femur shaft

      ea0029p204
    • Vitamin D levels and carbohydrate metabolism

      ea0029p205
    • A single metastatic lesion in the leg of a parathyroid carcinoma

      ea0029p206
    • Pseudohypoparathyroidism type Ia, hypothyroidism and insulin resistance

      ea0029p207
    • A diagnostic conundrum associated with hypercalcaemia

      ea0029p208
    • Expression of 25-hydroxyvitamin D3-1[alpha]-hydroxylase and 24-hydroxylase in human vascular smooth muscle cells

      ea0029p209
    • Longitudinal changes in serum 25-hydroxyvitamin D levels of older persons during 6 and 13 years of follow-up

      ea0029p210
    • Primary hyperparathyroidism, vitamin D deficiency and quality of life

      ea0029p211
    • Cinacalcet treatment in MEN1-associated hyperparathyroidism: a clinical trial

      ea0029p212
    • Serum levels of soluble secreted [alpha]-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis

      ea0029p213
    • Lack of effects of high dose colecalciferol (D3) on insulin sensitivity and metabolic markers in type 2 diabetic patients: a double-blind, randomised, placebo-controlled trial

      ea0029p214
    • Blood pressure after parathyroidectomy in patients with primary hyperparathyroidism and hypertension

      ea0029p215
    • Serum cystatin C is a reliable predictor of renal function and cardiometabolic risk in primary hyperparathyroidism

      ea0029p216
    • Usefulness of MS-MLPA for detection of genetic and epigenetic states of GNAS complex in Pseudohypoparathyroidism type1b

      ea0029p217
    • Pathophysiological changes in extracellular pH regulate calcium-sensing receptor responsiveness in HEK-293 and isolated parathyroid cells but not as a result of altered histidine residue ionisation

      ea0029p218
    • Normocalcemic hyperparathyroidism: a personal experience

      ea0029p219
    • Cardiac structure and functions in patients with asymptomatic primary hyperparathyroidism

      ea0029p220
    • Perioperative management difficulties in parathyroidectomy for primary vs secondary and tertiary hyperparathyroidism

      ea0029p221
    • Evaluation of glucose metabolism in primary hyperparathyroid patients

      ea0029p222
    • The prevalence of hypocalcaemia with low parathyroid hormone level in Polish elderly population

      ea0029p223
    • Obesity, carbohydrate, lipid metabolism and polymorphisms (Fok, Bsm) of vitamin D receptor gene in aging population: POLSENIOR study

      ea0029p224
    • Quality of life in premenopausal women with vitamin D deficiency and vitamin D insufficiency

      ea0029p225
    • Intraoperative parathormone monitoring allows successful minimally invasive parathyroidectomy in patients with non concordant preoperative imaging

      ea0029p226
    • Vitamin D status, chronic kidney disease and secondary hyperparathyroidism in Polish elderly population

      ea0029p227
    • Vitamin D status in primary hyperparathyroidism: a 'Southern European' observational study

      ea0029p228
    • Vitamin D and rheumatoid arthritis

      ea0029p229
    • The prevalence of primary hyperparathyroidism in Polish elderly population

      ea0029p230
    • Markers of bone turnover and polymorphism of vitamin D receptor gene in aging population: POLSENIOR study

      ea0029p231
    • Endothelial functions of the patients with hyperparathyroidism

      ea0029p232
    • The importance of citrate and the calcium/citrate ratio in patients with calcium renal lithiasis and severe lithogenesis

      ea0029p233
    • The diagnostic values of serum intact parathyroid hormone, calcium and phosphorus for the prediction of vitamin D deficiency

      ea0029p234
    • Vitamin D and gestational diabetes

      ea0029p235
    • Bone biomarkers, body composition and metabolic profile in patients with primary hyperparathyroidism

      ea0029p236
    • The daily calcium intake is associated with sarcopenia in older, non-obese koreans: the fourth korea national health an nutrition examination surveys (KNHANES IV) 2009

      ea0029p237
    • Role of chromogranin-A in the truncation of parathyroid hormone in cultured parathyroid cells from patients of the secondary hyperparathyroidism

      ea0029p238
    • Correlations between vitamin D supply and PTH-intact and PTH-bio-intact levels in dialysis patients

      ea0029p239
    • Relationship among time outside, sun exposure, clothing worn, adiposity and serum 25(OH)D in overweight and obese adults

      ea0029p240
    • Prospects of patients with oligosymptomatic primary hyperparathyroidism

      ea0029p241
    • Cross-reactivity of 25-hydroxyvitamin D2 in ADVIA centaur vitamin D assay

      ea0029p242
    • Primary hyperparathyroidism: association of imaging and pathology

      ea0029p243
    • Vitamin D modulates composition of extracellular matrix in cultured human vascular cells

      ea0029p244
    • Vitamin D level and ALT level in Chinese-American patients with chronic hepaitits B in the new york city downtown area

      ea0029p245
    • High levels of parathormone after parathyroidectomy in primary hyperparathyroidism patients does not always mean disease recurrence...

      ea0029p246
    • Sporadic pseudohypoparathyroidism with osteitis fibrosa cystica

      ea0029p247
    • Vitamin D supply in healthy blood donors: is there relationship with the use of oral contraceptives?

      ea0029p248
    • Chronic hypercalcemia, an unusual presentation in Q1011E heterozygous CaSR polymorphism

      ea0029p249
    • Quantification of serum 25-hydroxyvitamin D: a comparison among immunoassay, HPLC-UV, and HPLC-MS

      ea0029p250
    • Vitamin D deficiency and insufficiency and secondary hyperparathyroidism in Ukrainian population

      ea0029p251
    • Prevalence of hypovitaminosis D in adult patients with hypopituitarism

      ea0029p252
    • Treatment of vitamin D insufficiency with oral loading doses of cholecalciferol

      ea0029p253
    • A 10-year study of vitamin D in Moldova

      ea0029p254
    • 25-Hydroxi-vitamin-D levels in clinical conditions with low plasma albumin

      ea0029p255
    • The impact of different vitamin D preparations for the treatment of vitamin D deficiency in primary hyperparathyroidism (PTHP)

      ea0029p256
    • Identification of a novel mutation in the calcium sensing receptor gene in FHH

      ea0029p257
    • Vitamin D status in patients with musculoskeletal symptoms in Haryana, India

      ea0029p258
    • Evaluation of the platelet functions in hyperparathyroid patients

      ea0029p259
    • The relation between endocrine and radiological changes in adolescents with vitamin D deficiency

      ea0029p260
    • Remember calcium! Fahr's syndrome diagnosed after repeated generalized seizures: a case report

      ea0029p261
    • Assessment of vitamin D 3 status in general population

      ea0029p262
    • Unrecognized severe vitamin D deficiency

      ea0029p263
    • Evaluation of clinical and laboratory findings of our primary hyperparathyroid patients

      ea0029p264
    • Experience in the treatment of primary hyperparathyroidism with cinacalcet: Preliminary data

      ea0029p265
    • Primary hypoparathyroidism presenting as adult onset seizure: a report of two cases

      ea0029p266
    • Vitamin D status in primary hyperparathyroidism

      ea0029p267
    • Vitamin D deficiency repletion in patients with co-existing vitamin D deficiency and primary hyperparathyreoidism: pro for early postoperative or preoperative treatment: case reports

      ea0029p268
  • Cardiovascular Endocrinology and Lipid Metabolism
  • • Testosterone replacement therapy inhibits key enzymes of fatty acid synthesis in mouse liver

      ea0029p269
    • Effect of testosterone on hepatic liver X receptor and ApoE expression as a potential mechanism of atheroprotection in the testicular feminised mouse

      ea0029p270
    • The effect of potassium supplementation on the endothelium, the renin-angiotensin-aldosterone system (RAAS) and blood pressure in patients at moderate cardiovascular disease risk

      ea0029p271
    • (Pro)renin Receptor is essential for filtration barrier in glomerular podocyte

      ea0029p272
    • Testosterone replacement therapy: a safety audit of clinical practice including men with Type 2 diabetes and cardiovascular disease

      ea0029p273
    • Thyroid axis hormones and cortisol are associated with subjective fatigue in patients with coronary artery disease

      ea0029p274
    • Familiar hypercholesterolemia: effects of treatment with rosuvastin

      ea0029p275
    • Metabolic and glycaemic profile in patients with acute coronary syndrome

      ea0029p276
    • Impact of 6-month course of 1 mg finasteride tablets on levels of lipid profile in men with androgenic alopecia

      ea0029p277
    • Transient glucocorticoid excess does not cause persisting metabolic changes in mice

      ea0029p278
    • Gastrectomy for early gastric cancer is associated with decreased cardiovascular mortality in accordance with amelioration of metabolic abnormalities, visceral adiposity and atherosclerosis

      ea0029p279
    • The role of testosterone activation of liver X receptor in a human macrophage cell line and its implications for the treatment of type 2 diabetes and atherosclerosis

      ea0029p280
    • Chemerin/CMKLR1 and adiponectin/T-cadherin expression in human coronary arterial wall and pericoronary adipose tissue in correlation with atherosclerosis

      ea0029p281
    • Six loci associated with high-density lipoprotein cholesterol or triglycerides in Chinese pregnant women

      ea0029p282
    • Development of primary hyperparathyroidism is closely associated with the onset of dyslipidemia and insulin resistance in a large family harboring a MEN1 gene mutation

      ea0029p283
    • Level of adiponectin and vaspin, and adiponectin/vaspin ratio is associated with insulin resistance and clinical expression of metabolic syndrome in type 2 diabetic patients

      ea0029p284
    • Insulin mediates the glucagon-induced decrease in atrial natriuretic peptide: a randomized controlled trial

      ea0029p285
    • The role of [beta]-arrestin proteins in CB1 cannabinoid receptor endocytosis

      ea0029p286
    • Abstract unavailable

      ea0029p287
    • Plasma aldosterone to plasma renin ratio on an automated analyzer using two novel chemiluminescence immunoassays

      ea0029p288
    • Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study

      ea0029p289
    • Testosterone and cardiovascular risk in patients with erectile dysfunction

      ea0029p290
    • Oxytocin stimulates cardiomyogenesis and cardioprotection via stem cells activation

      ea0029p291
    • Metabolism of angiotensin II and angiotensin III in HAC15 cells

      ea0029p292
    • Chemerin/CMKLR1 and adiponectin/T-cadherin expression in human aortic wall and periaortic adipose tissue in correlation with atherosclerosis

      ea0029p293
    • In primary aldosteronism, plasma aldosterone concentration is an independent risk factor for albuminuria, and the higher baseline urinary albumin excretion predicts the less glomerular filtration rate after treatment

      ea0029p294
    • Relationships between insulin resistance and cardiovascular risk factors in primary hyperparathyroidism

      ea0029p295
    • Allosteric effects between the protomers of AT1 angiotensin receptor homodimer: role of the conserved DRY motif

      ea0029p296
    • Effect of triiodothyronine and angiotensin-II on expression of (pro)renin receptor in the human erythroid cell line, YN-1

      ea0029p297
    • The combined use of serum interleukin 6 and C-reactive protein is better than either alone in predicting cardiovascular events in a Chinese population

      ea0029p298
    • Short-term detraining cannot reverse insulin sensitivity improvement and serum retinol binding protein 4 in spontaneously hypertensive rats previously submitted to aerobic exercise

      ea0029p299
    • Multiple cardiovascular risk factors in patients with myotonic dystrophy type 1 and 2

      ea0029p300
    • Role of peroxisome proliferator-activated receptor-[gamma] (PPAR[gamma]) in regulation of glucocorticoid metabolism in vascular smooth muscle cells

      ea0029p301
    • Recombinant erythropoietin treatment enhances mitochondrial function in human skeletal muscle

      ea0029p302
    • Association of IL4 receptor gene polymorphisms with high density lipoprotein cholesterol

      ea0029p303
    • Cardiovascular risk factors in a large cohort of children with GH deficiency

      ea0029p304
    • Lipid profile in children with persistent idiopathic subclinical hypothyroidism

      ea0029p305
    • Variants of endothelial nitric oxide synthase gene are associated with components of metabolic syndrome in an Arab population

      ea0029p306
    • MRTF-A, a rho-dependent co-activator of SRF, regulates phenotypic modulation of vascular smooth muscle cells and plays an important role in vascular remodeling

      ea0029p307
    • Association of PON-1 activity and other anti-oxidative enzymes with long-chain fatty acids profile in T2DM

      ea0029p308
    • Risk factors of metabolic syndrome in adolescent with classical congenital adrenal hyperplasia

      ea0029p309
    • Alterations of protein expression profiles in 3T3-L1 adipocytes by interleukin 4

      ea0029p310
    • Anti-Mullerian hormone may be a hormonal regulator of the cardiovascular system

      ea0029p311
    • Anti-oxidataive actions of urocortin on HL-1 cardiomyocytes

      ea0029p312
    • Adipokine expression profile in pericoronary and periaortic adipose tissue in correlation with coronary and aortic atherosclerosis

      ea0029p313
    • Fatty liver index and lipid accumulation product index as markers of liver steatosis in premenopausal women with nonalcoholic fatty liver disease

      ea0029p314
    • Effects of long-term treatment of hypogonadal men with testosterone undecanoate on blood pressure, fasting glucose, HbA1c and C-reactive protein

      ea0029p315
    • Dysregulation of tissue renin-angiotensin-aldosterone system in obese hypertensive rats

      ea0029p316
    • The relationship between 25(OH)D levels and markers of atherosclerosis and inflammation in type 2 diabetic patients

      ea0029p317
    • Plasma total homocysteine levels in transsexuals after cross-sex hormonal treatment

      ea0029p318
    • Body composition and association to NT-proBNP and myostatin levels in heart failure patients

      ea0029p319
    • Subclinical atherosclerosis and arterial stiffness are associated with levels of circulating androgens in healthy recently menopausal women

      ea0029p320
    • Metabolic syndrome, hormone levels and inflammation in patients with erectile dysfunction

      ea0029p321
    • Duration effect of statin therapy on bone metabolism in dyslipidemic patients

      ea0029p322
    • Coronary flow reserve is inversely related to urinary cortisol in Cushing's syndrome

      ea0029p323
    • Myeloperoxidase is not associated with applications of coronary artery disease and type 2 diabetic patients

      ea0029p324
    • Analysis of hyponatremia in a tertiary hospital during a 5 year period

      ea0029p325
    • Effect of melatonin supplementation on lipid peroxidation and on the enzymes of antioxidative system in patients with chronic coronary artery disease.

      ea0029p326
    • N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with non-ST-elevation myocardial infarction (NSTEMI) compared to patients with unstable angina (UA) in a lot of patients admitted for non-ST-elevation acute coronary syndrome (NSTE-ACS)

      ea0029p327
    • Effect of medical therapy on 24-h blood pressure profile in acromegaly

      ea0029p328
    • Polycystic ovary syndrome induces leukocyte/endothelial cell interactions

      ea0029p329
    • Effect of weight loss on C3 and C4 components of complement in obesity

      ea0029p330
    • Vitamin D serum levels and cardiovascular risk factors in postmenopausal women

      ea0029p331
    • Sympathetic over-activity and low adrenocortical responses to hypoglycemia in patients in early stage of hypertension

      ea0029p332
    • The effect of thyroxine replacement on reduction of small dense low-density lipoprotein (sdLDL) in patients with primary hypothyroidism.

      ea0029p333
    • Metabolic consequences of obesity in children and adolescents

      ea0029p334
    • Study on the DHEA-S secretion dynamics in elderly pacients with cardiovascular diseases

      ea0029p335
    • Testosterone and androstane-3[alpha], 17[beta]-diol glucuronide correlate with coronary disease

      ea0029p336
    • Cardiovascular function and IGF1 deficit (IGF1-D) in [beta]-thalassemia major

      ea0029p337
    • Psoriasis is associated with decreased adiponectin levels beyond cardiovascular and metabolic risk factors

      ea0029p338
    • The importance of HDL cholesterol to predict adiponectin and retinol binding protein 4 concentration after one session resistance exercise

      ea0029p339
    • Intrinsic myocardial disease in adults with GH deficiency is characterised by subclinical left ventricular longitudinal dysfunction revealed by tissue Doppler

      ea0029p340
    • Paraoxonase, malondialdehyde and lipids in subjects with asymptomatic gallstones

      ea0029p341
    • Cardiac hormones are dual inhibitors of vascular endothelial growth factor and the VEGFR2 receptor

      ea0029p341.1
  • Clinical case reports - Pituitary/Adrenal
  • • Localization of occult adrenal tissue with cosyntropin-stimulated 18F-FDG-PET/CT in a patient with metachronous adrenocortical tumor who presented with persistently elevated SDHEA after bilateral adrenalectomy

      ea0029p342
    • A case of pheochromocytoma which represented multiple myeloma like change

      ea0029p343
    • Reactivation of Takayasu arteritis in two patients with Cushing's disease after normalization of cortisol secretion.

      ea0029p344
    • Delayed presentation of late onset CSF rhinorrhoea following dopamine agonist therapy for giant prolactinoma

      ea0029p345
    • ACTH-dependent Cushing's syndrome secondary to an ectopic source of ACTH/CRH: three clinical cases with different prognosis and outcome

      ea0029p346
    • Hyponatraemia assessment and outcomes in acute medically ill patients

      ea0029p347
    • A clinical case of a 21 years old man with inborn pituitary dystopia

      ea0029p348
    • A case of acromegaly without clear evidence of pituitary adenoma or ectopic GH/GHRH secreting tumors

      ea0029p349
    • Evaluation on clinical application and long term outcomes of microwave endometrial ablation

      ea0029p350
    • Familial central diabetes insipidus due to a novel mutation in exon 3 of the arginine vasopressin gene

      ea0029p351
    • Successful pregnancy during use of octreotide and pegvisomant in an acromegalic patient

      ea0029p352
    • Long-term efficacy and safety of pasireotide in Cushing's disease: a 36-month case report

      ea0029p353
    • Control of acromegaly in an era where it is technically feasible in almost every patient, is by no means invariable even in a specialist unit

      ea0029p354
    • A case of adrenocortical carcinoma with fever of unknown origin and elevated serum IL6 level

      ea0029p355
    • Desmopressin and non steroidal anti-inflammatory drugs: a case report of severe water intoxication during replacement therapy and review of the literature

      ea0029p356
    • Germ cell tumor of the pituitary-hypothalamic region: case series and clinical experience in the Hospital Universitario Virgen del Rocio

      ea0029p357
    • Adrenal venous sampling for two cases with primary pigmented nodular adrenocortical disease

      ea0029p358
    • Cyclic Cushing's syndrome due to occult ectopic ACTH secretion

      ea0029p359
    • Use of tolvaptan for delayed hyponatremia after transsphenoidal surgery for pituitary adenoma: a case report

      ea0029p360
    • Familial isolated pituitary adenoma cases in Hungary

      ea0029p361
    • Hypopituitarism in an adult patient as the first sign of langerhans cell histiocytosis

      ea0029p362
    • A case of cyclic Cushing's syndrome which was induced remission dramatically by dopamine agonist

      ea0029p363
    • Antinociceptive effect of pasireotide on octreotide-resistant acromegaly-related headache

      ea0029p364
    • Giant cystic pheochromocytoma in an asymptomatic man

      ea0029p365
    • Unusual presentation of hypopituitarism

      ea0029p366
    • Rhabdomyolysis and myopathy in Addison's disease: is there a connection?

      ea0029p367
    • Efficacy of tolvaptan treatment in a patient with syndrome of inappropriate antidiuresis (SIAD) after severe traumatic brain injury

      ea0029p368
    • A rare case of primary tubercular pituitary abscess in a diabetic patient

      ea0029p369
    • Central diabetes insipidus as first sign of progression to accelerated phase in a chronic myeloid leukemia patient

      ea0029p370
    • Contrast-enhanced ultrasound supports diagnosis in a patient with paravesical paraganglioma

      ea0029p371
    • Pituicytoma and meningeoma presenting as suprasellar tumor: case report

      ea0029p372
    • A clinical case report of an successful spontaneous pregnancy in acromegaly

      ea0029p373
    • Childhood onset hypopituitarism and central apnea: looking beyond hormonal replacement

      ea0029p374
    • Cystic pituitary macroadenoma complicated by recurrent mucocoeles: a rare case report

      ea0029p375
    • A patient with TSH-secreting pituitary macroadenoma, after previous thyroid ablation, successfully treated with long-acting octreotide formulation (octreotide-LAR) and transsphenoidal surgery

      ea0029p376
    • Synchronous papillary and medullary thyroid carcinoma in an acromegaly patient

      ea0029p377
    • Pregnancy in an acromegalic woman: a case report

      ea0029p378
    • Acromegaly, primary hyperparathyroidism and renal cell carcinoma

      ea0029p379
    • Late diagnosis of adrenal tuberculosis

      ea0029p380
    • Spontaneous remission of acromegaly due to pituitary apoplexy: case report

      ea0029p381
    • Oligosymptomatic paraganglioma in the setting of neurofibromatosis type 1

      ea0029p382
    • Histiocytosis X-manifested with insipid diabetes clinical case

      ea0029p383
    • A case history as example for diagnostics and treatment of acromegaly: started and ended with pregnancy

      ea0029p384
    • Adrenal neurilemoma

      ea0029p385
    • A case of autoimmune polyglandular syndrome type II presenting with adrenal crisis

      ea0029p386
    • Elephantiasis nostras verrucosa as a presenting cause of Cushings' disease

      ea0029p387
    • Syndrome of inappropriate secretion of antidiuretic hormone in a elderly women affected with herpes zoster infection: a case report

      ea0029p388
    • Hyponatremia and cytolysis as first signs of decompensated pituitary insufficiency: case report

      ea0029p389
    • Acromegaly and pregnancy: two acromegalic patients treated with somatostatin analogues

      ea0029p390
    • Particular course of a case of acromegaly associated with Waldenstrom's macroglobulinaemia

      ea0029p391
    • A case of acromegaly with nephrogenic adenoma of the bladder: a rare association?

      ea0029p392
    • Recovery of prolactin function following spontaneous pregnancy in a patient with Sheehan's syndrome

      ea0029p393
    • Giant macroprolactinoma: recidive after 12 years (case report)

      ea0029p394
    • An uncommon cause of hypoglycaemia: a case report

      ea0029p395
    • Central diabetes insipidus: about two clinical cases

      ea0029p396
    • Macroprolactinomas: therapy compliance (case report)

      ea0029p397
    • Endocrine hypertension due to primary aldosteronism

      ea0029p398
    • Unusual association between pheochromocytoma, adrenocortical nodular hyperplasia and empty sella: case report

      ea0029p399
  • Clinical case reports - Thyroid/Others
  • • New diabetic emergency; acute rhabdomyolysis complicating hyperglycemic hyperosmolar coma successful management and insight into pathogenesis

      ea0029p400
    • Laminopathy and auto-immune sclerodermia: chance or necessity?

      ea0029p401
    • Pendred's syndrome: genetics and phenotypic variability

      ea0029p402
    • A rare case of vanishing fetal goiter and role of colour doppler ultrasound in the diagnosis

      ea0029p403
    • Gastrostomy solves severe hypoglycemias after bariatric surgery

      ea0029p404
    • Pubertal induction with testosterone of a boy with bilateral anorchia guided by the development of his monozygotic twin brother

      ea0029p405
    • Pseudohypoparathyroidism type Ib: a case of occult familial disease

      ea0029p406
    • Considering familial benign hypocalciuric hypercalcemia on differential diagnosis of primary hyperparathyroidism

      ea0029p407
    • The diagnostic challenge of a parathyroid adenoma undetectable by Tc-99m Sestamibi scintigraphy or computed tomography in a patient with newly diagnosed sarcoidosis and hypercalcaemia

      ea0029p408
    • Severe gestational hypothyroidism due to anti-TSH receptor blocking antibodies

      ea0029p409
    • A case of refractory hypoglycemia

      ea0029p410
    • Double jeopardy in pregnancy: a case of autoimmune polyglandular syndrome type 2 in a pregnant patient

      ea0029p411
    • Pseudo malabsorption of levothyroxine

      ea0029p412
    • Vitamin D deficiency and elevation of para-thyroid in Thalassemia minor: a case study

      ea0029p413
    • Study of hormone and thyroid antibodies of auto-immune thyroid disorders

      ea0029p414
    • New insulin receptor mutation in a patient with primary amenorrhea

      ea0029p415
    • Plasmapheresis therapy in a case with recurrent pancraetitis attacks as a consequence of hypertryglyceridemia

      ea0029p416
    • Association of thyroid hormone resistance and hypogonadotropic hypogonadism

      ea0029p417
    • 5-Alpha reductase type 2 deficiency: a case report

      ea0029p418
    • Subacute or hashimoto thyroiditis? a diagnostic dilemma: case report

      ea0029p419
    • True hermaphroditism with a rare 46,XX/47,XXY Klinefelter's mosaicism: a new unique case and review of previous reports

      ea0029p420
    • Genetics of HLA-identical monozygous twins with different manifestations of polyglandular autoimmune syndrome

      ea0029p421
    • Papillary thyroid-type carcinoma arising from struma ovarii: a case report

      ea0029p422
    • Hypothyroidism with extensive pericardial effusion: different therapeutical approaches

      ea0029p423
    • Abstract unavailable

      ea0029p424
    • A case of persistent hypoglycemia in the setting of connective tissue disease

      ea0029p425
    • Successful pregnancy in a patient with biologically inactive LH or partial LHCGR resistance

      ea0029p426
    • Quadruple metachronous malignancy in a single patient with multiple sclerosis: case report

      ea0029p427
    • Hungry bone syndrome in a patient with McCune-Albright syndrome after total thyroidectomy: case report

      ea0029p428
    • A case with thyroid metastasis from small cell lung carcinoma

      ea0029p429
    • Central hypothyroidism following peripheral hyperthyroidism: a brief case report

      ea0029p430
    • Impact of glibenclamide therapy in a patient with neonatal diabetes and intermediate DEND syndrome with the V59M mutation in the KCNJ11 gene

      ea0029p431
    • Parkinson-like syndrom as a unusual manifestation of primary hypoparathyroidism: case report

      ea0029p432
    • Van Wyk e Grumbach syndrome: case report

      ea0029p433
    • Primary hyperparathyroidism associated with autoimmune polyglandular syndrome type III and isolated IgA deficiency

      ea0029p434
    • Reversible Hashimoto's thyroiditis: clinical, hormonal, autoimmune and ultrasonographic evidence

      ea0029p435
    • Hypoparathyroidism - a rare cause of heart failure

      ea0029p436
    • Hypogonadism with subsequent multi-organ involvement: a mystery solved

      ea0029p437
    • Thyrotoxicosis-associated acute myocardial infarction and ventricular fibrillation in a patient with normal epicardial coronary arteries

      ea0029p438
    • A case of papillary thyroid carcinoma with esophageal invasion treated by targeting PEI and transesophageal argon plasma coagulation

      ea0029p439
    • Association between diabetes mellitus and sarcoidosis: a case report

      ea0029p440
    • Noninsulinoma pancreatogenous hypoglycemia syndrome as a rare cause of hyperinsulinemic hypoglycemia: case report

      ea0029p441
    • A case of pneumomediastinum and tracheomalasia in thyroid storm with longstanding goiter

      ea0029p442
    • A case of pancytopenia with hyperthyroidism

      ea0029p443
    • Struma ovarii and the thyroid surgeon

      ea0029p444
    • Multiple myeloma associated with primary hyperparathyroidism

      ea0029p445
    • Graves' disease with a transient lung mass

      ea0029p446
    • Combination of recombinant TSH (rhTSH) and lithium overcomes amiodarone-induced low radioiodine uptake in a thyrotoxic female

      ea0029p447
    • Primary hypoparathyroidism presenting as recurrent TIAs with intracranial calcification

      ea0029p448
    • Ampullary NET presenting as Virchow's node

      ea0029p449
    • Unusual cause of hypokalemic paralysis

      ea0029p450
    • Paraneoplastic severe hyponatremia in a patient with GIST: case report

      ea0029p451
    • Papillary thyroid carcinoma in two patients with primary hyperparathyroidism

      ea0029p452
    • Marked improvement of gastrointestinal pseudo-obstruction after debulking surgery of malignant pheochromocytoma by Intravenous administration of [alpha]-blocker phentolamine

      ea0029p453
    • Primary and secondary hyperparathyroidism coexisting in patient with liver cirrhosis and coeliac disease: efficiency of preoperative treatment with vitamin D

      ea0029p454
    • Primary hyperparathyroidism and metastatic breast cancer: a simultaneous presentation

      ea0029p455
    • Insulinoma presenting as post-prandial hypoglycaemia

      ea0029p456
    • Malignant, ectopic ACTH secreting occult neuroendocrine tumor: a case report

      ea0029p457
    • Noonan Syndrome in adulthood: two cases reports

      ea0029p458
    • Unusual course of Amiodarone-induced hypothyroidism: case report

      ea0029p459
    • Anaplastic thyroid carcinoma: case report

      ea0029p460
    • 'Collision tumor' of the thyroid: a case report

      ea0029p461
    • Unknown reason of continuing hypercalcemia after successful extirpation of parathyroid gland

      ea0029p462
    • Catastrophic bone deformities associated with primary hyperparathyroidism in a middle-aged man

      ea0029p463
    • Severe fetal and neonatal hyperthyroidism following radioiodine therapy in a woman with Graves' disease

      ea0029p464
    • Hypercalcaemia in pregnancy

      ea0029p465
    • Ectopic Cushing's syndrome and thymic hyperplasia

      ea0029p466
    • Synchronous papillary thyroid cancer and astrocytoma: case report

      ea0029p467
    • Exogenous thyrotoxicosis by consumption of pork sausage

      ea0029p468
    • Ovarian hyperstimulation syndrome and autoimmune primary hypothyroidism in two members of a family

      ea0029p469
    • Novel treatment option in the management of SIADH related Hyponatremia: two case reports

      ea0029p470
    • Growth hormone: 'beginning of a new life'

      ea0029p471
    • Severe amiodaron: induced thyrotoxicosis

      ea0029p472
    • Thyreotoxic periodic paralysis in a Caucasian man after corticosteroid administration

      ea0029p473
    • Adrenal crisis due to unusual cause: case report

      ea0029p474
    • Persistently abnormal thyroid function in a 26 year old Afro-Caribbean man: a diagnostically challenging case

      ea0029p475
    • Asymptomatic hypocalcemia in elderly

      ea0029p476
    • Thyroid nodule: dormant, but lethal

      ea0029p477
    • Morbid obesity: what can be and should be done?

      ea0029p478
    • Sever Grave's disease and diabetes melitus

      ea0029p479
    • Secondary hypertension: a case presentation

      ea0029p480
  • Developmental endocrinology
  • • Regulation of trophoblast 11[beta]-hydroxysteroid dehydrogenase type 2 expression and role of corticotropin-releasing hormone

      ea0029p481
    • Dimensional profiles of male to female gender identity disorder: an exploratory research

      ea0029p482
    • GH replacement therapy in patients with primary paediatric brain tumours

      ea0029p483
    • The effect of educational program based on BASNEF model on diabetic (type II) control blood sugar

      ea0029p484
    • The timing of the onset of adrenarche in Pakistani boys

      ea0029p485
    • Post prandial gut hormones: novel activators and regulators of innate immune function

      ea0029p486
    • Opposite effect of LXR on myelination process in the central and peripheral nervous systems and interplay with Wnt pathway

      ea0029p487
    • Increased oxidative stress associated with angiogenic growth factors in preeclampsia

      ea0029p488
    • Congenital hypothyroidism influences hepatic gene expression of suppressors of cytokine signaling (SOCS) in adulthood

      ea0029p489
    • Characterization of a mouse model of paediatric combined hormone deficiency

      ea0029p490
    • DHEA attenuated mature adipocyte proliferation

      ea0029p491
    • Oestradiol and its biochemical precursor levels decline in men around the age of their late twenties, what may determine the conclusion of bone maturation

      ea0029p492
    • The origins and lineages of somatic cells during the formation of the mammalian ovary

      ea0029p493
    • Childhood maltreatment in subjects with male to female gender identity disorder

      ea0029p494
    • Post prandial responses of insulin and free fatty acids following consumption malaysian vs mediterranean-like meals among healthy subjects

      ea0029p495
    • Evaluation of cognitive, affective and relational skills of adolescents treated with testosterone for 47XXY klinefelter syndrome

      ea0029p496
    • The development of endocrinologic dysfunction after allogeneic HSCT in children.

      ea0029p497
    • 46 XX Male syndrome: is there any relationship with dysembryoplastic neuroepithelioma?

      ea0029p498
  • Diabetes
  • • Selective suppression of slow wave sleep does not affect insulin sensitivity in patients with type 1 diabetes

      ea0029p499
    • Evidence that abscissic acid participates in the response to hyperglycemia in humans

      ea0029p500
    • Mitochondrial biogenesis is not significantly impaired in non obese asian indians with type 2 diabetes

      ea0029p501
    • Iron overload induces visceral adipose tissue insulin resistance

      ea0029p502
    • Comprehensive evaluation of type 2 diabetes susceptibility loci in the Japanese population by using 1000 Genomes Project data

      ea0029p503
    • Glycoalbumin is the best indicator for glycemic variability assessed by continuous glucose monitoring

      ea0029p504
    • Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly chinese

      ea0029p505
    • Altered Mitochondrial Bioenergetics Does Not Explain Increased Ros Production In Non-Obese Asian Indians With Type 2 Diabetes (T2D)

      ea0029p506
    • QRFP43 and its fragment 26RFa both promote [beta]-cell survival but differently regulate insulin secretion and glucose uptake in pancreatic [beta]-cells and human pancreatic islets

      ea0029p507
    • Influences of the 2011 Tohoku Earthquake on glycemic control in patients with diabetes mellitus in Tokyo

      ea0029p508
    • The impact of pioglitazone administration on circulating endothelial progenitor cells, inflammation and endothelial function of diabetic patients with and without coronary artery disease

      ea0029p509
    • The redution hypothalamic PP2A expression improve peripheral insulin sensitivity

      ea0029p510
    • The new combination of risk factors determining a high risk of gestational diabetes mellitus

      ea0029p511
    • Glycemic control influences CA19-9, CEA and ferritin levels in type 2 diabetes.

      ea0029p512
    • Effects of perindopril on circulating endothelial progenitor cells, inflammation and endothelial function of diabetic patients with and without coronary artery disease

      ea0029p513
    • Glycemic control in type 1 diabetic patients experience of a university hospital in tunis

      ea0029p514
    • Progression to impaired fasting glucose, impaired glucose tolerance and diabetes in urban population during 8 years follow up

      ea0029p515
    • The role of sex hormone-binding globulin in the risk of incident metabolic syndrome: further evidence from a longitudinal population-based sample of adult men.

      ea0029p516
    • Fracture predictors in diabetic postmenopausal women without hyperparathyroidism

      ea0029p517
    • Characteristics and prevalence of latent autoimmune diabetes in adults (LADA) in a diabetic population

      ea0029p518
    • Non Governmental Organizations [NGO's] [amp] Diabetes- Advocacy for support services in resource-poor nations

      ea0029p519
    • Mesenchymal stem cells-derived microvesicles modulate cellular immune response to islet antigen GAD in type 1 diabetes.

      ea0029p520
    • Prevalence of autoimmune diseases in a Type 1 diabetic population

      ea0029p521
    • Relation of glycemic control to Easter and summer holiday times

      ea0029p522
    • Change in quality of life by multiple education program in type 1 diabetic patients

      ea0029p523
    • Cystatin levels in diabetic and prediabetic patients

      ea0029p524
    • Psychoemotional state of diabetic women with fracture

      ea0029p525
    • Hypoglycemic and hyperglycemic patients in emergency room

      ea0029p526
    • Diabetes risk in relation to weight loss, weight stability and degree of obesity - The Swedish Obese Subjects (SOS) study

      ea0029p527
    • The role of Insulin Receptor in Cancer

      ea0029p528
    • Local effects of cytokine TNF-alpha on glucose, lipid and protein metabolism in the placebo controlled bilaterally perfused human leg

      ea0029p529
    • Increased nuclear translocation of GAPDH in peripheral blood mononuclear cells (PBMCs) of diabetic patients.

      ea0029p530
    • Conserved mitochondrial coupling and adaptive substrate control in inuit and caucasians: acclimatization to active life styles in the arctic winter

      ea0029p531
    • Association of adiposity trajectories with insulin sensitivity and glycemic deterioration: a longitudinal study of rural chinese twin adults

      ea0029p532
    • Direct metabolic effects of locally administered lipopolysaccharide in the placebo controlled bilaterally infused human leg; decreased insulin sensitivity and insulin signaling with unaltered lipid and protein metabolism

      ea0029p533
    • Suppressive effect of hyperinsulinemia on serum interleukin 18 concentration in young healthy subjects

      ea0029p534
    • The Association of the severity of nonalcoholic fatty liver disease with development of type 2 diabetes: A 4-year longitudinal study

      ea0029p535
    • Predictive ability of prediabetes defined by fasting plasma glucose and HbA1c for progression to diabetes in Koreans

      ea0029p536
    • Relationship between serum levels of 1-84 parathormone (PTH1-84) and obesity, HOMA insulin-sensitivity or beta-cells function (HOMA-B) in type 2 diabetic patients

      ea0029p537
    • The burden of disease in elderly people with IFG

      ea0029p538
    • GABA A receptor gene regulatory networks in peripheral blood TCD4+, TCD8+ AND CD14+ cells of recently diagnosed type 1 diabetes mellitus

      ea0029p539
    • Diagnosis of Metabolic syndrome in Saudi Arabia: implications for the importance of local criteria

      ea0029p540
    • Comparison of plasma osteoprotegerin and related factors in two groups of pregnant women

      ea0029p541
    • Protein from Hevea brasiliensis latex rubber tree enhances wound healing in diabetic rats

      ea0029p542
    • Prevalence of Microalbuminuria in Galicia (NW Spain) and its association with risk factors: Hypertension, Type 2 diabetes mellitus and Pre-diabetes.

      ea0029p543
    • Sarcopenic phenotype in patients with newly diagnosed type 2 diabetes

      ea0029p544
    • Type 2 diabetes mellitus and Ramadan fasting: a continuous glucose monitoring (CGM) study of glucose excursions in a group of patients with good glycaemic control

      ea0029p545
    • Abstract unavailable

      ea0029p546
    • High GADA titre: a marker of insulin dependence in adult onset autoimmune diabetes

      ea0029p547
    • Aerobic and resistance exercise have different short-term effects on glucose levels in type 2 diabetes subjects

      ea0029p548
    • Regulation of somatostatin/cortistatin and ghrelin systems under diet induced obesity conditions at the mouse endocrine pancreas

      ea0029p549
    • Influence of iron metabolism indices on HbA1c in non-diabetic pregnant women with and without iron-deficiency anemia: effect of iron supplementation

      ea0029p550
    • Both [beta]-cell dysfunction and insulin resistance are primary determinants of diabetes mellitus in patients with liver cirrhosis candidate to organ transplant

      ea0029p551
    • The effects of fat distribution and some adipokines on insulin resistance in prediabetic patients

      ea0029p552
    • New fast and reversible leptin antagonist-induced mice model of metabolic syndrome and T2DM

      ea0029p553
    • High-fructose diet, an animal model of insulin resistance, causes mitochondrial dysfunction by altering the activity of respiratory chain complex I

      ea0029p554
    • Does the presence of thyroid antibodies affect the course and outcome of pregnancy in type1 diabetic women?

      ea0029p555
    • The association between insulin-like-growth-factor I and insulin resistance: a general population study in danish adults

      ea0029p556
    • Abstract unavailable

      ea0029p557
    • Alterations in fecal lactobacillus and bifidobacterium species are associated with differences in cholesterol metabolism in type 2 diabetic patients

      ea0029p558
    • Low testosterone is associated with decreased expression of glut-4 and hexokinase 2 in muscle of the testicular feminised mouse

      ea0029p559
    • Serum visfatin is differentially regulated by insulin and non-esterified fatty acids in healthy men

      ea0029p560
    • Mitochondrial impairment and oxidative stress in leukocytes from type 2 diabetic patients

      ea0029p561
    • High prevalence of autoimmunity in adult onset diabetes subjects with high GADA titre

      ea0029p562
    • Testing of type 2 diabetes risk locus rs7578597 in THADA gene in the czech population

      ea0029p563
    • Impact of diabetes on length of stay and inpatient mortality for elderly patients presenting with proximal fracture of the femur

      ea0029p564
    • Screening of latent autoimmune diabetes in insulin requiring diabetic adults

      ea0029p565
    • Epidemiological study of patients attended the pediatric outpatient clinic of national institute of diabetes [amp] endocrinology

      ea0029p566
    • Clinical and histopathology tumor characteristics of patients with invasive breast carcinoma on insulin glargine compared with other types of basal insulin

      ea0029p567
    • Evaluation of clinical care in young type 1 diabetes subjects: a nationwide multicenter study in brazil

      ea0029p568
    • Abstract unavailable

      ea0029p569
    • DNA methylation influenced [beta]-arrestin 2 expression in type 2 diabetes patients

      ea0029p570
    • Innervation and vascularization into islets of langerhans in the presence or absence of proglucagon-derived peptides

      ea0029p571
    • Expression of ghrelin and its receptor genes is tissue specific in streptozotocin treated piglets

      ea0029p572
    • Empowering patients with diabetes: a qualitative study focusing on knowledge of self-care behaviors amongst asians in south florida

      ea0029p573
    • Circulating ghrelin and leptin concentrations in metabolic disorders of obese and lean piglets

      ea0029p574
    • Effective utilization of anti-GAD measurement

      ea0029p575
    • The relationship between the level of knowledge of physicians on guidelines and the degree of glucometabolic control in type 2 DM patients in Turkey

      ea0029p576
    • Previous history of gestational diabetes mellitus and flow mediated dilation of brachial artery

      ea0029p577
    • Frequency and outcome of follow-up testing after a positive gestational diabetes screen

      ea0029p578
    • Relationship vitamin D levels and glycemic control in type 2 diabetic patient

      ea0029p579
    • Association between educational level with glycemic and risk factor control in type 1 diabetes: results from DIACAM 1 study

      ea0029p580
    • Basal and postprandial free fatty acid kinetics in normal and type 2 diabetic subjects: effects of various treatments

      ea0029p581
    • Measles and new onset type 1 diabetes presented with bilateral facial paralysis: report of a case

      ea0029p582
    • Identification of dipeptidyl peptidase-4 inhibitors among boioactive peptides derived from whey proteins

      ea0029p583
    • Decreased sucrose preference in humans and rodents with diabetes

      ea0029p584
    • Regulatory T cells number and function in patients with LADA

      ea0029p585
    • Depression as a predictive factor for glycemic control and family functioning in Japanese patients Swith type 2 diabetes: a 6-month follow-up study

      ea0029p586
    • What arises from the decrease of visceral adiposity in Japanese diabetic patients with visceral fat accumulation?

      ea0029p587
    • Outcome of a young adolescent diabetes transition clinic in an inner city ethnic population in Birmingham: an audit

      ea0029p588
    • Microcirculatory disorders in adolescents with type 1 diabetes mellitus

      ea0029p589
    • Screening for unknown diabetes mellitus or IFG in a population of South Italy

      ea0029p590
    • Adiponectin among markers of low grade inflammation in gestational diabetes mellitus

      ea0029p591
    • Comparative analysis of adiponectin isoforms distribution in pregnant women with gestational diabetes mellitus and after delivery

      ea0029p592
    • Three novel mutations in maturity-onset diabetes of the young genes in Spain

      ea0029p593
    • Proteomic identification of plasma biomarkers in type 1 diabetes mellitus: an implication of hemopexin overexpression in diabetes mellitus

      ea0029p594
    • Comparative incidence of type 1 diabetes mellitus in school-aged children between immigrated families and the background population living in Piedmont or in Morocco, 2005-2009: a role for vitamin D?

      ea0029p595
    • HbA1c as a tool for the diagnosis of type 2 diabetes in 208 premenopausal women with polycystic ovary syndrome

      ea0029p596
    • Non-HDL and LDL cholesterol in type 2 diabetes mellitus patients at tertiary care hospital of Pakistan

      ea0029p597
    • Prevalence of diabetes-associated antibodies and impaired insulin response to glucose in first degree relatives of diabetic patients Ebtissam M. Salah*, Hesham El-Hafnawy**, Mona Anwar*, Samar M. E. Salem*, Mai M. Youssef*, Atef Bassyoni** and Marry Aziz**

      ea0029p598
    • Is there a seasonal variation in the incidence of gestational diabetes mellitus?

      ea0029p599
    • We can do better: activity report of ambulatory educative sessions for the patients treated with external pumps

      ea0029p600
    • Diagnostic value of cytogram analysis of different types of oral cavity mucous epithelium in type 2 diabetes mellitus elderly patients

      ea0029p601
    • Socio-demographic factors associated with pediatric diabetic ketoacidosis admissions in Southern West Virginia

      ea0029p602
    • Hypersomatotropism and glucose metabolism disorders

      ea0029p603
    • Questionnaire survey about a hospital adolescent transition diabetic clinic

      ea0029p604
    • Celiac disease, autoimmune thyroiditis, vitamin B12 deficiency and adrenal failure among adult Turkish patients with type 1 diabetes mellitus

      ea0029p605
    • Correlation of fasting blood glucose with menopausal status in middle aged women with their obesity status

      ea0029p606
    • Insulin resistance and C reactive protein level

      ea0029p607
    • The antropometric characteristic of type 1 diabetic patients in Kragujevac

      ea0029p608
    • Resolution of type 2 diabetes following IFN-[alpha]; therapy for chronic hepatitis C

      ea0029p609
    • Art and its role in therapeutic patient education

      ea0029p610
    • The antropometric characteristic of type 2 diabetic patients in Kragujevac

      ea0029p611
    • Prevalence of microvascular complications in youth with type 2 diabetes: systematic review and meta-analysis

      ea0029p612
    • The intake of fiber suppresses the high fat high carbohydrate meal induced endotoxemia, oxidative stress and inflammation

      ea0029p613
    • Blocking Notch pathway improves wound healing in diabetic mice

      ea0029p614
    • The role of AMP-activated protein kinase in myocardial tolerance to ischemia in rats with diabetes mellitus type 2 and its relation to metformin therapy

      ea0029p615
    • A novel case of diabetes mellitus and aniridia in a Caucasian family

      ea0029p616
    • Experience of diabetic dyslipidemia correction in patients with ischemic heart disease and type 2 diabetes mellitus using [apha]-lipoic acid in combination therapy

      ea0029p617
    • Changes of NO concentration in the cause of streptozotocin diabetes mellitus and under action of different NOS inhibitors in streptozotocin rats

      ea0029p618
    • Cardiac dyssynchrony as a pathophysiological mechanism of heart failure development and progression in type 2 diabetic patients

      ea0029p619
    • Possible risk factors of type 2 diabetes and role of long term oral hypoglycemic agent, metformin

      ea0029p620
    • Complex ventricular arrhythmias with early repolarization in type 2 diabetes mellitus

      ea0029p621
    • Diabetic nephropathy in pregnant women with type 1 diabetes mellitus

      ea0029p622
    • Effects of chronic administration of Vardenafil on endothelial function in patients with type 2 diabetes mellitus. A longitudinal, randomized, placebo-controlled, double blind, non-sponsored clinical trial

      ea0029p623
    • Pattern of chronic complications among Nigerian patients with DM: the need for focused prevention initiatives

      ea0029p624
    • The correlation between metabolic syndrome and albuminuria in type 2 diabetes mellitus

      ea0029p625
    • Diabetic nephropathy and risk factors associated with DM in newly diagnosed type 2 diabetics

      ea0029p626
    • Clinical experience of gel testosterone in men with diabetes type 2 and late-onset hypogonadism

      ea0029p627
    • Influence of planning pregnancy in pregestational diabetes

      ea0029p628
    • Diabetic nephropathy and retinopathy: complications in pregnancy and labor

      ea0029p629
    • Quality of life of people with diabetes living in rural area

      ea0029p630
    • Insulin resistance: policy plan to address burning issue by NGO from rural India

      ea0029p631
    • Seeking a new identity: the empowerment process in Iranian people with diabetes

      ea0029p632
    • Prevalence of Charchot arthropathy after the introduction of electronic foot ulcer patient record

      ea0029p633
    • Development of a high-sensitive urinary albumin immunosensor based on MCM-41-PVA nanocomposite and AuNPs

      ea0029p634
    • Metformin-associated lactic acidosis: prevention is the real challenge!

      ea0029p635
    • Oxidative stress and histopathological differences on the skin of diabetes mellitus compromised rats

      ea0029p636
    • Relationships between hyperglycemia and the oxidative stress in type 2 diabetes

      ea0029p637
    • Somatostatin eye drops prevent retinal neurodegeneration in experimental diabetes

      ea0029p638
    • Serum high sensitivity c-reactive protein as predictor of metabolic syndrome and its relationship with albuminuria in type 2 diabetes mellitus

      ea0029p639
    • Relationship between hyponatremia and diabetes mellitus

      ea0029p640
    • The relationship between daytime, nighttime and total heart rate with albumin and protein excretion in newly diagnosed type 2 diabetic patients

      ea0029p641
    • Cystatin C and TGF-[alpha] as a biomarker of diabetic nephropathy in normo and microalbuminuric patients

      ea0029p642
    • The impact of hyperinsulinemia on the serum IL12p40 subunit concentration

      ea0029p643
    • Association of cardio-ankle vascular index with diabetes mellitus-related peripheral arterial disease in chronic hemodialysis patients

      ea0029p644
    • Pituitary function in patients with autoimmune type 1 diabetes evaluated by CRH test

      ea0029p645
    • Microvascular complications in type 1 diabetes mellitus: prevalence and associated risk factors in DIACAM 1 study

      ea0029p646
    • Urinary pentosidine concentration in patients with type 2 diabetes and risk of vascular complications

      ea0029p647
    • The mechanisms of anemia development in patients with early stages of diabetic nephropathy

      ea0029p648
    • Non-alcoholic fatty liver disease and cardiovascular disease in type 2 diabetic patients with metabolic syndrome

      ea0029p649
    • Microalbuminuria and blood pressure in normotensive subjects with type 2 diabetes mellitus

      ea0029p650
    • The relationship Between Self-Reported Nocturnal Sleep Duration, Daytime Sleepiness and 24-hour urinary Albumin and Protein Excretion in Newly Diagnosed Type 2 Diabetic Patients

      ea0029p651
    • Office hypertension and masked hypertension and their association with left ventricular hypertrophy and diastolic dysfunction in patients with type 2 diabetes and hypertension

      ea0029p652
    • Dynamics of insulin-like growth factor-1 concentrations during diabetic ketoacidosis

      ea0029p653
    • Diabetic peripheral arterial occlusive disease is associated with microvascular complications but coronary atherosclerosis might not be associated with them

      ea0029p654
    • Predictors of Cardiovascular Risk: Metabolic Syndrome vs. Diabetes Mellitus and Hypertension

      ea0029p655
    • Risk Factors and Therapeutic Management of type 2 Diabetes in Georgia

      ea0029p656
    • Effects of Hyperglycemia on Oxidative Stress and Antioxidant Potential in Patients with Type 2 Diabetes

      ea0029p657
    • Serum vitamin D and parathormone (PTH) concentrations as predictors of the development and severity of diabetic retinopathy.

      ea0029p658
    • Epidemiology of Diabetic Ketoacidosis in National Institute of Diabetes and Endocrinology (NIDE) by:Bassyouni, A.; El Ebrashy, I.; El Hefnawy, H

      ea0029p659
    • Evaluation of capillary Beta-hydroxybutyrate measurement In diabetic ketoacidosis By: Hesham El Hefnawy By:El Hefnawy, H.*; Bassyouni, A.** and Emara, I.*** From: *Pediatric, **Internal Medicine and ***Biochemistry departments, National Institute of Diabetes [amp] Endocrinology (NIDE)

      ea0029p660
    • Clinical characteristics of diabetic peripheral neuropathy in past and present in Korea

      ea0029p661
    • The effects of metoprolol,diltiazem and pilocarpine in Prolonged QTc interval caused by insulin induced hypoglycemia in rats

      ea0029p662
    • Proximal upper and lower extremities severe pain, muscle weakness in a young diabetic male with multiple chronic complications. A rare and unusual clinical presentation

      ea0029p663
    • Risk factors for cardiovascular diseases in T1DM

      ea0029p664
    • Relationship Between HbA1c and Asymptomatic Coronary Artery Disease in Type 2 Diabetes Patients

      ea0029p665
    • Treating depression in type 2 diabetic patients improves depressive symptoms and quality of life but not metabolic control

      ea0029p666
    • Cardiorespiratory fitness is decreased and not correlated with C-Reactive Protein levels in adults with Diabetes Mellitus

      ea0029p667
    • Evaluation of Brainstem Auditory Evoked Potential in Diabetics

      ea0029p668
    • The Loss of Work Productivity in Type 2 Diabetes Mellitus in Turkey

      ea0029p669
    • The Relationship between Cognitive Function and Microalbuminuria in Elderly Type 2 Diabetic Patients

      ea0029p670
    • Is skin tag associated with diabetic macro and microangiopatyh? Preliminary Report

      ea0029p671
    • Incidence and mortality of diabetic ketoacidosis in Benghazi-Libya

      ea0029p672
    • Drugs or insulin used in diabetics not associated with increased risk of malignancy

      ea0029p673
    • Polyneuropathy in diabetic patients based on the clinical and paraclinical findings

      ea0029p674
    • Not all neuropathies in people with diabetes are due to diabetic neuropathy - a case of chronic inflammatory demyelinating polyneuropathy(CIDP) in a type 1 diabetic

      ea0029p675
    • High burden of comorbid disease and complications in underprivileged type 1 diabetes children

      ea0029p676
    • Effects of acute hyperglycaemia on ANP levels in diabetic patients

      ea0029p677
    • Hyperhomocysteinemia as Risk's Factor of Diabetic Nephropathy in the Patients with Diabetes Mellitus Type 1 and Depression

      ea0029p678
    • No influence of the chronic poor clycaemic control on ANP levels in diabetics with microvascular illness

      ea0029p679
    • Nephropathy could be a main factor in the increased levels of ANP in diabetes

      ea0029p680
    • Quality of life and its dimensions among the type2 diabetes patients referred to the diabetes center of Zanjan University of medical science (Vali-e-Asr Hospital)-2010

      ea0029p681
    • Sexual weakness: Different demographic and clinical features [amp] cost-effective management

      ea0029p682
    • Role of education in prevention and delay of complications in type 2 diabetic patients

      ea0029p683
    • Structured outpatient education and treatment program in type 1 diabetes patients during preconception care and pregnancy

      ea0029p684
    • A Randomized controlled trial of the effect of internet based mentoring program for type 1 diabetes patients with inadequate glycemic control

      ea0029p685
    • Type 1 diabetic women treated with insulin pumps or multiple daily injections of insulin: pregnancy outcome and glycemic control

      ea0029p686
    • DPP-4 inhibitor vildagliptin reduces urinary albumin excretion in type 2 diabetic patients with microalbuminuria

      ea0029p687
    • Insulin protocol for hospital management of diabetes: a retrospective evaluation one year after the implementation

      ea0029p688
    • Analysis of fasting glycemia variability in patients with type 1 diabetes mellitus undergoing different types of basal insulin therapy: glargine vs. NPH

      ea0029p689
    • To evaluate and compare the outcome of pregnancies in women with type 1 diabetes treated with continuous subcutaneous insulin pump or multiple insulin injections

      ea0029p690
    • Antihyperglycemic effects of sodium orthovanadate and Trigonella foenum graecum in diabetic rats

      ea0029p691
    • Therapy with analogous of glp 1 and basal insulin in patients with diabetes mellitus type 2. Our experience.

      ea0029p692
    • Variations in insulin daily dose and weight with continuous subcutaneous insulin infusion therapy

      ea0029p693
    • Insulin therapy requirement in ESRD patients (Our experience)

      ea0029p694
    • Comprehensive approach to Paediatric diabetes management: NGO initiatives in developing country India.

      ea0029p695
    • Renal sodium dependent glucose co-transporter 2 (SGLT2): A neoteric target for treatment of type2 diabetes mellitus

      ea0029p696
    • Management of Diabetes in Hospital

      ea0029p697
    • Relation between glucose daily profile (CGMS) and graft function after islet transplantation for type 1 diabetes mellitus

      ea0029p698
    • Evolution of macro-angiopathy 5-years after islet transplantation (IT) in type 1 diabetes

      ea0029p699
    • Sustained Exendin-4 secretion through gene therapy targeting salivary glands in Zucker fa/fa rats and high fat diet fed mice.

      ea0029p700
    • A Hydrophilic Derivative of Probucol, Probucol-(glutaric branched-triglycerol)2 (ProBGL2) Ameliorates Glucose Tolerance and Insulin Sensitivity by Independent Mechanism of the Canonical Potency of Probucol in HFD-fed mice.

      ea0029p701
    • Simultaneous Pancreatic Kidney Transplant Experience in The South West of Ireland between 2001-2011

      ea0029p702
    • Implementation of the principles of the personalized medicine in the clinical practice: a pilot study for type 2 diabetes

      ea0029p703
    • Pathway Integration of Pro-Inflammatory Cytokines, 12-Lipoxygenase and NADPH Oxidase in Beta Cell Dysfunction; Protection by Novel Selective 12-Lipoxygenase Inhibitors.

      ea0029p704
    • GLP-1 agonists enhance stress-induced corticosterone release

      ea0029p705
    • Bile acid binding resins affect diverse molecules to improve metabolic control.

      ea0029p706
    • A novel beneficial effect of liraglutide: the reduction in subclinical atherosclerosis in patients with type-2 diabetes

      ea0029p707
    • The Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Does Not Alter ECG Endpoints in a Thorough QT (TQT) Study

      ea0029p708
    • Safety and efficacy of linagliptin in type 2 diabetes (T2D) patients (pts) with common renal and cardiovascular risk factors

      ea0029p709
    • Effects of flaxseed oil on anti-oxidative system and membrane deformation of human erythrocytes in high glucose level

      ea0029p710
    • Rapidly and strong suppression of human acylated ghrelin serum concentrations during infusion of des-acyl ghrelin in obese diabetic subjects.

      ea0029p711
    • Educating educators - the way to improve health outcomes of people with diabetes

      ea0029p712
    • Reducing Residual Vascular Risk Through combination Therapy with Fenofibrate and Alpha-Lipoic Acid in Patients with Ischemic Heart Disease and Type 2 Diabetes Mellitus

      ea0029p713
    • Antidiabetic therapies and malignancy: a retrospective study in oncological cases.

      ea0029p714
    • Adding Liraglutide to insulin treated obese type 2 diabetics improves glycaemic control with sustained weight reduction and low hypoglycaemia rate

      ea0029p715
    • Clinical and Patient Reported Outcomes over the 24 Months of Insulin Therapy in Patients with Type 2 Diabetes in Greece: Data from The Instigate Study

      ea0029p716
    • The outcome of Beta cell function after early insulin therapy in the recently diagnosed type 2 diabetes (in Egyptian population) our experience in EL-Minia university hospital

      ea0029p717
    • Gender differences in metabolic outcomes of continuous subcutaneous insulin infusion therapy

      ea0029p718
    • Continuous subcutaneous insulin infusion systems: experience in 92 patients with type 1 diabetes

      ea0029p719
    • A 52-week efficacy and safety profile of sitagliptin in Japanese type 2 diabetic patients in clinical settings

      ea0029p720
    • Short-term liraglutide therapy as compared with basal insulin therapy on restoration effect of insulin secretion in Japanese patients with type 2 diabetes

      ea0029p721
    • Vitamin B-12 deficiency associated with metformin treatment of type 2 diabetes mellitus in daily practice: Clinical consequences

      ea0029p722
    • A comparison of pharmacokinetics and pharmacodynamics of insulin aspart, biphasic insulin aspart 70, biphasic insulin aspart 50 and human insulin: a randomized, quadruple crossover study

      ea0029p723
    • Resource utilization and patient satisfaction associated with switching insulin in Greece (Subanalysis of the SWING study).

      ea0029p724
    • Inpatient Hypoglycaemia Management

      ea0029p725
    • Study of the outcomes of application of ISPAS versus ADA guidelines of diabetic Ketoacidosis in type 1 diabetic children

      ea0029p726
    • Subcutaneous use of rapid insulin analog: an alternative treatment for patients with mild to moderate diabetic ketoacidosis

      ea0029p727
    • Planning Treatment of Diabetic Patients with Chronic Renal Disease Using Pre-mixed Insulins Having Higher Proportion of Soluble Insulin

      ea0029p728
    • Study on cases with hypoglycemia carried to the emergency room in the last two years

      ea0029p729
    • Treatment of obese type 2 Diabetes Mellitus patients with CSII Humulin U-500 Regular Insulin infusion vs. CSII Aspart insulin infusion coupled with basal insulin and metformin

      ea0029p730
    • Effects of DPP-IV inhibitors on the changes of glycemic and lipid control of type 2 diabetes patients at the great east Japan earthquake

      ea0029p731
    • Exenatide versus insulin glargine in type 2 diabetes inadequately treated with metformin

      ea0029p732
    • Vitamin D3 deficiency effect on the HbA1c in type 2 diabetic Population

      ea0029p733
    • Salsalate effect on BRACHIAL FLOW-MEDIATED DILATION in early diagnosed Diabetes mellitus

      ea0029p734
    • Differences in health related resource use and costs before and in 24 months after insulin initiation in patients with type 2 diabetes: final data from instigate study

      ea0029p735
    • Clinical Findings on the Effect of Early Insulin Therapy in Newly Diagnosed Type 2 Diabetes

      ea0029p736
    • The effect of nighttime glargine with morning NPH in type 2 DM.

      ea0029p737
    • Telemedicine and Type 1 diabetes: A pilot project

      ea0029p738
    • The State of Therapeutic Patient Education in Diabetes

      ea0029p739
    • Diabetes mellitus management in elderly over 80 years old.

      ea0029p740
    • Improving health numeracy: utilizing objective parameters to improve shared decision making for insulin initiation

      ea0029p741
    • Challenges and problems in the management of glycemia in patients with co-existing diabetes mellitus and a malignant disease in the Gerontology Institute - Hospice

      ea0029p742
    • Efficacy and Safety of Insulin Glargine in Type-2 Diabetes Mellitus Patients with Moderate Renal Failure

      ea0029p743
    • The weight reduction could be achieved on DPP-IV inhibitors in very obese T2D patients

      ea0029p744
    • Diabetes Mellitus Control Status of Turkish Diabetic Patients

      ea0029p745
    • Insulin analogues in the treatment of diabetes

      ea0029p746
  • Endocrine Disruptors
  • • Effects of octylphenol and bisphenol A on the expressions of calcium transport genes during pregnancy in mice

      ea0029p747
    • Effects of Quercetin on mRNA expression of Steroidogenesis genes in Primary Cultures of Interstitial Leydig cells treated with Atrazine

      ea0029p748
    • Octylphenol and triclosan induced proliferation of human breast cancer cells via an estrogen receptor-mediated signaling in vitro

      ea0029p749
    • Endocrine disrupting chemicals induced alteration of cell cycle related genes resulting in proliferation of human breast cancer cells via an estrogen receptor-mediated signaling pathway in vitro

      ea0029p750
    • Bisphenol A and phthalate stimulated the growth of human prostate cancer cells and altered downstream target genes of ras signaling pathway

      ea0029p751
    • Treatment with resveratrol resulted in an inhibition of cell proliferation induced by 17 [beta]-estradiol or various endocrine disrupting chemicals via down-regulating the cell cycle progression in BG-1 ovarian cancer cells

      ea0029p752
    • Perinatal exposure to a commercial formulation of glyphosate reduces the mRNA expression and increases the protein content of beta TSH in the pituitary of male offspring.

      ea0029p753
    • Synergistic effects of bisphenol A and paraben on the induction of calbindin-D9k and progesterone receptors via an estrogen receptor pathway in rat pituitary GH3 cells

      ea0029p754
    • Benzophenone-1 promoted cell growth of BG-1 ovarian cancer cells with estrogen receptors via progression of cell cycle

      ea0029p755
    • A phytoestrogen, genistein, reversed 17 [beta]-estradiol or bisphenol A-induced cell growth via downregulation of the cell cycle progression in BG-1 ovarian cancer cells

      ea0029p756
    • Proliferative and apoptotic effects of bisphenol A and its combination with estradiol in human breast carcinoma cells

      ea0029p757
    • Parabens inhibit ovarian follicle development of neonatal female rats

      ea0029p758
    • Bisphenol-A exposure from electronic gadgets: A risk assessment

      ea0029p759
    • Unconjugated bisphenol A cord blood levels in boys with descended or undescended testes

      ea0029p760
    • Measurement of estrogen receptor alpha homodimerization caused by xenoestrogens using bimolecular fluorescence complementation

      ea0029p761
    • The effects of BPA exposure on fat mass and serum leptin concentrations have no impact on bone mineral densities in non-obese premenopausal women.

      ea0029p762
    • The effects of endocrine disruptor compounds on the hormone release of rat pituitary in vitro

      ea0029p763
    • Activation of the enzymes of phase I (CYP1A1 and CYP2B1/2) and phase II (SULT1A and COMT) metabolism by BDE-47 in the ovary.

      ea0029p764
    • Changes of hemostatic variables during cross-sex hormone treatment in transsexual people.

      ea0029p765
    • The relation for normal fasting plasma glucose levels and metabolic syndrome in normoglycemic adults.

      ea0029p766
    • Effects of neonatal exposure to thyroid hormones on gene expression profile of the pituitary-thyroid-liver axis in rats

      ea0029p767
    • Apoptosis induced by arsenic is partially reverted by antioxidants in anterior pituitary cells.

      ea0029p768
    • Nigella Sativa oil alleviating the reproductive toxicity of chlorpyrifos in male rat

      ea0029p769
    • The Interference Endocrinous - Metabolic in Thyro-gonadal Failure

      ea0029p770
    • The Therapeutic Attitude Differentiated in Thyroadenitis

      ea0029p771
    • Hypertension - Endocrinous Causes - Therapeutic Attitude

      ea0029p772
  • Endocrine tumours and neoplasia
  • • New insights into the molecular and cellular pathogenesis of human craniopharyngioma: do pituitary stem cells underlie the origin of these tumours?

      ea0029p773
    • Diagnostic and Prognostic Role of 68GA-Dotatate in Patients with Neuroendocrine Tumors

      ea0029p774
    • Meta-analysis of mRNA, microRNA expression and chromosome aberrations in phaeochromocytoma and neuroblastoma

      ea0029p775
    • Metformin inhibits the androgen mediated up-regulation of Insulin Growth Factor-I Receptor in prostate cancer cells

      ea0029p776
    • Investigations into the epigenetic mechanisms regulating the prostanoid receptor EP2 in estrogen dependent breast cancer

      ea0029p777
    • GPR30, the non classical membrane G protein related estrogen receptor (GPER), is overexpressed in human seminoma and promotes seminoma cell proliferation.

      ea0029p778
    • Sorafenib stops disease progression in the majority of patients with advanced differentiated thyroid cancer refractory to radioactive iodine.

      ea0029p779
    • The pilot study on clinical presentation of pituitary adenomas (Pa) in patients with multiple endocrine neoplasia type 1 (Men1) phenotype with and without Men1 mutation

      ea0029p780
    • Hepatocellular carcinoma (HCC) as a neuroendocrine tumor: a preliminar molecular study.

      ea0029p781
    • Urinary steroid profiling demonstrates induction of CYP3A4 and inhibition of 5alpha-reductase by mitotane treatment for adrenocortical carcinoma

      ea0029p782
    • Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels

      ea0029p783
    • TNF[alpha] induced aromatase expression is mediated by the Early Growth Response transcription factors in breast adipose

      ea0029p784
    • Mitochondrial respiratory chain defects: a novel molecular mechanism of Mitotane for treatment of Adrenocortical Carcinoma

      ea0029p785
    • Screening of AIP mutations in young Romanian patients with sporadic pituitary adenomas

      ea0029p786
    • Expression of a novel isoform of thyroid peroxidase (TPO) gene in breast cancer (BC)

      ea0029p787
    • Is combined radionuclide therapy with 90y-Dotatate and 177lu-Dotatate an effective treatment option for patients with metastasised neuroendocrine tumours? An ongoing study

      ea0029p788
    • The pathogenesis of non functioning pituitary adenoma with positive staining for glycoproteins is associated with MEG3/DLK1 underexpression/GSTP1 overexpression and modulated by microRNAs (miRNAs)

      ea0029p789
    • The influence of surgery in the management of recurrent adrenocortical carcinoma.

      ea0029p790
    • Over-expression of AIP protein in GH3 cells reduces cAMP signalling and Growth hormone secretion

      ea0029p791
    • Novel 45A>G [amp] 46D>G mutation of SDHB Exon-1 in a Patient with Urinary Bladder [amp] Posterior Mediastinum Paraganglioma.

      ea0029p792
    • Refractory Seizures as a Presenting Feature of Insulinoma

      ea0029p793
    • Rare Case of Atypical Pituitary Adenoma: Intermediate form of Adenoma between the common Benign Adenoma [amp] exceedingly rare Pituitary Carcinoma

      ea0029p794
    • A novel mutation of the MEN1 gene in an Italian family with Multiple endocrine Neoplasia type 1

      ea0029p795
    • Pheochromocytoma releasing ACTH: two in one.

      ea0029p796
    • Hypergastrinemia in a Patient with Lymphocytic Colitis and Chronic Gastritis

      ea0029p797
    • Primary hyperparathyroidism due to a parathyroid adenoma, a parathyroid carcinoma and a subsequent adenoma: A case report

      ea0029p798
    • Neuroendocrine Tumor with Clinical Characteristics of Insulinoma

      ea0029p799
    • Effects of mTOR inhibitors in the control of non functioning pituitary adenomas cell growth

      ea0029p800
    • mTOR inhibitors hamper cell viability in selected human medullary thyroid carcinoma primary cultures

      ea0029p801
    • Disturbed alternative splicing of growth hormone is associated with increased expression of SF2/ASF oncogene in pituitary adenoma

      ea0029p802
    • Estradiol Potentiates the Inhibitory Effects of SOM230 on Prostate Cells in vitro Up-regulating Ligand Binding Domain Expression of SSTR2 and 5

      ea0029p803
    • [beta]-Catenin signaling controls tumorigenesis in menin-deficient insulinoma

      ea0029p804
    • Hypermethylated in cancer 1 (HIC1), a tumour suppressor gene epigenetically deregulated in hyperparathyroid tumours by histone modification

      ea0029p805
    • Stem cell genes are deregulated in parathyroid tumours

      ea0029p806
    • Long-acting somatostatin analogues are highly effective in men1 patients with early stage duodeno-pancreatic neuroendocrine tumors

      ea0029p807
    • Insulin, IGF-II and a low-affinity insulin analog differentially regulate insulin receptor isoform A trafficking and induce a different balance of metabolic and mitogenic effects

      ea0029p808
    • Immunohistochemical, ChIP, and microarray analysis reveals how stromal AR controls prostate cancer outcome through fibroblast specific action of androgen signalling on ECM production and DNA licensing

      ea0029p809
    • Looking for the molecular bridge between sex hormone-binding globulin (SHBG) and breast cancer cells

      ea0029p810
    • Parathyroid atypical adenomas: mutational screening of CDC73/HRPT2 gene

      ea0029p811
    • Is biochemical screening for pheochromocytoma in adrenal incidentalomas expressing low unenhanced attenuation on computed tomography necessary?

      ea0029p812
    • Clinical and biochemical characteristics of succinate dehydrogenase (SDH) mutation carriers

      ea0029p813
    • Efficacy of Everolimus to prevent hypoglycemia in patients with metastatic insulinomas: for the French group of endocrine tumors (GTE-Renaten)

      ea0029p814
    • Differential TNF[alpha] -synthesis and signaling in endocrine tumors after treatment with the Tumor-Vascular-Disrupting Agent ASA404 (vadimezan)

      ea0029p815
    • Anti-proliferative effect of GHRH antagonist JMR-132 on ovarian cancer cell via EGFR-Akt pathway

      ea0029p816
    • Characterization of circulating tumor cells in prostate cancer patients

      ea0029p817
    • Mitotane Inhibits Cell Growth Proliferation and Modulates MRP1 Protein Expression In Different Human Cancer Cell Lines

      ea0029p818
    • Hormone combinations produce unique steroid receptor binding and regulatory profiles in breast cancer cells

      ea0029p819
    • Medical and Peptide Receptor Radionuclide Therapy with Somatostatin Analogues in Well and Moderately Differentiated Neuroendocrine Tumours

      ea0029p820
    • Expression of ErbB2 in craniopharyngiomas: Possible therapeutic implications

      ea0029p821
    • Wnt-signalling in human insulinomas

      ea0029p822
    • How clinical presentation of insulinoma is changing

      ea0029p823
    • Effects of mitotane on gene expression in the NCI-H295R cell line

      ea0029p824
    • Ouabain as an antiproliferative agent on adrenocortical cell models and on primary adrenocortical tumor cells

      ea0029p825
    • Profile of Patients with Pheochromocytoma [amp] Paraganglioma

      ea0029p826
    • The role of circulating and tumor infiltrating T-cells on clinical outcome in adrenocortical carcinoma

      ea0029p827
    • Surgical management of primary hyperparathyroidism in a unit where Intra-operative PTH (IOPTH) monitoring is not routinely performed

      ea0029p828
    • Enhanced antitumor efficacy of fructose conjugated-gefitinib on lung cancer cell lines in vitro and in vivo

      ea0029p829
    • Specific transcriptional response of four blockers of estrogen receptors on estradiol-modulated genes in the mouse mammary gland

      ea0029p830
    • Non pituitary effects of GnRH analogues in prostate cancer cells: revertion of maligant phenotype and synergism with bicalutamide and radiotherapy

      ea0029p831
    • Histone deacetylase inhibitor belinostat (PXD-101) represses androgen receptor expression and acts synergistically with castration and bicalutamide treatment to inhibit prostate cancer growth in hormone refractory models

      ea0029p832
    • Confirmation of pathogenicity of the MEN1 missense mutations by analysis of protein instability and aberrant splicing

      ea0029p833
    • Expression of MAPK7 and CCNL1 in corticotrophinomas and functional analysis of miR-143 and miR-145 in corticotrophic tumoral lineage AtT20

      ea0029p834
    • Tc- 99m Sestamibi parathyroid scan in primary hyperparathyroidism and surgical outcomes

      ea0029p835
    • Vitamin D from genetics to the clinical in prostate cancer

      ea0029p836
    • Progesterone receptor B induces autophagy antagonizing the phosphatidylinositol-3 kinase PI3K/AKT pathway in breast cancer cell lines

      ea0029p837
    • Insulinoma in patients with multiple endocrine neoplasia type 1

      ea0029p838
    • Multiple endocrine neoplasia syndrome type 1 (MEN-1) in Sardinian population: low prevalence of Men-1 mutations and detection of a new inactivating mutation of the CDKI gene p27

      ea0029p839
    • Atypical paragangliomas responsible for adrenaline-dominant catecholamine secretion due to ectopic expression of phenylethanolamine-N-methyltransferase

      ea0029p840
    • Evaluation of patients with adrenal diseases operated laparoscopically between 1997 and 2011

      ea0029p841
    • Immunohistochemical detection of FSH receptors in endocrine tumors

      ea0029p842
    • Tumour-asssociated myofibroblasts in parathyroid tumours

      ea0029p843
    • Establishment of a Multidisciplinary Tumor Board for Patients with Neuroendocrine Neoplasms

      ea0029p844
    • Low detection Rate of Primary Aldosteronism when Screening Among Hypertensive Patients with Ongoing Medication

      ea0029p845
    • B-Lymphocyte Stimulator in neuroendocrine tumors: a new prognostic marker?

      ea0029p846
    • Clinical and morphological characterization of C cell hyperplastic and neoplastic lesions of thyroid

      ea0029p847
    • Hormonal Therapy Promotes Hormone-Resistant Phenotype by Increasing DNMT Activity and Expression in Prostate Cancer Models

      ea0029p848
    • Gene expression profile of LNCaP human prostate cancer cells after treatment with an antagonist of growth hormone-releasing hormone

      ea0029p849
    • Evaluation of beta-cell function and insulin sensitivity in a large series of insulinomas in one single tertiary centre

      ea0029p850
    • Can proteomic approach help us in diagnosis of Riedel's thyroiditis? A case report

      ea0029p851
    • Effect of dopamine agonists on the tumor size of prolactinomas: are suppressive doses different from those that normalize prolactin serum levels?

      ea0029p852
    • Expressions of estrogen receptor-[beta] splicing variants in papillary thyroid cancer

      ea0029p853
    • The high-mobility group A1-oestrogen receptor [beta] nuclear interaction impairs in human testicular seminomas

      ea0029p854
    • Long-term outcome of primary endocrine non-Hodgkin lymphomas

      ea0029p855
    • Performances of a new automated chromogranin-A assay

      ea0029p856
    • Virilization due to adrenocortical carcinoma in a 7 years-old female: a case report

      ea0029p857
    • Diagnosis and treatment of the surgical pathology of the suprarrenales glands. Bibliographical revision

      ea0029p858
    • 1,25-Dihydroxyvitamin D inhibits cell proliferation by promoting cell-cycle arrest in the human adrenocortical cancer cell line nci-h295r

      ea0029p859
    • A case of multiple endocrine neoplasia type 2a associated with rectal adenocarcinoma

      ea0029p860
    • Leptin affects gene expression in OVCAR-3 ovarian cancer cells. Effects on cell proliferation and apoptosis

      ea0029p861
    • Malignant adrenal incidentaloma

      ea0029p862
    • Maxillary gland could harbor a neuroendocrine metastasis

      ea0029p863
    • Circadian rhythm of prolactin release in patients with breast cancer

      ea0029p864
    • Non-medullary neuroendocrine carcinoma in the thyroid gland: a case-report

      ea0029p865
    • Adrenal myelolipomas in CAH: is there role for ultrasound screening of the adrenal glands?

      ea0029p866
    • An unusual association of hyperparathyroidism, ectopic GHRH secrection and bronchial carcinoid in a MEN1 family

      ea0029p867
    • Medullary thyroid carcinoma with liver metastasis presenting as watery diarrhea for 1 year

      ea0029p868
    • Antiproliferative effect and control of catecholamine release with octreotide in a patient with giant bilateral pheochromocytoma

      ea0029p869
    • Survival of patients with adrenocortical carcinoma: experience of one center

      ea0029p870
    • Leydig cell tumor of ovary: a rare case of virilization

      ea0029p871
    • Lutetium-177 DOTATATE for paraganglioma refractory to conventional chemotherapy: a single case report

      ea0029p872
    • Hypoglycemia by insulinoma: for the purposes of a case

      ea0029p873
    • Atypical presentation of type 1 gastric neuroendocrine tumor should increase our awareness

      ea0029p874
    • A case of multiple endocrine neoplasia type 1 associated with multicentric VIPoma

      ea0029p875
    • Disseminated insulinoma in 13-year-old patient

      ea0029p876
    • Management of ectopic Cushing's syndrome caused by bronchial carcinoid: four case reports

      ea0029p877
    • Metastatic malignant insulinoma

      ea0029p878
    • A rare case of hirsutism: mucinous cystoadenoma of the ovary with stromal luteinization and hilar cell hyperplasia

      ea0029p879
    • Neuroendocrine tumors of the gastrointestinal tract: a descriptive study

      ea0029p880
    • Prediction of remission of gestational trophoblastic disease based on initial levels of prolactin

      ea0029p881
    • Radioguided cortical-sparing approach for recurrent pheocromocytoma/paragangliomas

      ea0029p882
    • Clinically palpable parathyroid adenoma

      ea0029p883
    • Special diagnostic, therapeutic and evolutive aspects of insulinoma: a tunisian experience

      ea0029p884
  • Female Reproduction
  • • The ovarian failure associated Y235 residue of human BMP15 gene is target of evolutionary positive selection

      ea0029p885
    • Coordinate regulation of heterogeneous nuclear ribonucleoprotein dynamics by steroid hormones in the human Fallopian tube and endometrium in vivo and in vitro

      ea0029p886
    • Role of the CRH receptors and brainstem noradrenergic nuclei in the gonadotropins secretion induced by acute stress at proestrus morning

      ea0029p887
    • An invdup (15) associated with premature ovarian insufficiency

      ea0029p888
    • Impact of thyroid status and thyroid autoimmunity on assisted reproduction technology outcome

      ea0029p889
    • The association of thyroid hormones with menstrually related mood disorder, sexual abuse histories and mood symptoms

      ea0029p890
    • Androgen profiling in adolescent females by liquid chromatography-tandem mass spectrometry

      ea0029p891
    • Expression of CRH/urocortin gene family in mouse gestational tissues during late pregnancy

      ea0029p892
    • Hypoxia-induced oxidative stress regulates the expressions of calcium transport channels in the duodenum, kidney and placenta of rats

      ea0029p893
    • Daily serum testosterone during the menstrual cycle by ID-LC-MS/MS

      ea0029p894
    • NT-pro-BNP levels in patients with polycystic ovarian syndrome

      ea0029p895
    • Differential expression and regulation of Mg2+ inorganic phosphate transport channels by hypoxia stress in human placental cells

      ea0029p896
    • Progesterone levels on the hCG day and outcomes IVF in women with polycystic ovary syndrome

      ea0029p897
    • State of care in women affected by early premature ovarian failure (ePOF) within the first two years of treatment in a center for reproductive medicine and endocrinology (RME)

      ea0029p898
    • Nutritional status and reproductive morbidity among women (age 15-40 years) in Dhaka city

      ea0029p899
    • Anthropometric indices of visceral obesity and cardiovascular risk factors in patients with polycystic ovarian syndrome

      ea0029p900
    • Health related behaviour and understanding of menopausal therapies among women with premature menopause

      ea0029p901
    • The effects of the therapy with ethinylestradiol 30 [mu]g-drospirenone+metformin on endothelial dysfunction in the polycystic ovary syndrome

      ea0029p902
    • Hormonal contraception and female sexual function

      ea0029p903
    • Metformin in treatment of polycystic ovaries syndrome in women of birthing age

      ea0029p904
    • Letrozole induces metabolic and reproductive disorders in female rats: a dose response study

      ea0029p905
    • Increased prevalence of polycystic ovary syndrome in overweight and obese premenopausal women with nonalcoholic fatty liver disease

      ea0029p906
    • Association of the (TAAAA)n repeat polymorphism of SHBG gene with age at menopause in Greek postmenopausal women

      ea0029p907
    • Prevalence of elevated glycated hemoglobin in women with polycystic ovary syndrome: according to the recently defined criteria

      ea0029p908
    • Most of type 2 diabetes associated loci identified in genome-wide association studies are not associated with polycystic ovary syndrome

      ea0029p909
    • Optimization of a uterine leiomyoma xenograft model using different immunodeficient mice and grafting procedures

      ea0029p910
    • The polymorphic variants K121Q of the plasma cell membrane glycoprotein and G972R of the insulin receptor substrate-1 modulate in opposite ways the clinical and biochemical profiles of women with polycystic ovary syndrome

      ea0029p911
    • Exposure to soy isoflavones during postnatal life disrupts structural development of reproductive organs in female mice

      ea0029p912
    • The kisspeptin levels in girls

      ea0029p913
    • Subcutaneous adipose tissue in women with polycystic ovary syndrome

      ea0029p914
    • Plasma anti-Mullerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus

      ea0029p915
    • The role of subclinical hypothyroidism and vitamin D deficiency in the development of menstrual disorders in women with PCOS

      ea0029p916
    • Treatment of androgen excess in adolescent girls: ethinylestradiol-cyproteroneacetate vs low-dose pioglitazone-flutamide-metformin

      ea0029p917
    • Hyperandrogenism is related to adipose tissue dysfunction as reflected by VAI in polycystic ovary syndrome patients

      ea0029p918
    • Effects of berberine on the clinical, metabolic and reproductive features of obese polycystic ovary syndrome women

      ea0029p919
    • Large-for-gestational-age and macrosomic neonates born by women with gestational diabetes mellitus diagnosed by the new IADPSG criteria: a case-control study of 301 patients and 839 controls

      ea0029p920
    • Factors affecting time to pregnancy: lithuanian women cohort study

      ea0029p921
    • Insulin and androgens but not androgen receptor CAGn polymorphysm are determinant factors for hirsutism severity in PCOS

      ea0029p922
    • Frequency of insulin resistance, assessed by the glucose clamp technique, in 132 PCOS women

      ea0029p923
    • Propranolol prevents stress induced polycystic ovary syndrome

      ea0029p924
    • Variants of the NR5A1 gene in a large cohort of patients with primary ovarian insufficiency

      ea0029p925
    • Aberrant expression of TRAIL in placenta and maternal serum in early pregancy complications

      ea0029p926
    • Blood cell mitochondrial DNA content and premature ovarian aging

      ea0029p927
    • Fetal growth parameters and outcome of pregnancies complicated with thyroid disease

      ea0029p928
    • Endocrine effects of the FSHB-211 promoter polymorphism in females

      ea0029p929
    • The prevalence of endometrial hyperplasia and endometrial cancer in Danish women with PCOS or hyperandrogenism

      ea0029p930
    • Conformational control of P450aromatase by lipid membrane interactions and protein associations

      ea0029p931
    • Metabolic characteristics in women with polycystic ovary syndrome by phenotypes based on various diagnostic criteria

      ea0029p932
    • Prevalence of chronic autoimmune thyroiditis in patients with polycystic ovary syndrome

      ea0029p933
    • Lean muscle mass in classic or ovulatory PCOS: association with central obesity and insulin resistance

      ea0029p934
    • Candidate pathway genetic analysis of PCOS

      ea0029p935
    • Sex hormones and sexual function in postmenopause

      ea0029p936
    • Hypoandrogenemia at women with hypogonadotropic hypogonadism

      ea0029p937
    • Nonalcoholic fatty liver disease in pregnant women.

      ea0029p938
    • AMH and INSL3 levels in ovulatory and anovulatory women with the polycystic ovary syndrome

      ea0029p939
    • Increased risk of glucose metabolism impairment after gestational diabetes in polycystic ovary syndrome

      ea0029p940
    • Effect of antiandrogens on spontaneous apoptosis in cultured porcine granulosa cells

      ea0029p941
    • Prenatal exposure to anti-androgen flutamide influences connexin 43 expression in the porcine fetal gonads

      ea0029p942
    • Long term health status of POI Patients

      ea0029p943
    • Neonates of women with polycystic ovary syndrome display increased oxidative stress markers and metabolic aberrations comparable to gestational diabetes offspring

      ea0029p944
    • Impact of dietary advanced glycation end products modifications on metabolic and hormonal profile in women with polycystic ovary syndrome

      ea0029p945
    • Inhibin-[alpha] gene promoter polymorphisms in patients with idiopathic premature ovarian failure

      ea0029p946
    • Skeletal frame size in females with polycystic ovary syndrome

      ea0029p947
    • Quality of life and the frequency of anxiety and depression in women with PCOS

      ea0029p948
    • Examination of the generation of vaginal epithelium of the new vagina formed using oxidized regenerated cellulose

      ea0029p949
    • Efficacy of sex hormone replacement therapy on induction of puberty in patients with Turner syndrome

      ea0029p950
    • Different effects of electrical and manual acupuncture stimulation on estrous cyclicity and neuroendocrine function in rats with DHT-induced polycystic ovary syndrome

      ea0029p951
    • The influence of endocannabinoid receptor 1 gene variations on anthropometric and metabolic parameters in women with polycystic ovary syndrome

      ea0029p952
    • Androgens profile in Cushing's disease with hirsutism

      ea0029p953
    • Action of elevated leptin levels on steroidogenic enzymes expression in porcine small and medium size follicles collected from prepubertal and cycling pig

      ea0029p954
    • The role and mechanisms of action of leptin in control of ovarian functions

      ea0029p955
    • What is the earliest predictor of atherosclerosis in normal weight polycystic ovary syndrome; carotid intima media thickness or visceral fat ratio?

      ea0029p956
    • Prevalence of hyperandrogenism, polycystic ovary syndrome and metabolic syndrome in female-to-male transsexuals

      ea0029p957
    • Examination of the role of gynecologists in the management of patients with disorders of sex development

      ea0029p958
    • Polycystic ovary syndrome, hyperprolactinemia, hyperinsulinemia and congenital adrenal hyperplasia

      ea0029p959
    • The future of HRT

      ea0029p960
    • Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study

      ea0029p961
    • Impaired beta cell function in Chinese women with polycystic ovary syndrome

      ea0029p962
    • Epicardial adipose tissue thickness in patients with polycystic ovary syndrome

      ea0029p963
    • High plasma level of long pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome

      ea0029p964
    • Sertoli cells ovarian tumor- an ovarian incidentaloma?

      ea0029p965
    • Clinical, hormonal and metabolic profile in overweight and obese women with polycystic ovary syndrome

      ea0029p966
    • Serum 17[beta]-estradiol concentration and depression symptoms presence in climacteric women

      ea0029p967
    • Assessment of insulin resistance and carotid intima media thickness, cardiovascular risk factors in PCOS with normal OGTT

      ea0029p968
    • Relation of hyperandrogenism and metabolic derangements in women with polycystic ovary syndrome

      ea0029p969
    • Micronized progesterone: a beneficial new modality of treatment for Egyptian patients with hyperemesis gravidarum

      ea0029p970
    • Significance of obesity in the genesis of metabolic syndrome in women with polycystic ovary syndrome

      ea0029p971
    • Lipid accumulation product as a marker of metabolic syndrome in women with polycystic ovary syndrome

      ea0029p972
    • Serum 25-hydroxyvitamin D and hsCRP levels in young obese women with polycystic ovary syndrome

      ea0029p973
    • Association of metabolic disturbances and carotid intima-media thickness in women with polycystic ovary syndrome

      ea0029p974
    • Prevalence of dyslipidemia in Algerian PCOS women

      ea0029p975
    • Serial serum levels of vitamin D in lean and obese pregnant women

      ea0029p976
    • Erythrocytosis and thrombocytosis secondary to hypertestosteronemia caused by ovarian leydig cell tumor

      ea0029p977
    • Quality of life in patients affected by polycystic ovary syndrome

      ea0029p978
    • Effects of dopamine agonist administration during seasonal cyclicity in the mare

      ea0029p979
    • Differences in gonadal axis reaction to ketoconasole between PCOS and healthy individuals

      ea0029p980
    • Metabolic and hormonal parameters in lean PCOS women

      ea0029p981
    • Adiponectin, resistin, leptin and selected cytokines in association with insulin resistance in lean women with polycystic ovary syndrome

      ea0029p982
    • Solution of an old endocrinological puzzle the rise and fall of an endocrinological doctrine Dr. Laszlo Makay, DVM H-2000 Szentendre, Sztaravodai u. 42, Hungary Tel./Fax: +36 26 316 791 E-mail: [email protected]

      ea0029p983
  • Growth hormone IGF axis - basic
  • • Evidence of direct mitogenic activity of insulin and the insulin receptor in prostate cancer cell lines

      ea0029p984
    • Insulin receptor compensates for IGF1R inhibition and induces mitogenic activity in prostate cancer cell lines

      ea0029p985
    • Designing long acting recombinant proteins: from bench to clinics

      ea0029p986
    • GH harmonisation: it sounds simple...,?

      ea0029p987
    • Plasma ghrelin levels appeared to be elevated in patients with medium-chain acyl-CoA dehydrogenase deficiency and glutaric aciduria type II: evidence for that acyl-CoA is the substrate for ghrelin acylation

      ea0029p988
    • Ghrelin suppresses angiotensin II-induced tissue damages by reducing oxidative stress

      ea0029p989
    • The effect of ghrelin on the mitochondrial dysfunction in muscle and physical disability associated with aging

      ea0029p990
    • Health related quality of life and psychological functioning of short statured German children and adolescents: findings form the quality of life in short stature youth study

      ea0029p991
    • C677T methylenetetrahydrofolate reductase gene polymorphism and colorectal neoplasms in acromegalic patients

      ea0029p992
    • Clinical characteristics and outcome of acromegaly induced by ectopic secretion of GHRH: a French nationwide series of 21 cases

      ea0029p993
    • Comparison of intuitiveness, ease of use and preference in two disposable GH injection devices

      ea0029p994
    • Diabetic retinopathy and GH the case of acromegaly

      ea0029p995
    • Assessing the quality of life of children and adolescents with short stature: development and psychometric testing of the QOLISSY: instrument

      ea0029p996
    • Factors affecting IGF1 response to GH during transition

      ea0029p997
    • Quality of life in adult patients with GH deficiency and neurosecretory dysfunction at the end of GH therapy

      ea0029p998
    • Hypertension and cardiovascular risk factors in GH deficiency

      ea0029p999
    • Anti-androgen flutamide alters gene expression in the porcine fetal ovary

      ea0029p1000
    • Relationship between GH activity and reproductive hormones: a randomized cross-over study in healthy male volunteers treated with GH and a GH receptor antagonist for three weeks

      ea0029p1001
    • Baseline characteristics and differences in short- and long-term response to rhGH between GHD adults with craniopharyngioma and nonfunctioning pituitary adenoma

      ea0029p1002
    • A new somavert (pegvisomant) 30 mg/ml formulation compared to the currently marketed 15 mg/ml formulation: pharmacokinetics, safety, and tolerability in healthy subjects

      ea0029p1003
    • Thyroid function during long-term GH treatment in children affected by idiopathic GH deficiency

      ea0029p1004
    • Variations of IGF1 in GH deficiency and Algerian health children

      ea0029p1005
    • Association Turner's syndrome and GH deficiency

      ea0029p1006
  • Male Reproduction
  • • The homologous hormones lutropin and choriogonadotropin are interacting differently with the LH/CG receptor

      ea0029p1007
    • Differential expression of pseudoautosomal region genes in patients with Klinefelter syndrome

      ea0029p1008
    • Rab-like 2 (RABL2) function in male fertility, intra-flagella transport and sperm tail assembly

      ea0029p1009
    • Prevalence of olfactory and other developmental anomalies in patients with central hypogonadotropic hypogonadism

      ea0029p1010
    • Abstract unavailable

      ea0029p1011
    • Total Testosterone levels and predisposing criteria for metabolic syndrome in healthy young men

      ea0029p1012
    • Functional status of pituitary--gonads axis in males with obesity

      ea0029p1013
    • Deletion of FSTL3 increases testicular size and delays testicular regression

      ea0029p1014
    • High prevalence and interaction of hypogonadism and the metabolic syndrome in long-term survivors with germ cell tumours

      ea0029p1015
    • Mutation analysis of NR5A1 gene encoding steroidogenic factor 1 in cryptorchidism and male infertility

      ea0029p1016
    • The Muenster EXAKT project: cardiovascular risk factors in Klinefelter patients and healthy controls

      ea0029p1017
    • Cellular distribution, regulated expression and functional role of the anorexigenic peptide, NUCB2/nesfatin-1, in the testis

      ea0029p1018
    • Neurocognitive phenotype and personality profile in men with Klinefelter syndrome and their vulnerability to psychiatric symptoms

      ea0029p1019
    • FSHB promotor polymorphism influences male reproductive parameters

      ea0029p1020
    • Side effect profile of long-term treatment of hypogonadal men with testosterone undecanoate

      ea0029p1021
    • Effect of testosterone on seminal proteome in male hypogonadism

      ea0029p1022
    • Comparing effects of weight loss on sexual, urinary and endothelial function, insulin resistance and quality of life in obese men with and without erectile dysfunction

      ea0029p1023
    • Inhibitors of 5[alpha]-reductase-related side effects in patients seeking medical care for sexual dysfunction

      ea0029p1024
    • Multiplex ligation dependent probe amplification analysis of KAL1, GnRH1, GnRHR, PROK2 and PROKR2 in male patients with idiopathic hypogonadotropic hypogonadism

      ea0029p1025
    • Cimetidine induces testosterone reduction and impairs leydig cell-microvasculature paracrine interaction in adult rats

      ea0029p1026
    • Gonadal status in adult male survivors of childhood cancer

      ea0029p1027
    • Cyclooxygenase-1 (COX-1) and COX-2, differently expressed in human sperm from normal and pathological patients, might be considered molecular markers in the diagnosis of male infertility disorders

      ea0029p1028
    • Activation of selective human sperm functions by EGF and TGF-[beta]3 is mediated by an ERK-depended mechanism

      ea0029p1029
    • Leydig and sertoli cell failure in myotonic dystrophy

      ea0029p1030
    • Decreased osteoprotegerin levels during testosterone therapy in ageing men were associated with changed distribution of regional fat

      ea0029p1031
    • New insights into sperm DNA methylation: intra-and inter individual stability and a comparative analysis versus somatic cells

      ea0029p1032
    • Complete reversal of isolated idiopathic hypogonadothropic hypogonadism in men

      ea0029p1033
    • G protein-coupled estrogen receptor 1- and estrogen receptor [alpha]-dependent pathways regulate spermatocytes apoptosis

      ea0029p1034
    • Single nucleotide polymorphism (SNP) of endothelial nitric oxide synthase (eNOS) gene (Glu298Asp variant) in infertile men with asthenozoospermia

      ea0029p1035
    • Severe depressive symptoms and cardiovascular risk in subjects with erectile dysfunction

      ea0029p1036
    • The protective role of ginger against Di-(2-ethylhexyl) phthalate-induced reproductive toxicity and oxidative stress in male rabbits

      ea0029p1037
    • Mutations and polymorphism of FSH and LH receptors and sperm quality in men with hypergonadotropic hypogonadism without obvious testicular noxa

      ea0029p1038
    • Poor response to alprostadil ici test is associated with arteriogenic erectile dysfunction and higher risk of major adverse cardiovascular events

      ea0029p1039
    • Hormonal associations and sexual dysfunctions in patients with impaired fasting glucose

      ea0029p1040
    • The relationship between total testosterone, cognitive function, depressive behavior and sleep quality in chronic renal failure patients not on dialysis

      ea0029p1041
    • Premature ejaculation and erectile dysfunction in a cohort of infertility men: clinical and ultrasonographic correlations

      ea0029p1042
    • Maternal malnutrition alters the leptin expression in the rats epididymis

      ea0029p1043
    • Scrotal and transrectal ultrasound correlates of prostatitis-like symptoms in a cohort of infertility patients

      ea0029p1044
    • Elevated body mass index correlates with higher seminal interleukin 8 levels and ultrasound prostate abnormalities in infertile men

      ea0029p1045
    • Ultrasonographic and clinical correlates of seminal plasma interleukin 8 levels in patients attending an Andrology Clinic for infertility

      ea0029p1046
    • Visceral adiposity index and the effect of testosterone treatment in young men with congenital hypogonadotropic hypogonadism

      ea0029p1047
    • Prevalence of erectile dysfunction is greater in young middle-aged HIV-infected men than in hiv-uninfected men

      ea0029p1048
    • Effectiveness of gonadotropin treatment for spermatogenesis induction in hypogonadotropic hypogonadism: a possible role of androgen receptor CAG repeat polymorphism

      ea0029p1049
    • Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats

      ea0029p1050
    • Ten years of EAA/EMQN quality control scheme for microdeletions of the Y chromosome

      ea0029p1051
    • SIEDY scale 3, a new instrument to detect intrapsychic component in subjects with erectile dysfunction

      ea0029p1052
    • Immunogold localization of testosterone and immunohistochemical detection of AR, SHBG, CYP1A1, ER[beta] and PCNA indicate a participation of steroid hormones in primordial germ cells of adult male bullfrogs

      ea0029p1053
    • The high prevalence of testosterone deficiency in population of Polish men over 65 years with erectile dysfunction

      ea0029p1054
    • Production of nitric oxide and peroxynitrite by human spermatozoa and their possible role on sperm motility

      ea0029p1055
    • Two infertile patients with 45X/46XY mosaicism and structural rearrangements of chromosome Y present with different phenotypes

      ea0029p1056
    • Abstract unavailable

      ea0029p1057
    • Seminal vesicles ultrasound features in a cohort of infertility patients

      ea0029p1058
    • Nitric oxide synthase and tyrosine nitration in idiopathic asthenozoospermia: an immunohistochemical study

      ea0029p1059
    • Testosterone replacement therapy: A comparison of testosterone mixed esters, extended release testosterone implants and testosterone undecanoate depot

      ea0029p1060
    • Abstract unavailable

      ea0029p1061
    • Reduced fatigue and improved sexual function in hypogonadal men treated with TESTIM in routine daily practice

      ea0029p1062
    • The mitochondrial citrate carrier regulates insulin secretion by human male gamete

      ea0029p1063
    • Mild androgen insensitivity syndrome due to novel mutation in androgen receptor gene

      ea0029p1064
    • Semen quality in patients with newly diagnosed Hodgkin's disease

      ea0029p1065
    • Subcutaneous gonadotropin therapy for male infertility by hypogonadotropic hypogonadism

      ea0029p1066
    • Translation of EMAS sexual functions questionnaire from English to Lithuanian

      ea0029p1067
    • A surprising diagnosis in a man with high testosterone levels

      ea0029p1068
    • Recapture of the study on the reproductive function of Estonian, Latvian and Lithuanian Young Men after 8 years

      ea0029p1069
  • Neuroendocrinology
  • • SNPs and CNVs genotyping analysis of patients with idiopathic central hypogonadism (ICH). A novel approach to detect new candidate mechanisms

      ea0029p1070
    • Cidea as a posible mediator of ghrelin resistance induced by high fat diet

      ea0029p1071
    • Effects of obestatin on proliferation and survival of adult rat hippocampal progenitor cells

      ea0029p1072
    • Normalization of cortisol levels in Cushing's disease after medical pretreatment before surgery: effects on somatostatin receptor subtype expression and in vitro response to somatostatin analogs.

      ea0029p1073
    • Mechanisms for the protective effects of 17-[beta]-estradiol: relevance to depressive symptoms in Parkinson's disease

      ea0029p1074
    • Transient inhibition of the resolvin system in the hypothalamus of diet-induced obese mice

      ea0029p1075
    • Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas

      ea0029p1076
    • Shift work at young age is associated with elevated long-term cortisol levels and body mass index

      ea0029p1077
    • The limited screening value of insulin-like growth factor-I as a marker for alterations in body composition in very long term adult survivors of childhood cancer

      ea0029p1078
    • Timing determines the suppressive effect of sleep loss on testosterone

      ea0029p1079
    • CT Scan of the anterior skull base in Kallmann syndrome reveals specific ethmoid abnormalities

      ea0029p1080
    • Wrist actigraphy detects sleep disorders in patients with Cushing's syndrome

      ea0029p1081
    • Comparison of Chinese herbal mixture and electro-acupuncture on regulating endocrine disturbances and hypothalamic androgen receptor in rats with DHT-induced PCOS

      ea0029p1082
    • Endogenous estradiol levels in female acute stroke patients: an independent determinant of stroke severity and early outcome

      ea0029p1083
    • Long term evolution of patients with transsphenoidal surgery due to pituitary adenomas

      ea0029p1084
    • Panhypopituitarism treated and untreated with GH: long term evolution of echocardiographic parameters

      ea0029p1085
    • Relationship between sex hormones, cognitive performance and substance use

      ea0029p1086
    • The proliferation and apoptosis activity of blood lymphocytes in acromegaly

      ea0029p1087
    • Long term evolution of patients with prolactinoma in a neuroendocrinology unit

      ea0029p1088
    • Influence of various doses of Cabergoline in dynamics of long-term treatment on the level of blood soluble apoptosis markers in patients with inactive pituitary adenomas

      ea0029p1089
    • The blood lymphocytes oxidoreductases activity in patients with active acromegaly

      ea0029p1090
    • Hypercortisolism in patients with diabetes mellitus, adrenal incidentaloma and obesity

      ea0029p1091
    • Levothyroxine therapy in patients with secondary hypothyroidism in nonfunctioning pituitary adenomas

      ea0029p1092
    • Neuroendocrine abnormalities in adolescents with the Turkish saddle volume formations

      ea0029p1093
    • Somatostatin analogue treatment of acromegaly

      ea0029p1094
    • Clinical manifestations of depression in patients with primary hyperparathyroidism

      ea0029p1095
    • Discovery of a novel peptide, neuroendocrine regulatory peptide-2 regulating feeding behavior and glucose metabolism

      ea0029p1096
    • Effects of low sodium concentrations on neuronal cell models

      ea0029p1097
    • SEMA3A deletion in a family with Kallmann syndrome validates the role of semaphorin 3A in human puberty and olfactory system development

      ea0029p1098
    • Stimulatory role of neurokinin B in the control of the gonadotropic axis in the rat: developmental changes, sexual dimorphism and regulation by gonadal steroids

      ea0029p1099
    • Intracerebroventricular administration of metformin inhibits ghrelin-induced hypothalamic AMP-kinase signalling and food intake

      ea0029p1100
    • Genetic variation of the hypothalamo-pituitary axis may increase susceptibility of postnatal depression

      ea0029p1101
    • Differential diagnosis of acromegaly: a new gene for pachydermoperiostosis

      ea0029p1102
    • Magnetic risonance imaging (mri) of olfactory bulbs and other brain structures in kallmann syndrome

      ea0029p1103
    • Kisspeptin is the peptide linking metabolism and reproduction

      ea0029p1104
    • Topiramate treatment improves hypothalamic insulin and leptin signaling and action and reduces obesity in mice

      ea0029p1105
    • Insulin improves memory and cognition via protein kinase c delta ([delta])

      ea0029p1106
    • The Tuebingen Cushing's disease quality of life inventory: development and normative data from 1784 healthy people

      ea0029p1107
    • Oligogenicity in the idiopathic central hypogonadism

      ea0029p1108
    • Investigating glucose responsive neuropeptide release using a static hypothalamic incubation system

      ea0029p1109
    • Expanding the clinical and genetic spectrum of the reversal of congenital hypogonadotropic hypogonadism

      ea0029p1110
    • Retinoic acid regulates growth-related gene expression in the rat hypothalamus

      ea0029p1111
    • Crf type 2 receptor mediates estradiol-induced increase in hypothalamic leptin sensitivity

      ea0029p1112
    • Retinal growth hormone: local regulation by GH-releasing hormone (GHRH)?

      ea0029p1113
    • Cu-gnrh and pacap-induced cAMP/PKA and cGMP/PKG pathways activity in anterior pituitary cells in vitro.

      ea0029p1114
    • Corticosterone interferes with the stimulatory effect of cAMP on proTRH transcription by promoting a GR-PKAc interaction and not through chromatin remodelling

      ea0029p1115
    • Effects of mineralocorticoid agonists and antagonists on survival, proliferation and differentiation of adult rat hippocampal progenitor cells

      ea0029p1116
    • Sleep deprivation-induced changes in rat hypothalamic arginine-vasopressin content

      ea0029p1117
    • Abstract unavailable

      ea0029p1118
    • Ghrelin, leptin and adiponectin plasma levels in narcolepsy with cataplexy

      ea0029p1119
    • High serum cortisol levels in patients with Alzheimer's Disease

      ea0029p1120
    • Melatonin levels, sleep and psychosocial impairment in patients after radiotherapy for brain tumors or leukemia

      ea0029p1121
    • Ten years of gastroenteropancreatic neuroendocrine tumours: evolution of the classification and correlation with follow-up in 50 patients

      ea0029p1122
    • Orexigenic neuropeptide 26RFa: new evidence for an adaptive profile of appetite regulation in anorexia nervosa

      ea0029p1123
    • Autoimmune thyroid disease and neuroendocrine gastric tumors: early detection and efficacy of somatostatin analogue treatment

      ea0029p1124
    • Contemporary microsurgical treatment of Cushing's disease

      ea0029p1125
    • Effect of ghrelin on aromatase gene expression and estradiol 17-[beta] concentrations in ventromedial and lateral hypothalamic area

      ea0029p1126
    • Regional distributions of kisspeptin and gonadotropin-inhibiting hormone peptides in ovine and rat brains

      ea0029p1127
    • Right hemicolectomy in the treatment of patients with appendiceal neuroendocrine tumors: does size matter?

      ea0029p1128
    • Delay in the onset of puberty of intrauterine growth retarded female rats cannot be rescued by hypernutrition after birth

      ea0029p1129
    • Fasting induces a delayed increase of thyrotropin-releasing hormone degrading ectoenzyme activity in the tanycytes of the median eminence of the rat hypothalamus

      ea0029p1130
    • Estradiol effects on hypothalamic stat3 phosphorylation induced by leptin

      ea0029p1131
    • Evaluation of cushings disease remission and serum cortisol dynamic early after transsphenoidal surgery

      ea0029p1132
    • Hyponatremia in hospitalised patients: are we investigating and managing them properly?

      ea0029p1133
    • Epidemiology, clinical behaviour and prognostic factors of gastroenteropancreatic neuroendocrine tumours in Castilla-La Mancha (Spain) from 1995 to 2010

      ea0029p1134
    • Effect of galanin on aromataze gene expression and estradiol 17-[beta] concentrations in ventromedial and lateral hypothalamic area

      ea0029p1135
    • Leptin resistance and desensitization of hypophagia during prolonged inflammatory challenge are associated with high ptp1b expression in the hypothalamus

      ea0029p1136
    • Obestatin does not modify weight and nutritional behavior but is associated to metabolic syndrome in old women

      ea0029p1137
    • Hypopituitarism 3 and 12 months after TBI and SAH

      ea0029p1138
    • Pituitary incidentaloma: clinical presentation and endocrine evaluation in a Spanish population

      ea0029p1139
    • Comparison of the effect of chronic restraint and crowding on hypothalamic-pituitary-adrenocortical response to acute restraint stress

      ea0029p1140
    • Circulating interleukin 6 and soluble forms of interleukin 6 receptor and glycoprotein 130 in women with anorexia nervosa

      ea0029p1141
    • Ghrelin and growth hormone levels are decreased in Saudi autistic children

      ea0029p1142
    • Basal and stimulated GH secretion in active cushing's syndrome and 2 years after remission

      ea0029p1143
    • Overly rapid correction of severe hyponatremia with vasopressin receptor antagonists poses a risk of inducing osmotic demyelination syndrome

      ea0029p1144
    • Relationship between leptin, markers of bone turnover, bone mineral density, and body weight in patients with schizophrenia treated with long acting risperidone (LAIR)

      ea0029p1145
    • Estrogen receptor alpha PvuII polymorphism in female acute stroke patients: no associations with disease severity and short-term prognosis

      ea0029p1146
    • The incidence of acromegaly in iceland from 1955 through 2010

      ea0029p1147
    • The incidence of hypoglycaemia in non-diabetic hospital patients outside critical care estimated by a capture-recapture technique: retrospective analysis

      ea0029p1148
    • An initial dose of 7.5 mg Tolvaptan is safe and effective in the treatment of hyponatremia caused by SIADH

      ea0029p1149
    • Role of endocrine nurse in simultaneous bilateral inferior petrosal sinus sampling (BIPSS): single center experience

      ea0029p1150
    • PTHrP-induced hypercalcemia: a rare and challenging presentation in metastatic pancreatic neuroendocrine tumour

      ea0029p1151
    • Profile of neurosarcoidosis observed in internal medecine practice

      ea0029p1152
  • Nuclear receptors and Signal transduction
  • • Effects of estradiol on tight junction in the human breast cancer cell line MCF-7

      ea0029p1153
    • Insufficiency of the chaperones GRP78 and GRP94 links TLR4 signaling to endoplasmic reticulum stress

      ea0029p1154
    • Central diabetes insipidus associated with impaired renal aquaporin-1 expression in mice lacking the oxysterol receptor liver X receptor [beta]

      ea0029p1155
    • PAK1-Nck interaction regulates prolactin-dependent cyclin D1 promoter activity

      ea0029p1156
    • Estrogen priming is critical for effective progesterone receptor engagement with DNA in breast cancer cells: ChIP sequencing and microarray studies

      ea0029p1157
    • Hypoxia-induced estrogen receptor alpha activation is mediated by both the MAPK and PI3K phosphorylation pathways

      ea0029p1158
    • GH-STAT5 signaling pathway is down-regulated by Liver X Receptor agonists in liver

      ea0029p1159
    • Post-translational modification of the thyroid hormone receptor interferes with its transcriptional activity

      ea0029p1160
    • Impact of receptor tyrosine kinase ErbB2/Her-2 and chemokine receptor CXCR4 crosstalk on estrogen receptor [beta] activity

      ea0029p1161
    • Characterisation of the N321K mutation in the type-2 vasopressin receptor causing nephrogenic diabetes insipidus

      ea0029p1162
    • Protein metabolism in human skeletal muscle after 72 h fasting; increased muscle protein breakdown and impaired insulin signaling

      ea0029p1163
    • Chronic and acute effect of IL1[bata] on sex hormone-binding globulin by decreasing HNF-4[alpha] via JNK/c-Jun pathway

      ea0029p1164
    • LPS administration modulates hypothalamic AMPK and glucose homeostasis in mice

      ea0029p1165
    • Evaluation of K[plus] flux-dependent regulation of mitochondrial potential ([Delta][Phi]m) by [alpha]-adrenergic agonist phenylephrine in single hepatocytes

      ea0029p1166
    • Altered muscle mitochondrial amount and physical performance in 5/6 nephrectomy CKD model mice

      ea0029p1167
    • PPAR[gamma] activator may improve sepsis symptom by inhibiting inflammation in adipose tissue

      ea0029p1168
    • Effects of benzbromarone on serum CRP in patients with gout

      ea0029p1169
  • Obesity
  • • Association of 3111t/c polymorphism of the clock gene with binge eating disorder in obese children and adolescents

      ea0029p1170
    • Nicotine induces negative energy balance through hypothalamic AMP-activated protein kinase

      ea0029p1171
    • Ac 2-26, an annexin A1-derived peptide, reduces inflammation in human SGBS adipocytes after hypoxia treatment

      ea0029p1172
    • Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects

      ea0029p1173
    • Zinc-[alpha]2-glycoprotein in adipose tissue is related with insulin resistance and lipolytic genes in morbidly obese patients

      ea0029p1174
    • Longitudinal changes in body mass index and body composition among 417 adult survivors of childhood cancer

      ea0029p1175
    • Brown rice and its component, [gamma]-oryzanol, attenuate the preference for dietary fat by decreasing hypothalamic endoplasmic reticulum stress in mice

      ea0029p1176
    • Weight-perception in male career US firefighters and its association with cardiovascular risk factors

      ea0029p1177
    • GH secretagogue receptor gene 171 C/T polymorphism association with metabolic features in obese children and adolescents

      ea0029p1178
    • Using 1H-nuclear magnetic resonance spectroscopy to identify changes in the plasma metabolome of rats fed low-carbohydrate/high fat diets

      ea0029p1179
    • Metabolic syndrome after liver transplantation: pre- and post-operative risk factors

      ea0029p1180
    • Metformin in normoglycemic obesity: a systematic review

      ea0029p1181
    • Growth differentiation factor-15 and transforming growth factor-[beta]1 in healthy adults with and without obesity

      ea0029p1182
    • Abstract unavailable

      ea0029p1183
    • The effect of 'The Programme of weight loss' in women, Arkhangelsk, Russia

      ea0029p1184
    • Efficacy of orlistat vs placebo in the improvement of lipid profile among overweight and obese patients: a meta-analysis

      ea0029p1185
    • Insulin resistance and acne: a new risk factor for men?

      ea0029p1186
    • Metabolic syndrome in benign and malignant nodular thyroid diseases

      ea0029p1187
    • Abstract unavailable

      ea0029p1188
    • A pilot study in obese patients who refer to plastic surgery: temperamental-personality traits

      ea0029p1189
    • Evaluation of success of an obesity consultation (2004-2010)

      ea0029p1190
    • Regulation of lipid droplet function in adipocytes: role of RAB18

      ea0029p1191
    • Frequency of obesity, insulin resistance, cardio-metabolic risk factors and genetic variation in the genes encoding ADIPOQ and PPAR-[gamma] in urban adults

      ea0029p1192
    • Melanocortin 4 receptor genetics in defining the morbid obesity in general population: common polymorphisms vs mutations

      ea0029p1193
    • Effects of bezafibrate treatment on pancreatic remodeling and insulin resistance in ovariectomized C57BL/6 mice fed high-fat diet

      ea0029p1194
    • Abstract unavailable

      ea0029p1195
    • Prediabetes in adult GH deficiency is associated with a substantial reduction in serum and adipose tissue expression levels of zinc-[alpha]2-glycoprotein

      ea0029p1196
    • Signalling properties of the melanocortin 3 receptor are modified by interaction with different ghrelin receptor variants in heterodimers

      ea0029p1197
    • Metabolic signature of visceral and subcutaneous obese adipose tissue secretomes reveal altered tissular amino acid metabolism

      ea0029p1198
    • Time-course of changes of GLUT4 expression in insulin-sensitive tissues in an animal model of metabolic syndrome

      ea0029p1199
    • Acute ghrelin effects on depressive-like behavior in bulbectomyced mice: a possible mechanism of action

      ea0029p1200
    • Association of the obesity/type 2 diabetes-related genetic variants with visceral fat acccumulation in obese, overweight and lean subjects

      ea0029p1201
    • Abstract unavailable

      ea0029p1202
    • Loss of hypothalamic-pituitary-adrenal axis improves obese phenotype and restores hypothalamic agouti-related protein mRNA in leptin-deficient ob/ob mice

      ea0029p1203
    • Different metabolic response to intagastric balloon treatment between non-morbid and morbid type of obesity

      ea0029p1204
    • Metabolic and hormonal consequences of circadian rhythm disruption in Bmal1 null mice

      ea0029p1205
    • Aldosterone increases oxidative stress in differentiated, but not in undifferentiated 3T3-L1 adipocytes via activation of mineralocorticoid receptors

      ea0029p1206
    • Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit

      ea0029p1207
    • GPR83 in interaction with GHSR and MC3R: lessons from in vitro studies

      ea0029p1208
    • Metabolic effects of 3-iodothyronamine in hepatocytes

      ea0029p1209
    • The adipokines TNF-[alpha] and IL6 predicted incident cancer development in a Chinese community-based cohort

      ea0029p1210
    • ASP injection promotes macrophage infiltration and M1 polarization in obese adipose tissue

      ea0029p1211
    • Regulation of adiponectin by free fatty acids in lean and obese subjects

      ea0029p1212
    • SUR2a gene is upregulated in skeletal muscle insulin resistance of obese rats: correlation with GLUT4 gene

      ea0029p1213
    • Circulating oxidized LDL in patients with visceral obesity

      ea0029p1214
    • Leptin modulates brain neural activity associated with feeding behavior in patients with lipodystrophy

      ea0029p1215
    • Age variations in adiposity and body fat composition among spanish women

      ea0029p1216
    • Serum liver fatty acid binding protein levels correlate positively with obesity and insulin resistance in chinese young adults

      ea0029p1217
    • Gender differences in measurements of total and regional body composition in preschool children

      ea0029p1218
    • Comparison of serum high-molecular-weight (HMW) adiponectin and homeostasis model assessment of insulin resistance (HOMA-IR) as markers for metabolic syndrome (MS) in estonian adult population

      ea0029p1219
    • Local inflammatory response in adipose tissue dysfunction

      ea0029p1220
    • Effect of two different types of bariatric surgery on metabolic profile in obese type 2 diabetic women

      ea0029p1221
    • Visceral-to-subcutaneous fat ratio using fat measurement CT is essential for the assessment of risk for diabetes, hypertension and early atherosclerosis

      ea0029p1222
    • Effect of obesity on vitamin d and parathormone levels

      ea0029p1223
    • Limited effects of leptin and adiponectin on proliferation and protein metabolism of porcine myoblasts under serum-free culture conditions

      ea0029p1224
    • Effect of secreted frizzled-related protein 2 (sFRP2) from adipose tissue on pancreatic cell function

      ea0029p1225
    • Curcumin inhibits the upregulation of cathepsin L by palmitate in fat

      ea0029p1226
    • Preventing childhood obesity by community based intervention approaches

      ea0029p1227
    • Reduction of body weight and waist circumference after long-term treatment of hypogonadal men with testosterone undecanoate

      ea0029p1228
    • Connection of adipocitokines and inflammatory markers in obese woman: influence of body weight reduction

      ea0029p1229
    • Proteomic analysis identifies adiponectin as a key plasma protein associated to vitamin D deficiency in pediatric obesity

      ea0029p1230
    • Plasma adipokines and improvement of insulin sensitivity during multi-phase long-term dietary intervention

      ea0029p1231
    • Obesity the first year of life: influence of glycemia at pregnancy, breastfeeding and sleep

      ea0029p1232
    • Anthropometric, hormonal and nutritional correlates of epicardial fat in obese women

      ea0029p1233
    • How informative is visceral fat measurement by bioelectrical impedance?

      ea0029p1234
    • A selective androgen receptor modulator, S42 possesses beneficial metabolic effects

      ea0029p1235
    • Effect of orlistat in Russian adolescents with metabolic syndrome: a randomized controlled trial

      ea0029p1236
    • Extreme obesity partly blunts the discriminative metabolic effects of polycystic ovary syndrome (PCOS)

      ea0029p1237
    • Low dose 3-iodothyronamine increases acute lipolysis followed by protein catabolism in mouse

      ea0029p1238
    • Lipid metabolism is impaired in obesity/diabetes model mice

      ea0029p1239
    • Comparing effects of lifestyle modification-induced weight loss on androgen levels, endothelial, sexual and urinary function, and quality of life in obese men with and without androgen deficiency

      ea0029p1240
    • How safe is the use of herbal weight-loss products sold over the Internet?

      ea0029p1241
    • Obesity related comorbidities 2 years following bariatric surgery in a group of 215 German subjects

      ea0029p1242
    • Changes in gut hormone levels and glucose homeostasis in obese patients during the first year after laparoscopic sleeve gastrectomy

      ea0029p1243
    • Changes of peripheral [alpha]-melanocortin stimulating hormone ([alpha]-MSH) in childhood craniopharyngioma patients in comparison with other forms of childhood obesity

      ea0029p1244
    • Measurement of serum high-molecular-weight (HMW) adiponectin level using recently-developed chemiluminescence enzyme immunoassay (CLEIA) at health check-up

      ea0029p1245
    • Anti-inflammatory effects of full-length and globular protein fragments of the new adipokine CTRP-3

      ea0029p1246
    • Cholinergic and purinergic markers are increased in lymphocytes of patients with Metabolic Syndrome

      ea0029p1247
    • Association between osteocalcin and insulin resistance in obese women

      ea0029p1248
    • Serum leptin levels in patients with type 1 gaucher disease

      ea0029p1249
    • Relationship between neck circumference and cardiometabolic parameters in non-obese brazilian adult population

      ea0029p1250
    • A different method in obesity treatment; external gastric balloon

      ea0029p1251
    • Hyperuricemia and components of metabolic syndrome among patients of different age

      ea0029p1252
    • The comparison of obesity treatment with intragastric balloon and bihevioral-cognitive approach

      ea0029p1253
    • Therapeutic efficacy of obesity treatment methods in teenagers

      ea0029p1254
    • Insulin and C-peptide response after a test meal in obese patients before and 5 days after bariatric gastric by pass surgery

      ea0029p1255
    • The oxidative stress parameters within the context of metabolic syndrome evolution in men

      ea0029p1256
    • Relationships between metabolic syndrome components and bone mineral density in ukrainian postmenopausal women

      ea0029p1257
    • Allograft inflammatory factor 1 is a new human adipokine regulating adipose inflammation

      ea0029p1258
    • Body composition and radiation exposure in the Adult Health Study

      ea0029p1259
    • Usefulness of preoperativee exenatide in control of risk factors for bariatric surgery on type 2 diabetic patients with morbid obesity

      ea0029p1260
    • Preclinical anti-obesity activity and safety assessment of a novel drug affecting CB1 receptor

      ea0029p1261
    • Green tea consumption, weight loss and resting energy expenditure

      ea0029p1262
    • Waist and abdominal circumference in seven years old children: relationship between methods

      ea0029p1263
    • Bariatric surgery in men: effects on gonadal hormones, body composition, glucose, lipid and bone metabolism

      ea0029p1264
    • Outcome of obese adults after laparoscopic adjustable gastric banding: a retrospective follow-up study

      ea0029p1265
    • Proteomic analysis of adipose tissue in health and disease

      ea0029p1266
    • Is fat mass index superior to total fat mass percentage in predicting the metabolic syndrome?

      ea0029p1267
    • Relationships between hypovitaminosis D, low-grade chronic inflammation, and leptin-to-adiponectin ratio in PCOS: is this a matter of fatness?

      ea0029p1268
    • Incidence of glucose and lipid metabolism disorders in overweight children and adolescents in Croatia

      ea0029p1269
    • Factors determining weight gain in adults and relation with glucose tolerance

      ea0029p1270
    • Obesity prevention: main findings of the EPODE European network project

      ea0029p1271
    • Dietary habits and body weight in an unselected population of Italian high-school students

      ea0029p1272
    • Relationship between obesity and Leptin (G-2548A) and Leptin receptor (668A[gt]G (Q223R)) gene polymorphisms in Turkish population

      ea0029p1273
    • Atherosclerosis risk factors before and 90 days after bariatric surgery

      ea0029p1274
    • Obesity prevalence in west black sea region of turkey, the Melen Study

      ea0029p1275
    • Association between metabolic syndrome and serum leptin level in postmenopausal women

      ea0029p1276
    • Effects of diet and physical activity-induced weight loss on insulin resistance in severely obese patients

      ea0029p1277
    • Evaluation of depressive symptoms and quality of life in obese patients

      ea0029p1278
    • Plantar heel pain and relation with different diseases in obese Turkish patients

      ea0029p1279
    • Relationship between visceral fat and neck circumference in patients with metabolic syndrome

      ea0029p1280
    • Morbid child obesity-possible Rohhadnet syndrome: case report

      ea0029p1281
    • The correlation between metabolic syndrome and serum resistin, adiponectin, TNF[alpha], leptin levels and abdominal adipose tissue thickness

      ea0029p1282
    • Study of insulin resistance in overweight and obese children by: M Hesham El Hefnawy and Ibrahim Emara

      ea0029p1283
  • Paediatric endocrinology
  • • Insulin secretion and sensitivity in GH deficient children at the end of rhGH therapy and after 1 year of follow-up: influences of d3GH receptor polymorphism on metabolic parameters

      ea0029p1284
    • ACTH and cortisol are differently associated with metabolic syndrome components in a large cohort of Caucasian obese children and adolescents

      ea0029p1285
    • Subclinical hypothyroidism in obese children and metabolic implications

      ea0029p1286
    • Addressing issues of diabetes patients community: Role of NGO's in resource poor settings

      ea0029p1287
    • Influence of cranial and craniospinal irradiation in childhood on reproductive system of women and men cancer survivals

      ea0029p1288
    • Etiology of delay of puberty in adolescents with different neuroendocrine diseases

      ea0029p1289
    • Noonan syndrome: short stature and pubertal delay

      ea0029p1290
    • The neuroendocrine complications of teenagers with diabetes insipidus of central genesis

      ea0029p1291
    • Systemic administration of C-type natriuretic peptide rescues impaired endochondral bone growth in mice model of achondroplasia

      ea0029p1292
    • Exclusion of aldosterone signaling pathway genes as candidates for renal pseudohypoaldosteronism type 1 in 32 families

      ea0029p1293
    • Serum adiponectin levels in adolescents and young adults with GH deficiency

      ea0029p1294
    • Serum concentrations of chemerin, omentin and vaspin in girls with anorexia nervosa

      ea0029p1295
    • Evaluation of circulating kisspeptin as a biomarker for differential diagnostic of central precocious puberty

      ea0029p1296
    • Two novel IGF1R gene heterozygous mutations in two unrelated children with pre and postnatal growth retardation, and microcephaly

      ea0029p1297
    • Pediatric and adolescent somatotrop adenomas

      ea0029p1298
    • Wolfram syndrome: new cases and new mutations

      ea0029p1299
    • Growth and response to rhGH treatment in patients with congenital combined pituitary hormone deficiency younger than 3 years of age

      ea0029p1300
    • Hyperandrogenism and PCOS in adolescent girls with type 1 diabetes treated with intensive and continous insulin therapy

      ea0029p1301
    • Diagnosis of glycemic abnormalities in thalassemic adolescents: continuous glucose monitoring versus glucose tolerance, and insulin: glucose parameters

      ea0029p1302
    • Linear growth of children with congenital hypothyroidism detected by neonatal screening compared to normal children and their mid-parental height

      ea0029p1303
    • A novel splicing mutation of the POU1F1 gene in Japanese identical twins with mild combined pituitary hormone deficiency

      ea0029p1304
    • Analysis of selected FOXP3 gene polymorphisms in children and adolescents with Graves' disease and Hashimoto's thyroiditis

      ea0029p1305
    • Characterization of a population of patients with 46,XX disorders of sex development followed at a Pediatric Center of Argentina

      ea0029p1306
    • Randomized multicenter trial on patients with childhood craniopharyngioma (KRANIOPHARYNGEOM 2007): update after 49 months of recruitment

      ea0029p1307
    • Effect of calcitriol on bone metabolism in adolescents with type 1 diabetes

      ea0029p1308
    • Vitamin D levels in a paediatric population of normal weight and obese subjects

      ea0029p1309
    • A particular phenotype in a case of Down-Turner syndrome

      ea0029p1310
    • Dysfunction of adrenal steroidgenesis in preterm infants with late-onset circulatory collapse

      ea0029p1311
    • Thyroid abnormalities in a 13 year old girl with an androgen secreting juvenile granulosa cell tumor of the ovary: insight into the thyroid-androgen axis in girls

      ea0029p1312
    • Clinical practice guideline on linear growth measurement of children

      ea0029p1313
    • The presence of thyroid nodules in our morbid obese patients and its relation with metabolic parameters

      ea0029p1314
    • Mutations of the SRD5A2 gene in patients with 5 [alpha]-steroid reductase deficiency

      ea0029p1315
    • Lipid storage myopathy in a child with idiopathic short stature

      ea0029p1316
    • Care of patients with childhood onset growth hormone deficiency before and after the transition period

      ea0029p1317
    • Psychiatric symptoms in Addison's crisis in childhood: the complexity of diagnosis

      ea0029p1318
    • Insulin like growth factor-I (IGF-I) levels and metabolic parameters in a population of obese children and adolescents

      ea0029p1319
    • The median age of the onset of puberty in Uzbek boys of Tashkent city

      ea0029p1320
    • Thyroid function in a group of type 1 diabetes children without clinical evidence of thyroid diseases

      ea0029p1321
    • The EURO-WABB project

      ea0029p1322
    • Kearns-Sayre syndrome: clinical and molecular diagnosis of the disease and treatment with recombinant GH (rGH) complicated by a severe cardiac conduction deficit and cardiomyopathy

      ea0029p1323
    • Newborn screening for congenital hypothyreoidism(CH) in Georgia

      ea0029p1324
    • GH deficiency in the transitional age: retesting and reassessment of ninety personal cases

      ea0029p1325
    • Building a Brazilian national network for pediatric endocrinology: the RUTE SIG experience

      ea0029p1326
    • Peculiarities of autoimmune thyroiditis in children

      ea0029p1327
    • Short stature due to late-onset congenital adrenal hyperplasia

      ea0029p1328
    • Actual preparation of the growth hormone treatment for small-for-gestational-age children

      ea0029p1329
    • 47XYY syndrome is one of the cause of tall in children

      ea0029p1330
  • Pituitary Basic
  • • A recessive mutation resulting in a disabling amino acid substitution (T194R) in the LHX3 homeodomain causes combined pituitary hormone deficiency

      ea0029p1331
    • Evidence of the involvement of gherline and obestatin in the regulation of GH secretion during pubertal development in boys

      ea0029p1332
    • T3 and T4 rapidly regulate the TSH, FSH and LH [alpha] subunit gene expression at posttranscriptional level

      ea0029p1333
    • Development of novel AIP (Aryl hydrocarbon receptor-interacting protein) gene study models using the fruitfly and the zebrafish

      ea0029p1334
    • Multiple enhancers regulate expression of the human LHX3 gene in the developing pituitary

      ea0029p1335
    • Role of a preformed signalosome in GnRH-stimulated FAK and paxillin phosphorylation by ERK at focal adhesions: possible role in gonadotropes migration

      ea0029p1336
    • T3 acts posttranscriptionally reducing the poly(a) tail length and the translational rate of alpha and beta TSH mRNA in T[alpha]T1 cells

      ea0029p1337
    • Estradiol induces the rapid trafficking of membrane-associated ER[alpha] isoforms in pituitary cells

      ea0029p1338
    • Pasireotide (SOM230) prevents sulfonylurea-induced hypoglycemia in fasted male rats

      ea0029p1339
    • mTOR inhibitor Torin1 induces antiproliferative effects in MtT/E cell line and human pituitary tumors

      ea0029p1340
    • Effect of estrogen and FGF-2 interaction on lactotroph cell proliferation mediated by membrane-initiated signaling

      ea0029p1341
    • Importance of topoisomerase II[alpha] and Ki-67 as markers of invasiveness and predictors of recurrence in pituitary tumours

      ea0029p1342
    • Aryl hydrocarbon receptor interacting protein in somatotroph adenomas: a molecular target for somatostatin analogues?

      ea0029p1343
    • Estradiol regulates the expression of c-FLIP in anterior pituitary cells

      ea0029p1344
    • Increased interleukin 22 circulating levels in patients with tumors involving the hypothalamic-pituitary region

      ea0029p1345
    • Expression of Ras related proteins in ES cell-derived AVP secreting cells

      ea0029p1346
    • Inhibition of methylation stimulates POMC expression and ACTH secretion in human pituitary ACTH-secreting tumors

      ea0029p1347
    • Effect of valproate on inositol 1,4,5 triphosphate and protein kinase C pathways activity in anterior pituitary cells of female rat

      ea0029p1348
    • The role of familial pituitary adenoma gene, aryl hydrocarbon receptor-interacting protein, in the proliferative and invasive activity of a malignant pancreatic cell line

      ea0029p1349
    • Combined intra- and inter-individual variability in macroprolactinaemia

      ea0029p1350
    • Reduced expression of glucocorticoid stimulated genes in large and dedifferentiated corticotroph adenomas

      ea0029p1351
    • Effects of the combined treatment with AMPK activator and somatostatin-14 on hormone secretion and cell proliferation in cultured GH-secreting pituitary tumor cells

      ea0029p1352
    • The relationship between Ki-67 labeling index and p53 with age, gender, number of surgeries, cure after surgery and cavernous sinus invasion in pituitary adenomas of patients with acromegaly

      ea0029p1353
    • Characterization of mutant AIPV49M in somatotroph cells

      ea0029p1354
    • Lycopene and [beta]-carotene induce growth-inhibitory and proapoptotic effects on pituitary tumor cells: the mechanism could involve Connexin 43

      ea0029p1355
    • Somatostatine receptors expression in various pathological types of clinically non-functioning pituitary adenomas

      ea0029p1356
    • Lymphocyte subpopulations in Sheehan's syndrome

      ea0029p1357
    • Modulation of intrapituitary CRH gene expression

      ea0029p1358
    • Resveratrol induces apoptosis in GH3 pituitary adenoma cells of the rat

      ea0029p1359
    • Effects of Brazilian palm tree extract on ACTH-secreting mouse pituitary tumor cells

      ea0029p1360
  • Pituitary Clinical
  • • Case series of diabetic ketoacidosis as the first presentation of 860 patients with acromegaly

      ea0029p1361
    • Markers of recurrence and long-term morbidity in craniopharyngioma

      ea0029p1362
    • Familial isolated pituitary adenoma: review of four families

      ea0029p1363
    • A prospective study of cardiac valvular status in patients treated with cabergoline for endocrine disease

      ea0029p1364
    • IGF1 as a risk factor for insulin resisitance and glucose intolerance in acromegaly

      ea0029p1365
    • An insight into the mechanisms underlying the sympathoinhibition of acromegaly

      ea0029p1366
    • Aneurysmal subarachnoid haemorrhage is a rare cause of acute glucocorticoid deficiency and long term hypopituitarism

      ea0029p1367
    • Hyponatraemia in aneurysmal subarachnoid haemorrhage is due to the syndrome of inappropriate antidiuresis and acute glucocorticoid deficiency

      ea0029p1368
    • Pregnancy outcomes following cabergoline treatment in hyperprolactinemic patients: an observational survey study

      ea0029p1369
    • Sleep apnea in acromegaly: pathogenetic factors and long-term follow up

      ea0029p1370
    • Japan National Survey of metastatic pituitary tumor: preliminary report on 164 cases

      ea0029p1371
    • Effects of previous GH excess and current medical treatment for acromegaly on cognition

      ea0029p1372
    • Abstract unavailable

      ea0029p1373
    • Circulating total and high molecular weight adiponectin levels are lower in adult GH deficient subjects

      ea0029p1374
    • Quality of life and mood disturbances in patients with acromegaly followed-up in a single center

      ea0029p1375
    • Low total cortisol correlates closely with low free cortisol in traumatic brain injury and predicts mortality and long term hypopituitarism

      ea0029p1376
    • Array-comparative genomic hybridization in congenital morphological alteration of the pituitary gland

      ea0029p1377
    • Low IGF1 levels are associated with a lower prevalence and incidence of anxiety disorders in primary care patients (DETECT cohort) and the general population (SHIP cohort)

      ea0029p1378
    • Epidemiology, histophatological characteristics and clinical manifestations of aggressive pituitary tumors, evaluated on the basis of KI-67 immunostaining: a single center experiense

      ea0029p1379
    • Congenital hypopituitarism with ectopic posterior pituitary and pulmonic stenosis: hormonal and radiologic followup into adulthood

      ea0029p1380
    • Childhood onset craniopharyngiomas have normal selfrating quality of life but impaired neurocognitive function in adult life

      ea0029p1381
    • Orexin A concentration is reduced in acromegaly, regardless activity of the disease

      ea0029p1382
    • No evidence for detrimental effect of cabergoline therapy on cardiac valves in patients with acromegaly

      ea0029p1383
    • Prevalence and incidence of pituitary adenomas; a population based study in Malta

      ea0029p1384
    • Markers of disease activity correlate with cephalometric parameters in acromegalic patients

      ea0029p1385
    • Management of giant cystic invasive prolactinoma-the role of medical therapy revisited

      ea0029p1386
    • Surveillance study on the prevalence of manifestations, complications and illness associated to acromegaly

      ea0029p1387
    • Diabetes insipidus could be the initial sign of primary hypophysitis

      ea0029p1388
    • Evaluation of metabolic parameters in patients with craniopharyngiomas using visceral adiposity index

      ea0029p1389
    • Oxidative stress and reduced anti-oxidative status, along with endothelial dysfunction in acromegaly

      ea0029p1390
    • Evaluation of clinical presentation, treatment approach and outcome of a cohort of patients with acromegaly: a single centre experience

      ea0029p1391
    • Permanent panhypopituitarism is a rare complication of acute bacterial sinusitis

      ea0029p1392
    • Carboplatin is a novel cause of the syndrome of inappropriate antidiuresis

      ea0029p1393
    • Evaluation of ejaculatory function in acromegalic men: preliminary study

      ea0029p1394
    • Evaluation of male sexual function in active acromegalic patients and after disease remission: preliminary study

      ea0029p1395
    • The clinical outcome of pituitary adenomas in the cavernous sinus

      ea0029p1396
    • Outcome of transsphenoidal surgery for Cushing's disease dependent on tumor size: a single center experience

      ea0029p1397
    • Effects of medical therapy of acromegaly on glucose metabolism

      ea0029p1398
    • Insulin resistance and the effect of treatment on insulin resistance in patients with prolactinoma

      ea0029p1399
    • Effects on GH/IGF1 hypersecretion and tumor size of long-acting somatostatin analogue (Sandostatin LAR) in patients with untreated acromegaly and in previously treated with surgery and/or radiotherapy

      ea0029p1400
    • Management of hyponatremia in the hospital: interim results from a prospective, observational, multi-center, global registry

      ea0029p1401
    • Cardiac magnetic resonance imaging detects myocardial fibrosis in patients with active acromegaly

      ea0029p1402
    • Pregnancies in a large cohort of patients on growth hormone replacement therapy

      ea0029p1403
    • Pasireotide LAR vs octreotide LAR in patients with acromegaly: double-blind, crossover, extension period to a randomized, double-blind, multicenter, phase III study

      ea0029p1404
    • Long-term use of pasireotide in Cushing's disease: 24-month safety results from a randomized phase III study

      ea0029p1405
    • Pasireotide treatment is associated with improvements in hypertension: 12-month results from a large phase III study in Cushing's disease

      ea0029p1406
    • GH Secretion response to triple secretagogue stimulus (ghrh, ghrelin and arginine) is gender and BMI dependent in healthy postmenopausal women and older men

      ea0029p1407
    • Pasireotide treatment is associated with clinically meaningful improvements in health-related quality of life in Cushing's disease: results from a large, randomized, double-blind phase III trial

      ea0029p1408
    • Increased risk of hypothalamic pituitary dysfunction amongst nasopharyngeal cancer survivors with the use of concurrent chemo-irradiation

      ea0029p1409
    • Long-term pasireotide use leads to improvements in the biochemical parameters of Cushing's disease: 24-month results from a randomized phase III study

      ea0029p1410
    • Hyperprolactinemic patients are prone to increased protein oxidation: a risk for low grade inflammation?

      ea0029p1411
    • Fifteen years of GH replacement improves body composition and metabolic parameters

      ea0029p1412
    • Incidence of hypogonadism and evaluation of its impact on cardiovascular risk factors and quality of life in acromegalic patients

      ea0029p1413
    • GH secretory function is well preserved in surgically cured acromegalics

      ea0029p1414
    • The effect of GH replacement therapy on exercise capacity, fat mass, ectopic lipids intramyocellular and intrahepatocellular lipids and insulin resistance in hypopituitary patients with GH deficiency

      ea0029p1415
    • Prevalence of central adrenal insufficiency during lifespan in Prader-Willi syndrome

      ea0029p1416
    • Limited effects of temozolomide monotherapy on aggressive pituitary tumors. -Based on our own experiences of three cases-

      ea0029p1417
    • The impact of long-acting somatostatin analogs treatment on glucose tolerance and insulin resistance in acromegaly.

      ea0029p1418
    • Immunohistochemical detection of sstr2 and 5 ligand binding domains in 110 pituitary tumors

      ea0029p1419
    • Symptomatic hypotonic hyponatraemia after endoscopic transsphenoidal surgery: results from two large series

      ea0029p1420
    • Audit of pituitary dysfunction after traumatic brain injury: caution in interpretation of glucagon stimulation test in diagnosis of GH and ACTH deficiency.

      ea0029p1421
    • Body composition has a higher impact on peak GH during the pyridostigmine-GHRH test than the insulin tolerance test in healthy individuals

      ea0029p1422
    • Progression of acromegalic arthropathy despite long-term biochemical control: a prospective, radiological study

      ea0029p1423
    • Cavernous Sinus Sampling (CSS) - a specific method for localization of minute ACTH secreting adenomas in Cushing Disease (CD)

      ea0029p1424
    • Effects of medical treatment on proliferation parameters MIB-1 and topoisomerase-II[alpha] in GH secreting pituitary adenomas

      ea0029p1425
    • Comprasion of cycline D1 gene (Ccnd1) polymorphism in invasive and non-invasive prolactinomas

      ea0029p1426
    • Control of GH and IGF1 in acromegaly in the UK: responses to medical treatment

      ea0029p1427
    • Low tumoral mRNA IGF2 might balance the mechanism of tumorigenesis in GH-secreting adenomas

      ea0029p1428
    • Synergistic effects of combined stimulation with CRH+ghrelin on ACTH and cortisol responses in patients with Cushing's disease: a pilot study

      ea0029p1429
    • Bone turnover in patients with active acromegaly in relation to glucose metabolism

      ea0029p1430
    • Relationship between gsp mutations and clinico-pathological features in GH producing pituitary adenomas

      ea0029p1431
    • Decreased IGF1 levels and GH-resistant hepatic state to estrogens during the first trimester of pregnancy in non-acromegalic women

      ea0029p1432
    • Coexistence of macroprolactinaemia and hyperprolactinaemia in women with oligo-/amenorrhoea is associated with high risk of pituitary adenomas

      ea0029p1433
    • Mortality rates in childhood and adult onset GH deficient patients enrolled in the Global Hypopituitary Control and Complications Study (HypoCCS)

      ea0029p1434
    • Experience in the use of tolvaptan in patients with syndrome of inappropriate antidiuretic hormone secretion (SIADH)

      ea0029p1435
    • Blast concussion is associated with high frequency of pituitary dysfunction

      ea0029p1436
    • Efficacy of transsphenoidal surgery for Cushing's disease: the role of combined dexamethasone desmopressin test

      ea0029p1437
    • Improved renal function after five years of GH therapy in GH deficient (GHD) adult survivors of childhood leukaemia

      ea0029p1438
    • Thyrotropin-secreting pituitary adenomas: experience of a single centre

      ea0029p1439
    • Detection of somatostatin receptors in aggressive non-functioning pituitary adenomas and effects of somatostatin analogs therapy in these tumors

      ea0029p1440
    • Effect of a modulation of somatostatin release on TSH secretion in healthy volunteers

      ea0029p1441
    • Are ''in silico'' predictions reliable regarding splice-site mutations? - Studies in the aryl hydrocarbon receptor-interacting protein (AIP)

      ea0029p1442
    • Effectiveness of cyberknife in the management of pituitary adenomas and craniopharyngiomas

      ea0029p1443
    • Evaluation of cardiovascular risk factors and metabolic profile in hyperprolactinemic subjects

      ea0029p1444
    • Pituitary tumor apoplexy: overview of 14 cases diagnosed during the last 12 years at a central hospital

      ea0029p1445
    • Copeptin is not associated with menstrual cycle hormones

      ea0029p1446
    • Acylated ghrelin as provocative test for the diagnosis of gh deficiency in adults

      ea0029p1447
    • National incidence and prevalence of TSH-secreting pituitary adenomas in Sweden

      ea0029p1448
    • High mean platelet volume and lipid abnormalities in prolactinoma patients without insulin resistance

      ea0029p1449
    • Asymptomatic nonfunctioning pituitary macroadenomas take advantage of surgery

      ea0029p1450
    • Mortality and survival in a large series of adult patients with hypopituitarism followed for 10 years

      ea0029p1451
    • Gastric and colonic pathology at patients with active acromegaly

      ea0029p1452
    • Pituitary dysfunction in adult patients after cranial radiotherapy for non-pituitary tumors: a long-term follow-up study

      ea0029p1453
    • The treatment of results of endoscopic transsphenoidal surgery for GH-secreting pituitary adenomas

      ea0029p1454
    • Glucose metabolism in children with GH deficiency before and after GH therapy

      ea0029p1455
    • Endocrine disturbances and quality of life in adult patients after multimodal treatment for brain tumors or leukemia

      ea0029p1456
    • Anterior pituitary autoantibodies in patients with diabetes mellitus

      ea0029p1457
    • Pitfalls in Cushing's disease: report of an ectopic ACTH-producing pituitary adenoma in the sphenoid sinus

      ea0029p1458
    • The effect of Ki67 index on tumor behavior in proloctanimas

      ea0029p1459
    • Cyclin D1 gene exon 4/intron 4 region A / G polymorphism and allele ratios in patients with prolactinoma

      ea0029p1460
    • Cancer detection in long-term follow-up of patients with acromegaly

      ea0029p1461
    • Study on IGF(CA)19 gene polymorphism in adults with GH deficiency

      ea0029p1462
    • META-analysis on the effects of octreotide on tumor mass in acromegaly

      ea0029p1463
    • Parasellar masses: experience in 47 patients

      ea0029p1464
    • Colonic neoplasms in acromegaly: are there serum risk factors?

      ea0029p1465
    • No long-term weight reduction after gastric banding in obese patients with craniopharyngioma involving hypothalamic structures: experiences from KRANIOPHARYNGEOM 2000

      ea0029p1466
    • Predictors of the acromegaly-associated mortality in the last decade

      ea0029p1467
    • Endoscopic transsphenoidal surgery as the therapy of choice for acromegaly: a 13-year experience in a single centre

      ea0029p1468
    • MALE macroprolactinomas: response to medical treatement

      ea0029p1469
    • Evaluation of pituitary gland with magnetic resonance imaging in hypogonadic patients

      ea0029p1470
    • Is acromegaly associated with irritable bowel syndrome?

      ea0029p1471
    • Acromegaly, does tumor size matters?

      ea0029p1472
    • Clinical and histological characteristics of giant GH producing pituitary adenomas

      ea0029p1473
    • Long-term outcomes after sterotactic radiosurgery for non-functioning pituitary adenomas

      ea0029p1474
    • Long-term outcomes after sterotactic radiosurgery for functioning pituitary adenomas

      ea0029p1475
    • Comparison of immunoassay and mass spectrometry measurement of cortisol during ACTH1-24 stimulation tests

      ea0029p1476
    • Cushing's disease: prospective assessment of factors influencing the efficacy of transsphenoidal surgery

      ea0029p1477
    • The results of surgical treatment on prolactinomas in females of child bearing ages

      ea0029p1478
    • Treatment outcomes in prolactinomas with and without cavernous sinus invasion

      ea0029p1479
    • Change in somatostatinergic tone of acromegalic patients according to the size of GH-producing pituitary tumors

      ea0029p1480
    • Two cases of sever congenital central hypothyroidism with TSH and prolactin deficiency-possible new syndrome

      ea0029p1481
    • Treatment response and comorbilities in acromegalic patients

      ea0029p1482
    • Reproductive function in acromegalic women: a one-center experience

      ea0029p1483
    • Evaluation of bone mass and fracture in patients with prolactinoma

      ea0029p1484
    • Prolactin levels are correlated with tumor size and invasiveness in prolactinomas

      ea0029p1485
    • Is every joint symptom related to acromegaly?

      ea0029p1486
    • Acromegaly and pregnancy: case reports

      ea0029p1487
    • Pegvisomant and cabergoline combination therapy in acromegaly

      ea0029p1488
    • Influence of the family environment during the early years in life in the vulnerability to the development of pituitary adenomas

      ea0029p1489
    • Hyperprolactinemia in polycystic ovary syndrome- diagnostic and therapeutic approach

      ea0029p1490
    • Hypothalamo-pituitary dysfunction in patients with chronic subdural hematoma

      ea0029p1491
    • Mood Disorders and Quality of Life in Patients with Acromegaly after Pituitary Adenomas

      ea0029p1492
    • Although dentists are frequently visited by acromegaly patients they do not diagnose the disease

      ea0029p1493
    • The long term recurrence rates of cushing's disease in turkish patients after transsphenodal surgery: a single-center experience

      ea0029p1494
    • Xanthoma disseminatum with cutaneous and pituitary stalk involvement

      ea0029p1495
    • Acromegaly and charles bonnet syndrome

      ea0029p1496
    • Planning for the future: preparing the endocrine specialist nurse of tomorrow

      ea0029p1497
    • Changes in body composition in patients with acromegaly

      ea0029p1498
    • Complications of pure endoscopic transsphenoidal surgery for pituitary adenoma

      ea0029p1499
    • A case of nephrotic syndrome hidden by cushing's disease

      ea0029p1500
    • Preliminary report of hypoglycemic response in obese metabolic syndrome males treated with metformin after weight loss intervention

      ea0029p1501
    • A difficult case of hyponatraemia in a neurosurgical patient

      ea0029p1502
    • Invasive and giant pituitary adenomas in the elderly

      ea0029p1503
    • Hyperprolactinemia: prolactinoma or pregnancy?

      ea0029p1504
    • DHEAS: a new marker in Cushing's disease? Preliminary results of 32 patients

      ea0029p1505
    • Clinical experience with acromegalic patients who have macroadenomas and long term follow-up results

      ea0029p1506
    • Glucose metabolism and lipid disturbances in acromegalic patients before and during treatment with long-acting somatostatin analogues

      ea0029p1507
    • The therapy with cabergoline evaluation of men with macroprolactinoma

      ea0029p1508
    • Efficacy of testerone 2% gel replacement therapy on erectile function, muscle strenght and general wellbeing in men affected by normo-hypogonadotropic hypogonadism

      ea0029p1509
    • Follow up of pituitary incidentaloma: a study in 140 patients

      ea0029p1510
    • Macroprolactin levels in healthy blood donors

      ea0029p1511
    • Sleep apnoea syndrome in acromegaly

      ea0029p1512
    • Therapeutic trends, long-term outcome and efficacy of different treatment modalities in acromegaly: a single center registry covering a 40 year period

      ea0029p1513
    • Prevalence of the metabolic syndrome in patients with adult growth hormone deficiency before GH treatment

      ea0029p1514
    • Familial central diabetes insipidus with extremely high water intake

      ea0029p1515
    • Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients

      ea0029p1516
    • Isolated diabetes insipidus happened during premenopause solution ten years after

      ea0029p1517
    • Metaplastic Rathke's cyst leading to hypopituitarism

      ea0029p1518
    • Pituitary macroadenomas: benefit from early GH substitution after surgery

      ea0029p1519
    • Pituitary insufficiency in the acute phase of traumatic brain injury or subarachnoid hemorrhage, prevalence and predictive factors: a prospective, population based study

      ea0029p1520
    • Difference of response to TRH (thyrotropin releasing hormone) stimulation according to octreotide response and the size of GH-producing pituitary adenomas

      ea0029p1521
    • Ovarian hyperstimulation syndrome due to a functioning gonadotroph adenoma

      ea0029p1522
    • GH deficiency after treatment of medulloblastoma and thyroid cancer: is this the case for GH therapy?

      ea0029p1523
    • Thyrotropinoma. A rare case report of hyperthyroidism

      ea0029p1524
    • The dermatologic evaluation of acromegaly patients

      ea0029p1525
    • Growth hormone effects on lipid profile in patients with acromegaly

      ea0029p1526
    • Pituitary lesions: Pituitary adenomas and what else?

      ea0029p1527
    • Progressive combined pituitary hormone deficiency produced by Prop1 gene mutation

      ea0029p1528
    • Neurohypohysis tumors: about two cases

      ea0029p1529
    • Hypersomatotropism and glucose metabolism disorders

      ea0029p1530
    • Hyperprolactinemia: etiology, diagnosis and therapeutic aspects

      ea0029p1531
    • Clinical, biological and radiological confrontation in Cushing disease

      ea0029p1532
    • Characteristics of giant and huge male prolactinomas

      ea0029p1533
    • A case of acromegaly in the presence of coincidental liver cirrhosis

      ea0029p1534
    • Adiponectin and cardiac structure in acromegaly

      ea0029p1535
    • A case of acromegaly diagnosed with diabetic ketoacidosis as a primary manifestation

      ea0029p1536
    • The role of long acting somatostatin analogues on glucose homeostasis in acromegaly

      ea0029p1537
    • Clinical features of inferior and lateral invasive expansion of GH-producing adenoma

      ea0029p1538
    • Predictive value of acute octreotide supression test in newly diagnosed acromegaly

      ea0029p1539
    • An unusual plurihormonal pituitary adenoma

      ea0029p1540
    • Results of pegvisomant therapy in patients with acromegaly

      ea0029p1541
    • Panhypopituitarism and central diabetes insipidus: a case report

      ea0029p1542
    • Evaluation of the efficacy and safety of pasireotide LAR in patients with mild-to-moderate cushing's disease: a randomized, double-blind, multicenter, phase III study design

      ea0029p1542.1
  • Steroid metabolism + action
  • • Anti-inflammatory effect of a high dose of corticosteroids is associated with some paradoxical pro-inflammatory effects

      ea0029p1543
    • Acute and chronic effects of low dose prednisolone on carbohydrate metabolism in subjects with inflammatory rheumatologic disease

      ea0029p1544
    • The influence of aromatizable and non-aromatizable steroids on anthropometric parameters

      ea0029p1545
    • Effect of smoking cessation on hormonal balance

      ea0029p1546
    • Conversion of 7[alpha]-hydroxyDHEA into 7-ketoDHEA: Role of type 2 11[beta]-hydroxysteroid dehydrogenase

      ea0029p1547
    • Steroid derivatives as pure antagonists of the androgen receptor

      ea0029p1548
    • The cellular fate of CYP19A1 (aromatase) protein

      ea0029p1549
    • Detection of BclI and A3669G polymorphisms in glucocorticoid receptor gene in patients with rheumatoid arthritis

      ea0029p1550
    • Aromatase activity after a short-course of Letrozole administration in adult men at sea level and in men at high altitude (with or without excessive erythrocytosis)

      ea0029p1551
    • Myostatin and Follistatin expression in orchidectomized rats submitted to exercise

      ea0029p1552
    • The role of long-acting parenteral testosterone undecanoate compound (Nebid 1000 mg) in the induction of secondary sexual characteristics (SSC) in males with hypogonadotropic hypogonadism (HH)

      ea0029p1553
    • IL-6, Cortisol and early morning stiffness in patients with rheumatoid arthritis: endocrine changes associated with clinical improvement in a chronic autoimmune disease

      ea0029p1554
    • Abstract unavailable

      ea0029p1555
    • Fetal liver may reinstate activity of GABAergic steroids inactivated by placental oxidoreductases

      ea0029p1556
    • Unconjugated steroids and steroid sulfates in maternal blood show comparable predictivity for assessment of gestational age from the 28th to 41st week of pregnancy

      ea0029p1557
    • Anabolic hormones in acute exacerbation of chronic obstructive pulmonary disease: relation of hypogonadism with indexes of severity and phlogosis

      ea0029p1558
    • Long-term evaluation of cross-sex hormone treatment in transsexual persons

      ea0029p1559
    • Physiological relevance of peripherally produced gabaergic and glycinergic steroids in human late pregnancy and around parturition

      ea0029p1560
    • Influence of endogenous hormones and testosterone in the prostate cancer

      ea0029p1561
  • Thyroid (non-cancer)
  • • Hypothyroidism is associated with increased intestinally derived lipoprotein particles and postprandial endothelial dysfunction

      ea0029p1562
    • P1563

      ea0029p1563
    • Hypothalamic mTOR pathway mediates thyroid hormone-induced hyperphagia in hyperthyroidism

      ea0029p1564
    • Potassium iodide, but not potassium iodate, as a potential protective agent against oxidative damage to membrane lipids in porcine thyroid

      ea0029p1565
    • Response to high dose glucocorticoid therapy in patients with dysthyroid optic neuropathy (DON)

      ea0029p1566
    • Effect of environmental nitrates on the thyroid and salivary glands in the population affected by the chernobyl fall-out

      ea0029p1567
    • Quantitative comparison of deiodinase I and II mRNA expression in ovine tissues

      ea0029p1568
    • Correlation between thyroid volume and body mass index 2 and 6 years later

      ea0029p1569
    • The relation between severity of obstructive sleep apnea and diagnosis of Hashimoto's thyroiditis

      ea0029p1570
    • An audit and patient satisfaction survey of the telephone endocrine clinic at University Hospital Lewisham, London

      ea0029p1571
    • Gestational hyperthyroidism in women from mild to moderate iodine deficiency (ID) areas

      ea0029p1572
    • The association between thyroid volume, L-thyroxine therapy and hepatocyte growth factor levels in euthyroid and hypothyroid goitrous and non-goitrous Hashimoto's thyroiditis

      ea0029p1573
    • Adaptation of the hypothalamo-pituitary-thyroid axis to pubertal development and exposure to acute and chronic physical stresses

      ea0029p1574
    • Thyroid nodules treated with percutaneous radiofrequency thermal ablation: a comparative study

      ea0029p1575
    • Predictors of long-term remission in patients with Graves' disease-a single centre experience

      ea0029p1576
    • The effect of L-thyroxine substitution on lipid profile, glucose homeostasis and coagulation in patients with subclinical hypothyroidism

      ea0029p1577
    • A novel familial variation of the thyroid hormone receptor beta gene (I276N) associated with resistance to thyroid hormone

      ea0029p1578
    • Short-term combined treatment with L-thyroxine plus L-triiodothyronine in drops (LT4 plus LT3) in patients with persistent hypothyroidism and malabsorption during replacement therapy with L-T4.

      ea0029p1579
    • The role of surgery in the treatment of amiodarone-induced thyrotoxicosis (AIT)

      ea0029p1580
    • Carbimazole induced ANCA associated renal vasculitis

      ea0029p1581
    • Thyroid dysfunction following cranial and craniospinal radiation in young adults

      ea0029p1582
    • Multi nodular goitre: when is it time for the surgeon?

      ea0029p1583
    • Amiodarone- induced thyroid dysfunction in an iodine- deficient region

      ea0029p1584
    • Hashimoto thyroiditis and carbohydrate metabolism disorders in patients hospitalized in Department of Endocrinology and Diabetology of Ludwik Rydygier Collegium Medicum in Bydgoszcz between 2001 and 2010

      ea0029p1585
    • Endocrine bioengineering: reconstruction of a bioartificial thyroid lobe using its natural, three-dimensional (3D) stromal / vascular matrix as a scaffold

      ea0029p1586
    • Thyroid hormone stimulates hepatic fatty acid metabolism via lipophagy

      ea0029p1587
    • Linking thyroid and central nervous system functions of cathepsin K: Implications for non-classical thyroid regulation

      ea0029p1588
    • SECISBP2 syndrome: Mouse models for an atypical form of resistance to thyroid hormone

      ea0029p1589
    • Polymorphism of the PPAR-[gamma]2 gene and Graves' orbitopathy: the Ala variant confers decreased risk of eye symptoms

      ea0029p1590
    • Thyroid hormone T3 induces ovarian activity in rat follicles and granulosa cells

      ea0029p1591
    • Recurrence of Amiodarone induced thyrotoxicosis after reinstitution of this drug

      ea0029p1592
    • Subclinical and overt hyperthyroidism in a long-term iodine sufficient area of Sweden (Gothenburg) 2003-2005

      ea0029p1593
    • Enhanced expression of the B cell activation factor (BAFF) and baff-receptor (BAFF-R) in the thyroid and in the orbital adipose tissue from patients with graves' disease (GD) and associated orbitopathy (GO)

      ea0029p1594
    • Utility of thiazide diuretics in the management of post- thyroidectomy hypocalcemia: a pilot study

      ea0029p1595
    • Maternal Graves' disease induces more perinatal complications and higher risk of thyroid dysfunction at early childhood

      ea0029p1596
    • No Correlations between TSH receptor antibody levels assayed with Elecsys TRAb and the activity or severity of Graves' ophthalmopathy

      ea0029p1597
    • The influence of recombinant human thyroid stimulating hormone (rhTSH) on the efficacy of radioiodine therapy in patients with toxic nodular goitre with low RAIU

      ea0029p1598
    • Peripheral blood lymphocyte apoptosis and its relationship with thyroid function tests in adolescents with hyperthyroidism due to Graves' disease

      ea0029p1599
    • Individual plasma ghrelin changes evaluated in the same patients in hyperthyroidism, hypothyroidism and euthyroidism

      ea0029p1600
    • The effect of radioiodine therapy in 950 patients with subclinical hyperthyroidism

      ea0029p1601
    • Genetic susceptibility to Graves' ophthalmopathy: the role of polymorphisms in anti-inflammatory cytokine genes

      ea0029p1602
    • The T and B cell subsets in thyroids of children with Graves' disease and Hashimoto's thyroiditis

      ea0029p1603
    • The thyroid gland is another victim of the insulin resistance syndrome university

      ea0029p1604
    • Four families with nonautoimmune hyperthyroidism harboring the same thyrotropin receptor germline mutation (Asn406Ser) in Kumamoto Prefecture, Japan

      ea0029p1605
    • Antigen mimicry between aeroallergens and thyroid antigens can modify the levels of thyroid hormones and antibodies in thyroid autoimmunity

      ea0029p1606
    • Diagnostic accuracy of elastography in thyroid nodule ultrasound evaluation. A prospective multicenter trial

      ea0029p1607
    • FOXA1 and FOXA2 oppositely regulate human type 1 Iodothyronine deiodinase gene in liver

      ea0029p1608
    • Dyrk1A (dual-specificity thyrosine (Y)-phosphorylation regulated kinase 1A) overexpression is linked to congenital hypothyroidism in Down syndrome

      ea0029p1609
    • Impaired absorption of thyroxine in occult celiac disease

      ea0029p1610
    • Frequency of PDE8B gene polymorphisms in patients affected by sporadic and familiar nonautoimmune subclinical hypothyroidism

      ea0029p1611
    • MicroRNA expression profile helps to distinguish benign and malignant thyroid nodules starting from cells of fine needle aspiration

      ea0029p1612
    • Effect of combination therapy with potassium iodide and 15 mg of methimazole for Graves' hyperthyroidism

      ea0029p1613
    • Estrogens block the apoptotic action of tgfb in human thyrocytes

      ea0029p1614
    • TRAb level and ophthalmopathy index as predictive factors of poor response and of severity of Graves ophthalmopathy in patients treated with anti-thyroid drugs and radioiodine

      ea0029p1615
    • A possible common link between Graves' disease and allergic immune response

      ea0029p1616
    • Subclinical hyperthyroidism (SH) in the elderly: symptoms, depression and quality of life (QoL) and relationship with TSH concentration in a prospective cohort of 110 patients

      ea0029p1617
    • Thyroid function of Japanese elderly

      ea0029p1618
    • Assessment of cognitive function in hypothyroidism using P300 evoked potentials

      ea0029p1619
    • Successful treatment of hyperthyroidism is associated with significant risks of overweight/obesity independent of the treatment modality employed

      ea0029p1620
    • Oral anticoagulant therapy: is it the same in hyperthyroid patients?

      ea0029p1621
    • Thyroid hormone abnormalities in haemodialyzed patients: low triiodothyronine as well as high reverse triiodothyronine are associated with increased mortality

      ea0029p1622
    • Perioperative clinical outcomes after robot-assited thyroid surgery by transaxillary approach

      ea0029p1623
    • Hyperthyroidism in patients with acute atrial fibrillation attended at an emergency room

      ea0029p1624
    • Alterations in adiponectin concentration in hyper- and hypothyroid patients; possible underlying mechanisms and role of metformin treatment in experimental animals

      ea0029p1625
    • A liquid formulation of L-thyroxine (L-T4) solves problems of incomplete normalization/suppression of serum TSH caused by proton pump inhibitors (PPI) on conventional tablet formulations of L-T4

      ea0029p1626
    • Serum chemokine CXCL10 is increased in chronic autoimmune thyroiditis associated with autoimmune gastritis

      ea0029p1627
    • Association between preoperative value of TSH and pathological findings in nodular thyroid disease

      ea0029p1628
    • Clinical presentation (symptoms and complications) of hyperthyroidism in a cohort of 1,144 patients: results of the Thyrdel study

      ea0029p1629
    • Beta (CCL2) and alpha (CXCL10) chemokines modulation by cytokines and by peroxisome proliferator-activated receptor-alpha agonists in Graves' ophthalmopathy

      ea0029p1630
    • Thyroid function in large elderly population - results of multicenter study performed in Poland

      ea0029p1631
    • Late manifestation of subclinical hyperthyroidism after goitrogenesis in an index patient with a N 670 S TSH receptor germline mutation causing familial non-autoimmune autosomal dominant hyperthyroidism (FNAH)

      ea0029p1632
    • The alterations of the endothelial function, haemostatic and inflammatory parameters in subclinical and overt hyperthyroidism

      ea0029p1633
    • Prediction of remission rate in the patients with Graves' disease after treatment with a minimum maintenance dose of Methimazole

      ea0029p1634
    • Predictors of relapse of Graves' disease after thionamide drugs treatment in clinical practice

      ea0029p1635
    • The significance of TSH receptor blocking antibody levels in gestational stage

      ea0029p1636
    • Evidence of humoral response to extracellular matrix proteins in Grave's diseace and thyroid associated ophtalmopathy

      ea0029p1637
    • Thyroid dysfunction in rheumatoid arthritis

      ea0029p1638
    • The usable markers of atherosclerosis measured by Doppler Ultrasound of lower limb artery in treatment- naive hypothyroid females

      ea0029p1639
    • Maternal-neonatal relationship of iodine metabolism in perinatal period: Changes in urinary iodine excretion in Japanese mothers and newborn infants

      ea0029p1640
    • Is Japan an iodine excess country? Current iodine status assessed by urinary iodine and food frequency questionnaire

      ea0029p1641
    • Determinants of children's iodine nutrition and epidemiological features of children's goiter and nodule in iodine-excessive areas

      ea0029p1642
    • Control of 217 hypothyroid women during pregnancy

      ea0029p1643
    • Vitamin D deficiency is not associated with thyroid autoimmunity

      ea0029p1644
    • Iodine prophylaxis in pregnant women: effects on offspring and the mother's thyroid hormones

      ea0029p1645
    • Low prevalence of postpartum hyperthyroidism in women after radioiodine treatment for Graves' disease before the pregnancy

      ea0029p1646
    • The outcome of radioiodine therapy after five years in patient with non-toxic nodular goitre

      ea0029p1647
    • Langerhans cell histiocytosis of the thyroid and pituitary gland

      ea0029p1648
    • Celiac disease in patients with autoimunne thyroiditis - pilot study

      ea0029p1649
    • Is thyroid volume (TV) in children related to the urinary iodine concentration (UIC) in urine spot sample?

      ea0029p1650
    • Evaluation of health related quality of life and general symptoms in Hashimoto's thyroiditis: are factors other than thyroid function effective? Analysis of preliminary results

      ea0029p1651
    • Proptosis reduction in patients with Graves' orbitopaty (go) at 12 weeks after intravenous steroid therapy is associated to disease inactivation

      ea0029p1652
    • Evaluation of the effect of radioactive iodine treatment on urea breath test

      ea0029p1653
    • Review of a thyrotoxicosis shared-care scheme: treatment choice and outcomes

      ea0029p1654
    • Left-shifted set point of calcium/PTH-relation in patients with Grave's thyrotoxicosis

      ea0029p1655
    • Correlation between thyroid hormone values and carotid intima media thickness in patients with subclinical hypothyroidism

      ea0029p1656
    • miRNA expression of the thyroid after goiter formation and involution using different iodine regimens

      ea0029p1657
    • Autoimmune thyroid disease and cardiovascular risk factors

      ea0029p1658
    • The syndromes of thyroid autoimmunity among patients with antiphospholipid syndrome

      ea0029p1659
    • Anti neutrophil cytoplasmic antibody levels in graves patients using propylthiourasil

      ea0029p1660
    • A rare case of interferon-[alpha]-induced hyperthyroidism in a patient with chronic hepatitis C with granulocytopaenia and transaminasemia treated successfully with radioiodine

      ea0029p1661
    • Elastography in the differential diagnosis of thyroid nodules

      ea0029p1662
    • Assessment of left atrial mechanical function in thyroid dysfunction

      ea0029p1663
    • Prevalence, risk and clinical features of subclinical hyperthyroidism in patients with type 2 diabetes

      ea0029p1664
    • Softgel capsules of levothyroxine in the treatment of patients with gastric disorders: preliminary results

      ea0029p1665
    • Serum thyrotropin, leptin concentrations, thyroid autoimmunity and smoking status, in an euthyroid, iodine-sufficient, Mediterranean population with different body mass index

      ea0029p1666
    • Resistance to thyroid hormone: clinical, biochemical and genetic features of Mediterranean population

      ea0029p1667
    • Diagnosis and therapeutic practices of hyperthyroidism in france. results of a survey on 263 endocrinologists and 1214 patients (the thyrdel study)

      ea0029p1668
    • The impact of TSH on diffusion of thyroglobulin through follicular lumina: possible relation to hormone formation

      ea0029p1669
    • Iodine supply and prevalence of thyroid autoimmunity and autoimmune thyroiditis in children and adolescents between 1 and 16 years old in our city

      ea0029p1670
    • Prevalence of thyroid diseases in a population of non-endocrine tumors in north-east Italy

      ea0029p1671
    • Serum concentrations of thrombospondin-1 and adiponectin in patients with hyperthyroidism before and after normalisation of thyroid function

      ea0029p1672
    • Changes in serum homocysteine, lipid, vitamin B12, folate levels and glomerular filtration rate before and after treatment in overt hypothyroidism

      ea0029p1673
    • Decreased echogenicity and increased vascularization of fetal thyroid on 2D-ultrasonography caused by mother's Graves' disease

      ea0029p1674
    • Measurement of TSH, FT4 and FT3 with immunoassays based on LOCI technology

      ea0029p1675
    • Thyroid function tests in acute kidney injury

      ea0029p1676
    • Spectrum and prevalence of thyroid diseases detected by ultrasonographic examination in west black sea region of Turkey, the MELEN study

      ea0029p1677
    • Optimal timing of thyroxine dose adjustment for treating patients with primary hypothyroidism: what is the estimated time required to reach stable TSH levels?

      ea0029p1678
    • The concept of ultrasonographic thyroid pattern: re-evaluation after 10 years

      ea0029p1679
    • The role of color-flow Doppler ultrasonography for differential diagnosis between gestational transient thyrotoxicosis and Graves' disease

      ea0029p1680
    • The prevalence of hypercreatininemia in patients with primary hypothyroidism

      ea0029p1681
    • Prevalence of thyroid diseases in patients with colon cancer and benign colon polyps

      ea0029p1682
    • 'Racing heart': a case of unrecognized hyperthyroidism presenting as monomorphic ventricular tachycardia

      ea0029p1683
    • A rare case of periodic hypokalaemic paralysis secondary to Graves' thyrotoxicosis

      ea0029p1684
    • Ultrasonographic aspects in post-partum thyroiditis

      ea0029p1685
    • Primary and secondary autoimmune thyroiditis in rheumatoid patients

      ea0029p1686
    • The effect of radio-iodine treatment on Helicobacter pylori eradication

      ea0029p1687
    • Hashimoto's (chronic) thyroiditis in perimenopausal women

      ea0029p1688
    • Hyperglycaemia in hyperthyroidism predictive factors

      ea0029p1689
    • An unusual case of hyperthyroidism

      ea0029p1690
    • Do thyroid hormone levels in critical illness predict outcome? Experience from a medical ICU in north east India

      ea0029p1691
    • Vitamin E and selenium have a protective role in apoptosis induced by H2O2 in human thyrocytes

      ea0029p1692
    • Exophtalmoses due to a bilateral lacrymal gland MALT lymphoma in first occurrence of Graves'disease

      ea0029p1693
    • A correlation study of thyroid nodule cytopathology and histopathology

      ea0029p1694
    • Prevalence of thyroid dysfunction in a subgroup of male patients with HIV

      ea0029p1695
    • Thyroid concentrations and leptin levels in patients with anorexia nervosa

      ea0029p1696
    • Congenital hypothyroidism as a rare cause of precocious puberty

      ea0029p1697
    • Evaluation of subclinical thyroiditis among Egyptian type 1 diabetic patients by Hesham El-Hefnawy, Atef Bassyouni*, Mohamed Abdel-Kareem**, Nibal Abdel-Rahman***, Mary Aziz****And Ibrahim Emara****

      ea0029p1698
    • Significant immune associations in chronic thyroiditis

      ea0029p1699
    • On cohorts (over 1000 patients), there are relationships between antithyroperoxydase antibody levels and thyroid function in chronic thyroiditis

      ea0029p1700
    • How evolves thyroid function in Hashimoto thyroiditis and related disorders

      ea0029p1701
    • Influence of thyroxin replacement therapy on cardiovascular system in patients with primary hypothyroidism and arterial hypertension

      ea0029p1702
    • Psychosis in hyperthyroidism: a case report

      ea0029p1703
    • TSH receptor antibody measurement in the diagnosis and management of Graves disease

      ea0029p1704
    • Life-threatening amiodarone induced thyrotoxicosis: optimizing the treatment and choosing radical therapy according to clinical course: own experience

      ea0029p1705
    • Thyroid hemiagenesis and bilateral parathyroid adenoma

      ea0029p1706
    • Laminin and poly-laminin, a polymeric form of laminin assembled at acidic pH, differentially modulate PCCL3 thyroid cell behavior

      ea0029p1707
    • Steroid-responsive encephalopathy associated with Graves' disease

      ea0029p1708
    • Evaluation of the cytopathologic findings of the thyroid nodules which include macrocalcification

      ea0029p1709
    • Autoimmune and allergic diseases associated with autoimmune thyroid diseases

      ea0029p1710
    • L-Thyroxine therapy and depression in subclinical hypothyroidism

      ea0029p1711
    • 'Too slow for the heart to go': a case of hypothyroidism-induced cardiomyopathy presenting as acute cardiogenic shock

      ea0029p1712
    • Graves' disease and gene polymorphism of TNF-[alpha], IL2, IL6, IL12, and IFN-[gamma]

      ea0029p1713
    • Evaluation of CD4+CD161+CD196+ and CD4+IL17+ Th17 cells in the peripheral blood of young patients with Graves' disease and Hashimoto's thyroiditis

      ea0029p1714
    • Study thyroid function in patients with acromegaly

      ea0029p1715
    • Subclinical hypothyroidism and thyroid autoimmunity during the 1st quarter of pregnancy in oran area

      ea0029p1716
    • Evaluation of hearing and balance functions in patients with Hashimoto's thyroiditis

      ea0029p1717
    • Stessful life events and Graves' disease

      ea0029p1718
    • Thyrotoxic storm: clinical challenges

      ea0029p1719
    • A case of toxic multinoduler goiter coexists in TSH-producing pituitary tumor

      ea0029p1720
    • Pattern of thyroid dysfunction in metabolic syndrome

      ea0029p1721
    • Alteration of clinical characteristics of subacute thyroiditis in last two decades in our hospital

      ea0029p1722
    • Disseminated tuberculosis involving the thyroid: an unlikely scenario

      ea0029p1723
    • Prevalence of goiter and thyroid nodular disease in patients with class III obesity

      ea0029p1724
    • Serum nesfatin-1 levels in overt and subclinical hyperthyroidism

      ea0029p1725
    • Spontaneous splenic rupture following plasmapheresis in a patient with refractory amiodarone-induced thyrotoxicosis

      ea0029p1726
    • Does serum inflammatory and cytokine profile influence graves disease severity at diagnosis?

      ea0029p1727
    • TSH according to age and sex. The future of normality

      ea0029p1728
    • Evaluation of the psychoemotional status of patients after surgical treatment of Graves' disease by catamnesis data

      ea0029p1729
    • Quality of life of patients after surgical treatment of Graves' disease by catamnesis data

      ea0029p1730
    • Thyroid dysfunctions in patients with chronic hepatitis c virus infection with and without interferon therapy

      ea0029p1731
    • Elevated levels of thyroid hormones without TSH suppression in two patients

      ea0029p1732
    • Hyper - and hypothyroidism without symptoms - how much can a patient tolerate ?

      ea0029p1733
    • The influence of chronic stimulation of thyrotropin on nodular thyroid goiter

      ea0029p1734
    • Ischemic stroke without cardiac arrhythmia in a middle age female with thyrotoxicosis

      ea0029p1735
    • Middle age female with long standing multinodular goiter, cardiac arrhythmia and thyroid dysfunction: the endocrinology and cardiology connection

      ea0029p1736
    • Body Mass Index and goiter in school children. Are there any relationship?

      ea0029p1737
    • The concept 'one thyroid specific immune mechanism - a specific thyroid disease'. Pleading for adoption of a new nomenclature for immune thyroid diseases

      ea0029p1738
    • The metabolic syndrome in thyroid disorders

      ea0029p1739
    • The influence of cure of subclinical hyperthyroidism on the level of serum triglycerides and cholesterol fractions

      ea0029p1740
    • Increase of Serum Adiponectin And Stable Concentrations of Matrix Metalloproteinases Confirm Safety of Radioiodine Treatment of Thyrotoxicosis

      ea0029p1741
    • Hyperthyroidism and Pregnancy

      ea0029p1742
    • Histopathological results of patients that were undergone thyroidectomy due to results of repeated non-diagnostic cytology

      ea0029p1743
    • Chlorpyrifos induced alterations in serum electrolytes (calcium, phosphate and magnesium) and endocrine glands (calcitonin cells and parathyroid gland) of Wistar rat

      ea0029p1744
    • Utility of sonographic features and citology obtained by ultrasound-guided fine needle aspiration in preoperative management of thyroid nodules

      ea0029p1745
    • Thyroid disorders and lipid abnormalities: An association between primary hypothyroidism and lipid profile pattern

      ea0029p1746
    • Clinical experience in a high-resolution thyroid nodule clinic

      ea0029p1747
    • Hypothyroxinemia and pregnancy

      ea0029p1748
    • A case of subacute thyroiditis in a patient on Adalimumab for treatment of refractory palmo-plantar pustular psoriasis

      ea0029p1749
  • Thyroid cancer
  • • Indoleamine 2,3-dioxygenase 1 (IDO1) and thyroid carcinoma: Ret/PTC appears as a strong genetic determinant for IDO1 expression

      ea0029p1750
    • Androgen receptor expression in human thyroid cancer tissues: a potential mechanism underlying the gender bias in the incidence of thyroid cancers

      ea0029p1751
    • cAMP analogs as potential therapeutic agents for poorly differentiated thyroid cancer

      ea0029p1752
    • The cross-talk between estrogen receptor and peroxisome proliferator-activated receptor gamma in thyroid cancer cells

      ea0029p1753
    • Thyroid autoimmunity and risk of malignancy in thyroid nodules submitted to fine-needle aspiration cytology

      ea0029p1754
    • The TRHR gene is associated to hypothalamo-pituitary sensitivity to levothyroxine in thyroidectomized patients

      ea0029p1755
    • Role of cAMP analogs in the therapy of medullary thyroid cancer

      ea0029p1756
    • Optimal prophylactic and definitive therapy for bicalutamide induced gynaecomastia: results of meta-analysis

      ea0029p1757
    • BRAFV600E mutation is an indipendent predictive prognostic factor for persistent/recurrent disease in low risk differentiated thyroid cancer patients: a 5 year follow up study

      ea0029p1758
    • Is elevated preoperative TSH level predictive for differentiated thyroid cancer

      ea0029p1759
    • Remarkable enhance in CYP24A1 expression in human thyroid cancer tissue

      ea0029p1760
    • Differential proteomics in human normal or papillary thyroid carcinoma cell cultures

      ea0029p1761
    • Lymphocytic chronic thyroiditis and papillary thyroid carcinoma: relation with prognostic factors

      ea0029p1762
    • Ultrasound-guided fine-needle aspiration biopsy (US-FNAB) of thyroid nodules: effects of the operator's experience on adequacy of sampling: the MoCyThy (Modena's Cytology of the Thyroid) DATABASE

      ea0029p1763
    • Value of repeated US-guided fine-needle aspirations (US-FNAB) in the follow-up of thyroid nodules: the MoCyThy (Modena's Cytology of the Thyroid) DATABASE

      ea0029p1764
    • The Association between thyroid carcinoma and Hashimoto's thyroiditis: is really Hashimoto's thyroiditis increase the risk of thyroid cancer?

      ea0029p1765
    • Clinicopathological characteristics of patients with thyroid papillary microcarcinoma: preliminary results

      ea0029p1766
    • Differentiated carcinoma in dysembriogenetic thyroid lesions

      ea0029p1767
    • Nursing assistance increases the efficiency of ultrasound-guided fine-needle aspiration biopsy (US-FNAB) in the management of thyroid nodules: the MoCyThy (Modena's Cytology of the Thyroid) DATABASE

      ea0029p1768
    • Multiplicity as a prognostic factor of papillary thyroid carcinoma

      ea0029p1769
    • Frequency and predictive factors of malignancy in residual thyroid tissue after partial thyroidectomy for differentiated thyroid cancer

      ea0029p1770
    • Ultrasound (US) features of thyroid nodules with cytology suspicious for malignancy

      ea0029p1771
    • Incidence of ultrasound thyroid scan anomalies in healthy volunteers in modena, italy

      ea0029p1772
    • Surgical treatment of locally advanced thyroid carcinoma with larynx infiltration: case report

      ea0029p1773
    • Role of intensity modulated radiation therapy in patients with non-anaplastic thyroid carcinoma: king fahad medical city experience

      ea0029p1774
    • Urine neopterin levels in differentiated thyroid cancer

      ea0029p1775
    • Hyperthyroidism and thyroid cancer-a prospective study

      ea0029p1776
    • Coexistence of chronic lymphocytic thyroiditis and well differentiated thyroid cancer-a prospective study

      ea0029p1777
    • Thyroid papillary carcinoma, 30 years of experience

      ea0029p1778
    • Thyroid cancer in multinodular toxic goiter: A report of two cases in the philippines

      ea0029p1779
    • CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo

      ea0029p1780
    • PI3K/HIF and ATM signalling in radio-resistance of thyroid-carcinoma: new therapeutic implications?

      ea0029p1781
    • Functional and molecular characterization of cancer stem cells in anaplastic thyroid carcinoma

      ea0029p1782
    • Regulation of hPTTG expression and phosphorylation: autocrine interactions with growth factors in thyroid cells

      ea0029p1783
    • Mass spectrometry allows accurate measurement of serum thyroglobulin (Tg) in the presence of anti-thyroglobulin auto-antibodies (TgAB)

      ea0029p1784
    • Dual specificity phosphatase 5 (DUSP5), a specific negative feedback regulator of ERK signaling, is controlled by serum response factor (SRF) and Elk-1 transcription factors

      ea0029p1785
    • Is thyroid cancer recurrence risk increased after transplantation?

      ea0029p1786
    • Simultaneous occurrence of BRAF mutation and RET/PTC rearrangement is frequent in papillary thyroid carcinoma

      ea0029p1787
    • Immunohistochemical expression of [beta]III-tubulin and cell-cell adhesion proteins in papillary thyroid carcinoma: a preliminary report

      ea0029p1788
    • The occurrence of mutations in the CHEK2 gene in patients with papillary thyroid carcinoma and its impact on the course of the disease and the coexistence of other neoplasms

      ea0029p1789
    • Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography. A systematic review

      ea0029p1790
    • Desmoplastic stromal reaction and extrathyroidal invasion predict lymph node involvement in sporadic macro medullary thyroid cancer

      ea0029p1791
    • Circulating BRAFV600E in the diagnosis and follow up of differentiated thyroid cancer

      ea0029p1792
    • Screening for thyroid diseases in people from former Soviet Union emigrated in USA after Chernobyl accident

      ea0029p1793
    • About the reproducibility of a Thyroglobulin assay

      ea0029p1794
    • Ret somatic mutations are not an early event in the tumoral transformation of sporadic medullary thyroid cancer

      ea0029p1795
    • A proposal of a new clinical, ultrasonographic and cytological scoring system for thyroid nodules: the 'cut' score

      ea0029p1796
    • Papillary thyroid carcinoma with high percentage of BRAFV600E alleles have a higher recurrence rate

      ea0029p1797
    • Sentinel lymph node biopsy in differentiated thyroid carcinoma and decision for selective modified radical neck dissection

      ea0029p1798
    • Therapeutic outcome and prognosis in young patients with papillary and follicular thyroid cancer

      ea0029p1799
    • High prevalence of BRAFV600E mutation in the papillary thyroid carcinomas in Korea by peptide nucleic acid clamp real-time PCR

      ea0029p1800
    • Role of realtime elastography in diagnostic of thyroid cancer

      ea0029p1801
    • Coexistence of multiple lipomatosis and differentiated thyroid cancer: more than a coincidence?

      ea0029p1802
    • Thyroid follicular lesion of undetermined significance - the risk of malignancy in postendemic area

      ea0029p1803
    • TSH levels do not associate with the risk of papillary thyroid microcarcinoma in Korean patients

      ea0029p1804
    • Differentiated thyroid cancer and hemodialysis: Long-term outcomes and safety after radioiodine use.

      ea0029p1805
    • Utility of repeated recombinant human TSH (rhTSH)-stimulated tiroglobulin (Tg) test in patients with differentiated thyroid carcinoma (DTC) without evidence of disease at their initial rh-TSH-stimulation test

      ea0029p1806
    • Epidemiology of refractory thyroid cancer

      ea0029p1807
    • Glucagonlike Peptide-1 Receptor Imaging as diagnostic tool in patients with Medullary Thyroid Carcinoma (MTC) - preliminary report.

      ea0029p1808
    • ARG982CYS is a new variant of the RET proto-oncogene: is it a polymorphism or a transforming mutation?

      ea0029p1809
    • Utility of the perciutaneous ethanol injection (PEI) in the treatment of metastatic adenopathies of thyroid carcinoma

      ea0029p1810
    • Genotype - phenotype correlations and timing of prophylactic thyroidectomy in patients with familial medullary thyroid carcinoma

      ea0029p1811
    • Morphology and metastatic potential of papillary thyroid carcinoma

      ea0029p1812
    • Surgical Management of Primary Thyroid Carcinoma Arising in Thyroglossal Duct Cyst

      ea0029p1813
    • Differentiation of thyroid nodules using Acoustic Radiation Force Impulse Imaging

      ea0029p1814
    • Calcitonin levels in washout of cytology needle on thyroid nodule without suspicion of medullary thyroid carcinoma

      ea0029p1815
    • Thyroid paraganglioma. Report of 3 cases and description of an immunohistochemical profile useful in the differential diagnosis with medullary thyroid carcinoma, based on complementary DNA array results

      ea0029p1816
    • Clinical trial of thyroid RFA for papillary microcarcinomas

      ea0029p1817
    • Intraoperative calcitonin stimulation testing in an individualized surgical strategy of medullary thyroid cancer - primum non nocere

      ea0029p1818
    • Detection of novel genetic changes in the ras genes in papillary thyroid carcinoma

      ea0029p1819
    • Elastosonographical characteristics, cytological results and histopathological features of nodules in patients with hurthle cells

      ea0029p1820
    • Usefulness of selective sentinel lymph node biopsy in determining the surgical approach of papillary thyroid cancer

      ea0029p1821
    • Prevalence of differentiated thyroid cancer is relevant in patiens with familial adenomatous polyposis: a case-control prospective study

      ea0029p1822
    • The role of serum levels of selenium, superoxide dismutase, catalase and thiobarbituric acid reactive substances in the association between Hashimoto's thyroiditis and papillary thyroid cancer

      ea0029p1823
    • Iodine-131 lung uptake in bronchiectasis: a potential pitfall in the follow up of differentiated thyroid carcinoma (DTC)

      ea0029p1824
    • Prognostic markers in Papillary Thyroid Cancer by immunohistochemistry

      ea0029p1825
    • Cytological thyroid: comparison (intra and interobserver) of results issued by pathologists with different skills of experience

      ea0029p1826
    • Follicular Neoplasms: Clinical, Sonographic and Cytological Determinants and its Histological Correlation

      ea0029p1827
    • Ultrasoundelastography: a useful tool to differentiate benign and malignant thyroid nodules?

      ea0029p1828
    • Differentiated Thyroid Cancer in Diabetic Patients

      ea0029p1829
    • Diagnostic value of thyroglobulin and antithyroglobulin antibody in the early follow-up of well differentiated thyroid carcinoma

      ea0029p1830
    • Prostate and bladder metastasis of Medullary Thyroid Carcinoma

      ea0029p1831
    • Role of FGR2 in thyroid tumor progression and their involement in the correlation between thyroid cancer and melanoma

      ea0029p1832
    • Clinical and Pathological Features of Pediatric Thyroid Carcinoma

      ea0029p1833
    • Malignancy rate of thyroid nodules which defined as follicular lesion of undetermined significance in thyroid cytopathology

      ea0029p1834
    • Appearance of secondary primary malignancies in patients with differentiated tumours of the thyroid gland

      ea0029p1835
    • Histological features of thyroid cancer in childhood and adolescence

      ea0029p1836
    • A novel tandem germline RET mutations on the same allele in a patient with MEN 2B

      ea0029p1837
    • Comparative examination of somatic oncogene mutation normal and pathologic thyroid tissues of Hungarian patients

      ea0029p1838
    • Thyroid Metastasis of Clear Cell Renal Carcinoma

      ea0029p1839
    • Diagnostic power of conventional and doppler ultrasound in identifying malignancy in thyroid nodules

      ea0029p1840
    • Malignancy rate of thyroid nodules which defined as atypia of undetermined significance in the thyroid cytopathology

      ea0029p1841
    • Rradioiodine-thyroid cancer link: re-evaluation of Chernobyl consequences

      ea0029p1842
    • Hyperfunctioning thyroid nodule and thyroid cancer

      ea0029p1843
    • Benefits and complications of total thyroidectomy as a surgical treatment for Graves'disease and for thyroid cancer

      ea0029p1844
    • Bilateral adrenal metastases due to follicular thyroid carcinoma: case report and litterature review.

      ea0029p1845
    • Primary Thyroid Lymphoma Diagnosed During Pregnancy: Report of a Case

      ea0029p1846
    • The efficacy of 50mCi versus 100mCi radioactive iodine for thyroid remnant ablation after total thyroidectomy among patients with low stage differentiated thyroid cancer

      ea0029p1847
    • Radioiodine ablation can be avoided in intrathyroidal papillary thyroid cancers [le]2 cm (pT1N0M0)

      ea0029p1848
    • Hurthle cell thyroid carcinoma metastatic to the choroid detected by radioiodine scintigraphy: a case report

      ea0029p1849
    • Features of incidental thyroid carcinoma in Gohierri county.

      ea0029p1850
    • The evaluation of fine needle aspiration biopsy results in thyroid nodules below and above one centimeter diameter

      ea0029p1851
    • Sonographic characteristics of thyroid nodules and the corresponding cytological results from the fine-needle aspiration biopsies

      ea0029p1852
    • Surgery of Papillary Thyroid Carcinoma in Children and Adolescents

      ea0029p1853
    • Diffuse Large B Cell Lymphoma of Thyroid Gland Presenting With Acute Tracheal Compression

      ea0029p1854
    • Papillary thyroid carcinoma with a sollitary central nervous system metastasis

      ea0029p1855
    • Papillary carcinoma in a hyperfunctioning thyroid nodule

      ea0029p1856
    • Concomitant hyperthyroidism and thyroid carcinoma

      ea0029p1857